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Abstract
SOYOUNG KIM : More efficient estimators for case-cohort studies with
univariate and multivariate failure times
(Under the direction of Dr. Jianwen Cai)
Case-cohort study design is generally used to reduce cost in large cohort studies when
the disease rate is low. The case-cohort design consists of a random sample of the entire
cohort, named subcohort, and all the subjects with the disease of interest. When the rate
of disease is not low or the number of cases are not small, the generalized case-cohort
study which selects subset of all cases is used. In this dissertation, we study more efficient
estimators of multiplicative hazards models and additive hazards models for the traditional
case-cohort study as well as the generalized case-cohort study.
We first study more efficient estimators for the traditional case-cohort studies with rare
diseases. When several diseases are of interest, several case-cohort studies are usually con-
ducted using the same subcohort. When these case-cohort data are analyzed, the common
practice is to analyze each disease separately ignoring data collected in subjects with the
other diseases. This is not an efficient use of the data. In this study, we propose more
efficient estimators by using all available information. We consider both joint analysis of
the multiple diseases and separate analysis for each disease. We propose an estimating
equation approach with a new weight function. We establish that the proposed estimator
is consistent and asymptotically normally distributed. Simulation studies show that the
proposed methods using all available information gain efficiency. For comparing the effect
of the exposure on different diseases, tests based on the joint analysis are more powerful
than those based on the separate analysis assuming independence. We apply our proposed
method to the data from the Busselton Health Study.
We extend this approach to the stratified case-cohort design with non-rare diseases.
iii
We also consider the additive hazards regression model for the stratified case-cohort stud-
ies. Additive hazards model is more appropriate when risk difference is of interest. Risk
difference is more relevant to public health because it translates directly into the number
of disease cases that would be avoided by eliminating a particular exposure. We propose
an estimating equation approach for parameter estimation in additive hazards regression
model by making full use of available information. Asymptotic properties of the proposed
estimators were developed and simulation studies were conducted. We apply our proposed
methods to data from the Atherosclerosis Risk in Communities (ARIC) study.
iv
Acknowledgments
I would like to thank my dissertation advisor, Dr. Jianwen Cai for supporting me
during past three years. I have learned the lesson and gained the experience throughout my
dissertation research process. She has set an example of excellence as a researcher, mentor,
instructor, and role model.
I also would like to thank the committee members, Dr. David Couper, Dr. Ka He, Dr.
Wenbin Lu, Dr. Donglin Zeng, and Dr. Haibo Zhou for all of their guidance through this
process.
v
Table of Contents
List of Tables . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . viii
1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
2 Literature review . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3
2.1 Univariate failure time from cohort studies . . . . . . . . . . . . . . . . . . . . 3
2.1.1 The Cox proportional hazards model . . . . . . . . . . . . . . . . . . . 3
2.1.2 Additive hazards model . . . . . . . . . . . . . . . . . . . . . . . . . . . 5
2.2 Multivariate failure time from cohort studies . . . . . . . . . . . . . . . . . . . 6
2.2.1 Multiplicative risk models . . . . . . . . . . . . . . . . . . . . . . . . . . 6
2.2.2 Additive risk models . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10
2.3 Case-cohort studies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11
2.3.1 Case-cohort studies vs nested case-control studies . . . . . . . . . . . . 11
2.3.2 Univariate failure time . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12
2.3.3 Multivariate failure time . . . . . . . . . . . . . . . . . . . . . . . . . . . 18
3 More efficient estimators for case-cohort studies with rare events . . . . 22
3.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22
3.2 Model definitions and assumptions . . . . . . . . . . . . . . . . . . . . . . . . . 23
3.2.1 Estimation for univariate failure time . . . . . . . . . . . . . . . . . . . 24
3.2.2 Estimation for multivariate failure time . . . . . . . . . . . . . . . . . . 25
3.3 Asymptotic properties . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 26
3.3.1 Asymptotic properties of β˜M and Λ˜M0k(β˜M , t) . . . . . . . . . . . . . . 26
vi
3.3.2 Proofs of Theorems . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28
3.4 Simulations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 45
3.5 Data analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 50
3.6 Concluding remarks . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 51
4 Stratified case-cohort studies with nonrare events . . . . . . . . . . . . . . . 53
4.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 53
4.2 Model and estimation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 55
4.2.1 Model . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 55
4.2.2 Estimation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 57
4.3 Asymptotic properties . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 59
4.3.1 Proofs of Theorems . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 63
4.4 Simulations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 91
4.5 Data analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 97
4.6 Concluding Remarks . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 98
5 Additive hazards model for stratified case-cohort design . . . . . . . . . . 101
5.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 101
5.2 Model . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 103
5.2.1 Estimation for univariate failure time . . . . . . . . . . . . . . . . . . . 105
5.2.2 Estimation for multivariate failure time . . . . . . . . . . . . . . . . . . 108
5.3 Asymptotic properties . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 109
5.3.1 Asymptotic properties of β˜IIG and Λ˜
II
0k(β˜IIG , t) . . . . . . . . . . . . . . . 109
5.3.2 Proofs of Theorems . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 111
5.4 Simulations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 129
5.5 Data Analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 136
5.6 Concluding remarks . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 139
6 Summary and Future Research . . . . . . . . . . . . . . . . . . . . . . . . . . . . 140
Bibliography . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 142
vii
List of Tables
3.1 Simulation result for a single disease outcome: β1 = log(2) = 0.693 . . . . . . 47
3.2 Simulation result for multiple disease outcomes: [β1, β2] = [0.1, 0.7] . . . . 48
3.3 Comparison between separate and joint analysis: β1 = log 2, Pr(∆ = 1)=0.2 48
3.4 Type I error and power (%) in separate and joint analyses: Pr(∆ = 1)=0.2 . 49
3.5 Analysis results for the Busselton Health Study . . . . . . . . . . . . . . . . . 51
4.1 Simulation result with a single disease outcome (K = 1): β1 = log(2) = 0.693 93
4.2 Simulation result with multiple disease outcomes (K = 2): β = [0.1, 0.7] . . . 95
4.3 Type I error and power (%) in separate and joint analyses: [η, ν] = [0.7,0.7] 96
4.4 Results for the effect of hs-CRP from the ARIC Study . . . . . . . . . . . . . 98
5.1 Simulation result for the traditional case-cohort study: K = 1, β1 = 0 . . . . . 131
5.2 Simulation result for the generalized case-cohort study: K = 1, β1 = 0 . . . . 132
5.3 Simulation result for the traditional case-cohort study: K = 2, β0 = 0.3 . . . . 133
5.4 Simulation result for the generalized case-cohort study: K = 2, β0 = 0.3 . . . 135
5.5 Analysis results for the effects of PTGS1 G/A+A/A versus G/G (×10−6) . . 138
viii
Chapter 1
Introduction
In large epidemiologic cohort studies, several thousands of subjects are usually followed
for many years and such studies can be expensive. Most of the cost and effort involve the
assembly of the covariate information for all cohort members. However, if the disease is rare,
much of the covariate information on disease free subjects is largely redundant [Prentice,
1986]. In order to reduce the high cost, Prentice [1986] proposed the case-cohort design.
Under the case-cohort study design, the covariate histories are collected only for subjects in
a randomly selected sample, named subcohort, from the entire cohort and all the cases (i.e.
the subjects with the event of interest). In this dissertation, we develop statistical methods
for case-cohort study design with univariate and multivariate failure time data.
One important advantage of the case-cohort study design is that the same subcohort can
be used for studying different diseases, whereas for other designs such as the nested case-
control design, new matching of cases and controls needs to be done for different diseases
[Wacholder et al., 1991; Langholz and Thomas, 1990].
For example, in the Busselton Health Study [Cullen, 1972] two case-cohort studies were
conducted. The purpose of this study is to investigate the effect of serum ferritin on coro-
nary heart disease and stroke, respectively. Serum ferritin was measured on a random
sample of the cohort as well as all subjects with coronary heart disease and/or stroke. The
existing methods do not use the covariate information collected on subjects with stroke
when studying the serum ferritin effect on coronary heart disease and vice versa. This is
not an efficient use of available resources and new statistical methods which use all available
exposure information is needed.
The case-cohort study design was originally proposed to reduce the cost in the cohort
study when the disease of interest is rare. Consequently, the traditional case-cohort sampling
involves all the cases (i.e. the subjects with the event of interest). In recent years, in order
to preserve the raw material collected in the study, case-cohort study design is also used
in situations when the disease is not rare. In such studies, it is not desirable to conduct
the traditional case-cohort studies which collect the expansive covariate information on all
cases. Sampling only a fraction of the cases is more practical [Breslow and Wellner, 2007;
Cai and Zeng, 2007; Kang and Cai, 2009]. Existing methods do not make the full use of
all available information about all diseases from the generalized case-cohort studies and a
correlate of the exposure available for all cohort members. It is desirable to develop new
statistical methods which use all available information.
There are two principal frameworks for modeling risks: the multiplicative and additive
risks model. Much work for the case-cohort studies were on multiplicative risks models
using proportional hazards models. However, the multiplicative risks model is not always
applicable in biomedical studies. Furthermore, the researchers could be interested in the
risk difference attributed to the exposure. The risk difference is more related to public
health since it translates directly into the number of disease cases that would be avoided by
eliminating a particular exposure [Kulich and Lin, 2000b]. Under such situation, the addi-
tive hazards model would be more appropriate. It will be important to develop statistical
methods for the additive hazards model using all available information from case-cohort or
generalized case-cohort studies.
In the next chapter, we will review the relevant literature in these areas.
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Chapter 2
Literature review
In this chapter, we review the literature on statistical methods for both univariate and
multivariate survival data from cohort studies, case-cohort studies, and case-control studies.
The rest of this chapter is organized as follows. We review literature on statistical methods
in cohort studies for univariate failure time in section 2.1 and multivariate failure time
in section 2.2. In section 2.3, we review literature on statistical methods for case-cohort
studies.
2.1 Univariate failure time from cohort studies
In subsection 2.1.1, we first review the Cox proportional hazards model, the most popular
model for survival analysis with a single failure time. We review the literature on survival
analysis for additive hazards models from cohort studies in subsection 2.1.2.
2.1.1 The Cox proportional hazards model
The Cox proportional hazards model [Cox, 1972] is the most commonly used method
in survival analysis to examine the relationship between the effects of covariates and the
failure time. The Cox proportional hazards model specifies the hazard rate for failure time
T for a given covariate vector Z. Specifically, the Cox model is given by
λ{t∣Z} = λ0(t)eβT0 Z(t), (2.1)
where λ0(t) is an unspecified baseline hazard function and β0 is a p-dimensional fixed and
unknown parameter vector.
Let Ti be the failure time, Ci denote the potential censoring time, and Xi = min(Ti,Ci)
denote the observed time for subject i. Let Yi(t) = I(Xi ≥ t) be an at risk indicator and
∆i = I(Ti ≤ Ci) be failure indicator where I(.) is the indicator function for subject i. Let
Ni(t) = I(Xi ≤ t,∆i = 1) denote the observed counting process for failure for subject i.
Suppose that there are n independent subjects and τ denotes the end of study time.
The partial likelihood score function introduced by Cox [1975] is given by
U1(β) = n∑
i=1{Zi(Xi) − S
(1)(β,Xi)
S(0)(β,Xi)}∆i,
or equivalently using counting process form
U2(β) = n∑
i=1∫ τ0 Zi(u)dNi(u) − ∫ τ0 S
(1)(β,u)
S(0)(β,u)dN¯i(u),
where
N¯i(t) = n∑
i=1Ni(t), S(0)(β, t) = n−1
n∑
i=1Yi(t)eβ′Zi(t), S(1)(β, t) = n−1
n∑
i=1Yi(t)Zi(t)eβ′Zi(t).
The regression parameter β can be estimated by solving the score equation U2(β) = 0.
We denote the solution by βˆ. Under some regularity conditions, βˆ has been shown to be
consistent and follow a normal distribution with mean β0 and covariance matrix Σ given by
Σ = ∫ τ
0
v(β0, t)s(0)(β0, t)λ0(t)dt,
where v(β0, t) = s(2)(β0, t)/s(0)(β0, t) − {s(1)(β0, t)/s(0)(β0, t)}⊗2, s(d)(β0, t) =
E[S(d)(β0, t)] for d = 0,1,2, and S(2)(β, t) = n−1∑ni=1 Yi(t)Zi(t)⊗2eβ′Zi(t). The asymptotic
variance Σ can be estimated by Σ̂ = −{∂U2(β)/∂β∣β=βˆ} [Andersen and Gill, 1982].
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2.1.2 Additive hazards model
Another framework commonly used for regression with censored failure time is the addi-
tive hazards model. Much work has been conducted under the assumption of multiplicative
hazards models. However, epidemiologists often are interested in the risk difference. Risk
difference is another measure of association. It is very relevant to public health decisions,
because it translates directly to the expected number of disease cases that would be pre-
vented in the population by removing a certain exposure [Kulich and Lin, 2000b]. When
the risk difference is of interest, the additive hazards model is very useful.
The additive hazards model takes the following form:
λa(t;Z) = λa0(t) + β′a0Z(t), (2.2)
where Z(.) is a p-vector of possibly time-varying covariates, βa0 is a p-vector of regression
parameters, and λa0(t) is an unspecified baseline hazard function. The regression param-
eter of the additive hazards model represents the risk difference for one unit change in
the covariate while adjusting for the other covariates in the model. Lin and Ying [1994]
proposed estimators under model (2.2) and studied the asymptotic properties of the esti-
mators. Mimicking the partial likelihood score function for the proportional hazards model,
the estimating function to estimate βa0 in (2.2) is given by
Ua(β) = n∑
i=1∫ τ0 {Zi(t) − Z¯a(t)}{dNi(t) − Yi(t)β′aZi(t)dt} ,
where Z¯a(t) = ∑nj=1 Yj(t)Zj(t)/∑nj=1 Yj(t). The estimator βˆa is defined as the solution to
U(β) = 0 and takes the explicit form
βˆa = [ n∑
i=1∫ τ0 Yi(t){Zi(t) − Z¯a(t)}⊗2dt]
−1 [ n∑
i=1∫ τ0 {Zi(t) − Z¯a(t)}dNi(t)] .
Under some regularity conditions, Lin and Ying [1994] showed the random vector
n−1/2(βˆa − β0) converges weakly to a p-variate normal distribution with mean zero and
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with a covariance matrix which can be consistently estimated by A−1BA−1, where
A = n−1 n∑
i=1∫ τ0 Yi(t) {Zi(t) − Z¯a(t)}⊗2 dt and B = n−1
n∑
i=1∫ τ0 {Zi(t) − Z¯a(t)}⊗2 dNi(t).
Lin and Ying [1994] also proposed the estimator for the baseline cumulative hazard function:
Λˆa0(βˆa, t) = ∫ t
0
∑ni=1{dNi(u) − Yi(u)βˆ′aZi(u)du}∑nj=1 Yj(t) .
They also showed that n1/2{Λˆa0(βˆ, .) − Λ0(.)} converges weakly to a zero-mean Gaussian
process whose covariance function at (t, s)(t ≥ s) can be consistently estimated by
∫ s
0
n∑ni=1 dNi(u){∑nj=1 Yj(u)}2 +C ′(t)A−1BA−1C(s) −C ′(t)A−1D(s) −C ′(s)A−1D(t),
where C(t) = ∫ t0 Z¯a(u)du and D(t) = ∫ t0 ∑ni=1{Zi(u)−Z¯a(u)}dNi(u)∑nj=1 Yj(u) .
2.2 Multivariate failure time from cohort studies
In section 2.2, we review the literature on survival analysis for multivariate failure time
data. Several approaches dealing with multiple failure times or recurrent event data have
been proposed. We review literature on statistical methods for multiplicative hazards mod-
els in subsection 2.2.1 and additive hazards models in subsection 2.2.2.
2.2.1 Multiplicative risk models
There are in general two types of commonly used models dealing with correlated failure
times: 1) marginal models, 2) frailty models. The marginal model approach does not
specify the form of the dependence among correlated failure times while the frailty model
approach formulates the exact nature of dependence among correlated failure times through
an unobservable random variable.
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Marginal models
Several authors have studied marginal models. Wei et al. [1989] proposed semiparametric
methods for each marginal distribution of failure times with Cox-type proportional hazards
form.
Let Zik(t) = (Zi1k(t), . . . , Zipk(t))′ be the covariate vector for the ith subject and the
kth failure type and βk = (β1k, . . . , βpk)′ be the failure-specific regression parameter. Under
the failure-specific model, the hazard function for the ith subject and the kth failure type
is given by
λk{t∣Zik(t)} = λ0k(t)eβkZik(t), (2.3)
where λ0k(t) is an unspecified baseline hazard function for k = 1, . . . ,K.
The kth failure-specific partial likelihood function [Cox, 1972, 1975] is
Lk(βk) = n∏
i=1 [ exp{β
′
kZik(Xik)}∑l∈Rk(Xik) exp{β′kZlk(Xik)}]
∆ik
,
whereRk(t) = {l ∶Xlk ≥ t} is the set of subjects at risk just prior to time t with respect to the
kth type of failure. The maximum partial likelihood estimator βˆk is defined as the solution
to the partial likelihood equation ∂ logLk(βk)/∂βk = 0 and they are generally correlated.
Under some regularity conditions, it is shown that βˆk is a consistent estimator for βk and
n1/2(βˆ′1 −β′1, . . . , βˆ′K −β′K) converges in distribution to a zero-mean normal random vector
with covariance matrix Q where
Q =
⎡⎢⎢⎢⎢⎢⎢⎢⎢⎢⎣
H11(β1, β1) ⋯ H1K(β1, βK)⋮ ⋮
HK1(βK , β1) ⋯ HKK(βK , βK)
⎤⎥⎥⎥⎥⎥⎥⎥⎥⎥⎦
,
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with
Hkl(βk, βl) = A−1k (βk)E{w1k(βk)w1l(βl)′}A−1l (βl),
Ak(βk) = ∫ τ
0
vk(βk, t)s(0)k (βk, t)λ0k(t)dt,
vk(β, t) = s(2)k (β, t)/s(0)k (β, t) − {s(1)k (βk, t)/s(0)k (βk, t)}⊗2,
s
(d)
k (β, t) = E[Y1k(t)Z1k(t)⊗d exp{β′Z1k(t)}],
wik(βk) = ∫ ∞
0
{Zik(t) − s(1)k (βk, t)/s(0)k (βk, t)}dMik(t), and
Mik(t) = Nik(t) − ∫ t
0
Yik(t)λik(u)du.
Spiekerman and Lin [1998] and Clegg et al. [1999] extended the models proposed by
Wei et al. [1989] to formulate the general form by allowing for exchangeable failure time
of each distinct failure type in the cluster. Suppose that there are J clusters, K distinct
failure types, each of which consists of L exchangeable failure times. Let Tjkl denote the
failure time and Cjkl the censoring time, and Xjkl = min (Tjkl,Cjkl) the observed time for
component l of disease k in cluster j. Let Yjkl(t) = I(Xjkl ≥ t) be an at risk indicator,
∆jkl = I(Tjkl ≤ Cjkl) be failure indicator where I(.) is the indicator function and Njkl(t) =
I(Xjkl ≤ t,∆jkl = 1) be the observed counting process for failure for component l of disease
k in cluster j. Specifically, the following model for the lth component of the kth type of
failure is considered:
λkl{t∣Zkl(t)} = λ0k(t)eβT0 Zkl(t),
where λ0k(t)(k = 1, . . . ,K) are unspecified baseline hazard functions.
The pseudo-partial score function is given by
USL(β) = J∑
j=1
K∑
k=1
L∑
l=1∫ τ0 {Zjkl(u) − S
(1)
k (β,u)
S
(0)
k (β,u)}dNjkl(u),
where Zjkl is the covariate vector for the lth component of the kth failure type in the jth
cluster and S
(d)
k (β, t) = J−1∑Jj=1∑Ll=1 Yjkl(t)Zjkl(t)⊗deβ′Zjkl(t) d = 0,1.
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The maximum pseudo-partial-likelihood estimator βˆSL for β0 is defined as the solu-
tion to USL(β) = 0 and n1/2(βˆSL − β0) is shown to converge weakly to a p-variate nor-
mal vector with mean 0 and covariance matrix Ω = A−1BSLA−1 where A = ∑Kk=1Ak and
BSL = E[∫ τ0 {Zjkl(u) − S(1)k (β0,u)S(0)
k
(β0,u)}dMjkl(u)]⊗2. In addition, Spiekerman and Lin [1998]
showed the uniform convergence and joint weak convergence of the Aalen-Breslow type
estimators for the cumulative baseline hazard functions Λˆ0k(t, β) where
Λˆ0k(t, βˆ) = ∫ t
0
dN.k.(u)
nS
(0)
k (βˆ, u) .
Frailty models
Marginal model approaches are appropriate when the main interest is to estimate the
effects of risk factors while the correlation among failure times is considered as a nuisance.
However, when the correlation among failure times is of interest, an alternative approach
is needed. Frailty models have been proposed under such situation. Frailty model specifies
the intra-subject correlation explicitly through an unobservable random variable (frailty).
Specifically, the failure times given the frailty are assumed independent and the conditional
hazard given the frailty Wi is assumed to follow the following model:
λik(t∣Wi) =Wiλ0(t) exp{βT0 Zik(t)},
where Wi, i = 1, . . . , n, are assumed to be independent and follow a probability distribution
is often assumed for the frailty distribution. Other distributions such as the positive stable
distribution, the inverse Gaussian distribution, or the log-normal distribution have also been
proposed.
Frailty models have been studied by many authors. In approaches for nonparametric
maximum likelihood, Klein [1992] proposed the estimation of the frailty by using an EM
algorithm based on a partial likelihood. As an alternative of a partial likelihood, a penal-
ized likelihood procedure is used by Therneau and Grambsch [2000] who showed an exact
connection between the shared gamma frailty model and a penalized likelihood procedure.
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Ripatti and Palmgren [2000] generalized the results of Therneau and Grambsch [2000] by as-
suming the frailties from a log-normal distribution and thus they got a flexible specification
of variance components which can explain negative dependencies.
2.2.2 Additive risk models
The previous subsection discussed multiplicative hazards models. In this subsection, we
will review additive hazards models with multivariate failure time data from cohort studies.
When all the failure times are independent, several authors have studied additive hazards
models from cohort studies. Martinussen and Scheike [2002] and Lin et al. [1998] has applied
the additive hazards model to interval censored data. Moreover, the additive hazards model
has been applied to measurement error problems by Kulich and Lin [2000b], to frailty models
by Lin and Ying [1997], and to cumulative incidence rates by Shen and Cheng [1999].
For correlated or clustered data, marginal additive hazards models are proposed by Yin
and Cai [2004]. They proposed the additive hazards model
Λjki(t;Zjki) = λ0k(t) + β′0kZikl(t),
where Zjki(t) is a possibly time-varying covariate vector for failure type k of subject i in
cluster j. An estimating function for β0k is
UAk (β) = J∑
j=1
n∑
i=1∫ τ0 {Zjki(t) − Z¯Ak (t)}{dNjki(t) − Yjki(t)β′Zjki(t)dt} ,
where Z¯Ak (t) = ∑Jj=1∑ni=1 Yjki(t)Zjki(t)∑Jj=1∑ni=1 Yjki(t) . The estimator βˆAk is defined as the solution to UAk (β) =
0, which is given by
βˆAk = ⎡⎢⎢⎢⎢⎣
J∑
j=1
n∑
i=1∫ τ0 Yjki(t){Zjki(t) − Z¯Ak (t)}⊗2dt
⎤⎥⎥⎥⎥⎦
−1 ⎡⎢⎢⎢⎢⎣
J∑
j=1
n∑
i=1∫ τ0 {Zjki(t) − Z¯Ak (t)}dNjki(t)
⎤⎥⎥⎥⎥⎦ .
Under some regularity conditions, n1/2(βˆA′1 − β′01, . . . , βˆA′K − β′0K)′ was shown to converge in
distribution to a zero-mean (p ×K)-dimensional normal random vector with a covariance
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vector DAjk(β′0j , β′0k) = A−1j E[UA1j(β0j)UA1k(β0k)] A−1j where Aj = E[∑Ll=1 ∫ τ0 Y1jl(t){Z1jl(t)−
Z¯j(t)}⊗2dt]. Under the working independence assumption, the baseline cumulative hazard
function for failure type k can be estimated by
ΛˆA0k(t; βˆk) = ∫ τ
0
∑Jj=1∑ni=1{dNjki(u) − Yjki(u)βˆA′k Zjki(u)du}∑Jj=1∑ni=1 Yjki(u) .
Under some regularity conditions, as n → ∞, n1/2[{ΛˆA01(t) − Λ01(t)}, . . . ,{ΛˆA0K(t) −
Λ0K(t)}] was shown to converge weakly to a zero-mean Gaussian random field. For a
specific subject with the covariate vector Z0(t), the cumulative hazard function can be es-
timated by ΛˆA(t; βˆAk , Z0) = ΛˆA0k(t; βˆAk ) + ∫ t0 βˆA′k Z0(u)du. To ensure monotonicity, a minor
modification was made, i.e. Λˆ∗0k(t) = maxs≤t ΛˆA0k(s) for k = 1, . . . ,K. By similar arguments
as in Lin and Ying [1994], it can be shown that Λˆ∗0k(t) and ΛˆA0k(t) are asymptotically
equivalent.
Pipper and Martinusse [2004] also considered marginal additive hazards models for clus-
tered data. By using Lin and Ying [1994]’s estimators, they provided estimating equations
for the regression parameters and association parameters for marginal additive hazards
models. Further, Yin [2007] developed a test for checking the additive structure using clus-
tered data. By relaxing the linear assumption about covariate effects, Zeng and Cai [2010]
proposed a general class of additive transformation risk models for clustered failure time
data.
2.3 Case-cohort studies
2.3.1 Case-cohort studies vs nested case-control studies
In large epidemiologic cohort studies, several thousands of subjects are followed and
thus such studies can be expensive. To reduce the cost in large cohort studies, several study
designs have been proposed. Among different sampling schemes, nested case-control study
design and case-cohort study design are widely used when the disease rate is low. In this
subsection, we will review the literature on nested case-control study design and case-cohort
study design.
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Thomas [1977] originally suggested nested case-control study design which involves se-
lection of a number of controls from those at risk at the failure time of each case. Prentice
and Breslow [1978] further developed the conceptual foundations of the nested case-control
design by deriving the conditional likelihood. However, there are some limitations in the
nested case-control studies: inefficiency for the alignment of each selected control subject
to its matched case and a strict application which involves the selection of a new set of
controls for each distinct disease category.
To address the problems, case-cohort study design was proposed by Prentice [1986] as
an alternative to the nested case-control study design. Case-cohort study design involves
selection of a random sample, named subcohort, and all cases. The subcohort constitutes
the comparison set of cases occurring at a range of failure times. The subcohort also provides
a basis for covariate monitoring during the course of cohort follow-up [Prentice, 1986].
Langholz and Thomas [1990] compared case-cohort studies with nested case-control
studies. They showed that the nested case-control approach is better than the case-cohort
study if there is moderate random censoring or staggered entry. It also has been shown
that case-cohort study design for a single disease outcome has higher efficiency than nested
case-control study design; however, the difference is very small. Compared to the nested
case-control studies, a major advantage of the case-cohort design is the ability to study
several disease outcomes using the same subcohort.
We will review the literature for case-cohort studies with univariate failure time in
subsection 2.3.2 and multivariate failure time in subsection 2.3.3.
2.3.2 Univariate failure time
Prentice [1986] proposed a case-cohort design and established asymptotic properties of
their proposed estimators. He considered a relative risk regression model [Cox, 1972]:
λ{t∣Z(u),0 ≤ u < t} = λ0(t)r{β′0Zi(t)}, (2.4)
where r(x) is a fixed function with r(0) = 1, β0 is a p-vector of regression parameters, and
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λ0(t) is a baseline hazard function.
Prentice [1986] proposed the pseudolikelihood function for estimation of the relative risk
parameter β0 in case-cohort studies given by
L̃(β) = n∏
i=1
⎛⎜⎝rii/ ∑l∈R˜(ti) rli
⎞⎟⎠
∆i
where rli = Yl(ti)r{β′0Zl(ti)}, R˜(ti) = F (t) ∪ C˜, F (t) = {i∣Ni(t) ≠ Ni(t−)}, and C˜ is a
random subcohort.
The maximum pseudolikelihood estimator β˜CC is defined as a solution to UCC(β˜) = 0
where
UCC(β) = ∂ log L̃(β)
∂β
= n∑
i=1Ui(β) =
n∑
i=1 ∆i
⎛⎜⎝cii − ∑l∈R˜(ti) bli/ ∑l∈R˜(ti) rli
⎞⎟⎠ ,
bli = Yl(ti)Zl(ti)r′{βTZl(ti)}, cli = blir−1{βTZl(ti)}, and r′(u) = dr(u)/du. Under some
regularity conditions, Prentice [1986] reasoned that n−1/2UCC(β) converge weakly to a nor-
mal variate with mean zero and variance matrix A and that n1/2(β˜CC − β0) converges in
distribution to a normal variate with mean zero and variance matrix S = Ω−1AΩ−1 which
can be estimated by nI(β˜)−1V˜ (β˜)I(β˜)−1 where
I(β) = −∂2 log L̃(β)
∂β∂βT
,
V˜ (β) = n∑
j=1 ∆j{vjj + 2δ(tj) ∑{k∣tk<tj}∆kvkj},
vkj = −∑(Bk + bjk − bik
Rk + rjk − rik )
′ (cij − Bj
Rj
) rijR−1j ,
Rj = ∑
l∈R˜(tj) rlj , Bj = ∑l∈R˜(tj) blj , δ(t) = 0 if C˜ = R˜(t) and 1 otherwise.
An estimator of the baseline cumulative failure rate function Λ0(t) = ∫ t0 λ0(u)du is
Λˆ0(t) = n˜n−1∫ t
0
[ n∑
i=1Yi(u)r{β′Zi(u)}]−1dN¯(u)
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where N¯(t) = ∑ni=1Ni(t).
Self and Prentice [1988] proposed a slightly different estimator from Prentice [1986].
While the “comparison risk set” of Self and Prentice [1988] at time t included only all sub-
cohort members at risk at time t, Prentice [1986] added any subjects out of subcohort but
who were observed to fail at time t. Self and Prentice [1988] established asymptotic dis-
tribution theory for the pseudolikelihood estimators along with that for the corresponding
cumulative failure rate estimators by using a combination of martingale and finite pop-
ulation convergence results. Specifically, they considered the maximum pseudolikelihood
estimator β˜SP , defined as a solution to ∂ logL(β˜)/∂β = 0, where
log L̃(β) = n∑
i=1∫ τ0 log r{β′Zi(t)}dNi(t) − ∫ τ0 log[∑i∈C˜ Yl(t)r{β′Zi(t)}]dN¯(t),
and C˜ is a random subcohort of size n˜. They also considered a natural estimator of the
cumulative baseline hazard function which is given by
Λ˜SP (t) = n˜n−1∫ t
0
[∑
i∈C˜ Yi(u)r{β˜′SPZi(u)}]−1dN¯(u).
Under some regularity conditions, they showed that β˜SP is a consistent estimator of β0 and
n−1/2U˜(β0) converges in distribution to zero mean Gaussian process with covariance matrix
Σ(β0) +A(β0) where Σ(β) = − limn→∞ n−1∂2 log L̃(β)/∂β2 is the variation associated with
the cohort and A(β) corresponds to the variation introduced by sampling the subcohort.
Therefore, n−1/2(β˜SP − β0) was shown to converge in distribution to a zero-mean Gaussian
random variable with covariance matrix Σ−1(β0) + Σ−1(β0)A(β0)Σ−1(β0) by Taylor series
expansions. Moreover, n−1/2(β˜SP −β0) and n−1/2(Λ˜SP −Λ0) were shown to converge weakly
and jointly to Gaussian random variables with mean zero. They also proposed the estimator
of the limiting covariance matrix between n−1/2{Λ˜SP (u)−Λ0(u)} and n−1/2{Λ˜SP (t)−Λ0(t)}.
Self and Prentice [1988] showed that Prentice [1986]’s estimator β˜ and their estimator
β˜SP are asymptotically equivalent by showing that an individual’s contributions to S
(1)
and S(0) are asymptotically negligible. Even though Prentice [1986]’s variance estimator
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is somewhat different from Self and Prentice [1988]’s one, two estimators converge to the
same form asymptotically.
Alternative variance estimators which can be computed easily using the existing software
are proposed since the variance estimators by Prentice [1986] and Self and Prentice [1988]
are complicated. Wacholder et al. [1989] developed bootstrap variance estimates. Barlow
[1994] proposed a robust estimator of the variance. By using time-varying weights, he
proposed a pseudolikelihood function which are different from those of Prentice [1986] and
Self and Prentice [1988]. The weight wi(t) of subject i at time t is defined as
wi(t) =
⎧⎪⎪⎪⎪⎪⎪⎪⎪⎨⎪⎪⎪⎪⎪⎪⎪⎪⎩
1 ifdNi(t) = 1
m(t)/m˜(t) if dNi(t) = 0 and i ∈ C˜
0 if dNi(t) = 0 and i /∈ C˜.
⎫⎪⎪⎪⎪⎪⎪⎪⎪⎬⎪⎪⎪⎪⎪⎪⎪⎪⎭
where m(t) is the number of disease-free individuals in the cohort at risk at time t and m˜(t)
is the number of disease-free individuals in subcohort at risk at time t. The conditional
probability of failure at failure time tj is given by
pi(tj) = Yi(tj)wi(tj)ri(tj)∑nk=1 Yk(tj)wk(tj)rk(tj) ,
where ri(t) = exp{βT0 Zi(t)}. Prentice [1986]’s likelihood used an indicator function as a
weight, i.e., wi(t) = 1 if dNi(t) = 1 or i ∈ C˜, otherwise the weight is zero. Whereas Self
and Prentice [1988]’s likelihood used a denominator summed over subcohort members only,
Barlow [1994]’s pseudolikelihood preserved the correct expectation for the denominator at
each failure time.
The estimator βˆB proposed by Barlow [1994] is defined as the solution to the estimating
equation defined by the derivative of the logarithm of the pseudolikelihood ∑t∑i dNi(t)
log(pi(t)). The robust variance estimator using infinitesimal jackknife estimator is
ˆV ar(βˆB) = I−1(βˆB)Vˆ (βˆB)I−1(βˆB) = 1
n
∑
i
eˆieˆi,
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where eˆi = βˆ− βˆ−i and βˆ−i is an estimate of β without observation i. Barlow [1994] proposed
to estimate eˆi by I
−1(βˆ)cˆi(τ) where I(βˆB) = ∑t∑i pˆi(t)[zi(t) − Eˆ(t)][zi(t) − Eˆ(t)]′ is the
information matrix, Eˆ(t) = ∑nk=1 pˆi(t)Zi(t) is the estimator for the conditional expectation
of the covariate at time t, and cˆi(τ) = ∫ τ0 Yi(t)[dNi(t) − pˆi(t)][zi(t) − Eˆ(t)]dN¯(t) is the
estimated influence of an individual observation on the overall score for subject i at time τ .
Stratified case-cohort studies were discussed in Prentice [1986]. Borgan et al. [2000]
developed methods for analysis of such exposure stratified case-cohort samples. Suppose
that the baseline data are available for the full cohort and can be partitioned into Q strata.
A stratified relative risk regression model is considered:
λq{t∣Z(t)} = λ0q(t)r{βTq Z(t)}, q = 1, . . . ,Q.
A pseudolikelihood function for β over strata is
L˜q(β) =∏
tj
⎛⎝ exp{β′Zij(tj)}wij(tj)∑k∈R˜(tj) Yk(tj) exp{β′Zk(tj)}wk(tj)⎞⎠ ,
where tj is failure time, R˜(tj) is case-cohort set, and wij(tj) is weight for the case ij at
time tj . They proposed three types of estimators for the stratified case-cohort design:
I ∶ R˜(tj) = C˜,wk(tj) = ns(k)/ms(k),
II ∶ R˜(tj) = C˜ ∪ F,wk(tj) = n0s(k)/m0s(k) if k ∈ C˜/F,wk(tj) = 1 if k ∈ F,
III ∶ wk(tj) = ns(k)/ms(k), R˜(tj) = C˜ if ij ∈ C˜, R˜(tj) = C˜ ∪ ij/{Js(ij)} if ij /∈ C˜,
where C˜ is the subcohort set, F is a set of all cases, nl and ml are the number of subjects
in the cohort and subcohort in stratum l, respectively, n0l and m
0
l are the number of cases
in the cohort and subcohort in stratum l, respectively, and s(k) is the sampling stratum of
individual k. If the case occurs outside the subcohort, subcohort member Js(ij) swaps place
with the case so that the case ij is inside R˜(tj) while the “swapper” Js(ij) is removed from
this set. They showed that all of the proposed analysis methods were more efficient than
a randomly sampled case-cohort study. Breslow and Wellner [2007] generalized asymptotic
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results of Borgan et al. [2000] by using weighted likelihood estimation in two-phase stratified
sample.
Chen [2001b] proposed a unified approach which includes 1) nested case-control sam-
pling, 2) case-cohort sampling, and 3) classical case-control designs and allow the presence
of staggered entry. The estimating equation to cover three samplings is given by
UCh(β) = n∑
i=1∫ τ0 [Zi(t) − ∑
n
j=1wijZj(t) exp{β′Zj(t)}Yj(t)∑nj=1wij exp{β′Zj(t)}Yj(t) ]dNi(t),
where wij is a weight function for the respective design. They also developed the weight
function based on estimating each missing covariate by a local average. Samuelsen et al.
[2007] extended the class of designs proposed by Chen [2001b] to accommodate stratified
designs.
All work that we discussed in this subsection so far was about proportional hazards mod-
els for case-cohort studies. Other type of models have also been studied. The accelerated
failure time model and the proportional odds regression model for case-cohort are proposed
[Kong and Cai, 2009; Chen, 2001a]. Kulich and Lin [2000a] applied additive hazards mod-
els to case-cohort studies. The model they considered is in the same form as (2.2). The
subcohort can be selected by Bernoulli sampling with arbitrary selection probabilities or
by stratified simple random sampling. Using Bernoulli sampling, they proposed a weighted
estimating function:
UH(β) = n∑
i=1ρi∫ τ0 {Zi(t) − Z¯H(t)}{dNi(t) − Yi(t)βTZi(t)dt} ,
where Z¯H(t) = ∑nj=1 ρjYj(t)Zj(t)∑nj=1 ρjYj(t) and the weight function ρi has the following form: ρi =
∆i + (1 −∆i)ξiαˆ−1, and αˆ = ∑ni=1 ξi(1 −∆i)/∑ni=1(1 −∆i). The estimator βˆH is defined as a
solution to UH(β) = 0. An estimator for the cumulative baseline hazard function Λ0(t) is
Λˆ0H(t) = ∫ τ
0
∑ni=1 dNi(u)∑nj=1 ρjYj(u) − ∫ τ0 βˆHZ¯H(u)du.
Under some regularity conditions, n1/2(βˆH − β0) was shown to converge in distribution
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to a zero-mean normal random vector with covariance matrix D−1A (ΣA + ΣH)D−1A , where
DA = E [∫ τ0 {Z1(t)−e(t)}⊗2Y1(t)dt], ΣA(β) = E [∫ τ0 {Z1(t)−e(t)}⊗2dN1(t)], ΣH(β) = E{(1−
α˜)α˜−1(1 − ∆1)[∫ τ0 {Z1(t) − e(t)}dM1(t)]⊗2}, e(t) = E{Z1(t)Y1(t)}/E{Y1(t)}, and Mi(t) =
Ni(t) − ∫ t0 Yi(s)sΛ0(s) − ∫ t0 βT0 Zi(s)Yi(s)ds. They also showed that n1/2(Λˆ0H(t) −Λ0H(t))
converges weakly on [0, τ] to a zero-mean Gaussian process whose covariance function at(s, t) is
hT (s)D−1A (ΣA +ΣH)D−1A h(t) +R1(s, t) − hT (s)D−1A R2(t) − hT (t)D−1A R2(s),
whereR1(s, t) = E[{∆1+(1−∆1)/α˜} ∫ s0 pi−10 (u)dM1(u) ∫ t0 pi−10 (v)dM1(v)], R2(t) = E[∫ t0 {Z1(u)−
e(u)}pi−10 (u)dN1(u)], h(t) = ∫ t0 e(u)du, and pi0(u) = Pr(X1 ≥ t).
2.3.3 Multivariate failure time
Clustered failure time and multiple outcomes have been studied for the case-cohort
design. In this subsection, we will review the related literature.
Lu and Shih [2006] considered the clustered failure time data. Conventional case-cohort
studies for univariate failure time data cannot be directly applied to clustered failure time
data since failure times within a cluster are correlated. Lu and Shih [2006] considered
marginal proportional hazards model (2.4). Suppose there are J independent clusters, and
each cluster contains n correlated subjects. The estimating function proposed by Lu and
Shih [2006] is given by
ULS(β) = J∑
j=1
n∑
i=1∫ τ0 [Zji(t) −ELS(β, t)dNji(t)] ,
where ELS(β, t) = S(1)LS (β, t)/S(0)LS (β, t), S(d)LS (β, t) = J−1∑Jj ∑ni=1HjHjiYji(t)e{βTZji(t)}×Zji(t)⊗d, Hj indicates whether or not cluster j is selected into the subcohort, and Hji is the
indicator for subject (j, i) being sampled as a potential individual in the subcohort. β˜LS can
be estimated by solving ULS(β) = 0. Under some regularity conditions, β˜LS was shown to be
a consistent estimator of β0. They showed that n
1/2(β˜LS −β0) converges in distribution to a
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normal distribution with mean zero and with covariance matrix A−1LS(β0)ΩLS(β0)A−1LS(β0)
where ΩLS(β) consists of the variations associated with the cohort and subcohort sampling
and ALS(β) = − limJ→∞ ∂ULS(β)/∂β.
Zhang et al. [2011] extended Lu and Shih [2006]’s method by proposing Bernoulli sam-
pling and using different risk sets. Since information on all failures in the full cohort is
available, failures outside the subcohort can also contribute to the risk set for independent
subjects. Thus, they constructed the risk sets using the information in the subcohort as
well as the information collected on future deaths whereas Lu and Shih [2006] used only
subcohort subjects to construct the risk set.
Kang and Cai [2009] considered case-cohort studies with multiple disease outcomes. The
marginal hazards function [Cox, 1972] is assumed to follow the model:
λik{t∣Zik(t)} = Yik(t)λ0k(t)eβT0 Zik(t),
where λ0k(t) is an unspecified baseline hazard function for disease outcome k. The pseudo-
partial likelihood score equation proposed by Kang and Cai [2009] is given by
ÛKC(β) = n∑
i=1
K∑
k=1∫ τ0 {Zik(t) − Ŝ
(1)
k (β, t)
Ŝ
(0)
k (β, t)}dNik(t),
where Ŝ
(d)
k (β, t) = n−1∑ni=1 ρik(t)Yik(t)Z⊗dik (t)eβTZik(t) for d = 0,1 and 2, ρik(t) = ∆ik + (1−
∆ik)ξiαˆ−1k (t), and αˆk(t) = ∑ni=1(1−∆ik)ξiYik(t)/{∑ni=1(1−∆ik)Yik(t)}. Moreover, Kang and
Cai [2009] proposed a weighted estimating equation approach for estimating the parameters
in the marginal hazards regression models for the multivariate failure time data from the
generalized case-cohort study with multiple disease outcomes. The weighted estimating
function follows as
ŨKC(β) = n∑
i=1
K∑
k=1∫ τ0 wik(t){Zik(t) − S̃
(1)
k (β, t)
S̃
(0)
k (β, t)}dNik(t),
where S̃
(d)
k (β, t) = n−1∑ni=1wik(t)Yik(t)Z⊗dik (t)eβTZik(t) for d = 0,1 and 2 , wik(t) = (1 −
∆ik)ξiαˆ−1k (t) + ∆ikξi + ∆ik(1 − ξi)ηikqˆ−1k (t), qˆk(t) = ∑ni=1 ∆ik(1 − ξi)ηikYik(t)/{∑ni=1 ∆ik(1 −
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ξi)Yik(t)}, ηik is an indicator for subject i outside the subcohort by random sampling. The
estimator β˜KC is defined as solution to the equations ŨKC(β) = 0. A Breslow-Aalen-type
estimator of the baseline cumulative hazard function is Λ˜0k(β˜KC , t), where
Λ˜0k(β, t) = ∫ t
0
∑ni=1wik(u)dNik(u)
nS˜
(0)
k (β,u)
Under some regularity conditions, they showed that β˜KC is a consistent estimator of β0 and
n1/2(β˜KC − β0) is asymptotically normally distributed with mean zero and with variance
matrix in the form
ΣKC(β0) = A(β0)−1 {Q(β0) + 1 − α
α
V1(β0) + (1 − α) K∑
k=1pr(∆1k = 1)(1 − qkqk )V2k(β0)}A(β0)−1,
where
A(β) = K∑
k=1∫ τ0 vk(β, t)s(0)k (β, t)λ0k(t)dt,Q(β) = E{
K∑
k=1MZ˜,1k(β)}⊗2,
V1(β) = var ( K∑
k=1(1 −∆1k)∫ t0 [R1k(β, t) − Y1k(t)E{(1 −∆1k)R1k(β, t)}E{(1 −∆1k)Y1k(β, t)} dΛ0k(t)]) ,
V2k(β) = var [dMZ˜,1k(β) − ∫ t
0
Y1k(t)E{dMZ˜,1k(β)∣∆1k = 1, ξ1 = 0}
E{Y1k(t)∣∆1k = 1} ] ,
Z˜ik(β, t) = Zik(t) − ek(β, t),MZ˜,ik(β) = ∫ τ
0
Z˜ik(β, t)dMik(t),
Rik(β, t) = Yik(t)Z˜ik(β, t)eβTZik(t).
Competing risks have also been considered for case-cohort studies with multiple dis-
eases. Sorensen and Andersen [2000] studied competing risks models for case-cohort studies
assuming proportional hazards models and considered correlation between estimated effects
of exposures on the different outcomes due to re-use of the same subcohort. By studying
competing risks data for case-cohort studies, the asymptotic correlation was established.
Despite progress of case-cohort studies for proportional hazards models with multiple
diseases outcomes, additive hazards models for the case-cohort design with multiple diseases
have been limited. The only reference is by Sun et al. [2004] which extended Kulich and Lin
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[2000a]’s method to competing risks analysis for the additive hazards model. Further study
on the additive hazards models for the case-cohort design with multiple diseases outcomes
is needed.
In this dissertation, we will study the following three topics: (1) more efficient estimators
for case-cohort studies, (2) Generalized case-cohort studies with multiple events, and (3)
Additive hazards models for traditional and generalized case-cohort studies. The proposal
is presented in the next chapter.
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Chapter 3
More efficient estimators for case-cohort
studies with rare events
3.1 Introduction
For large epidemiologic cohort studies, assembling some types of covariate information,
e.g. measuring genetic information or chemical exposures from stored blood samples, for all
cohort members may entail enormous cost. With cost in mind, Prentice [1986] proposed the
case-cohort study design, which requires covariate information only for a random sample
of the cohort, named the subcohort, as well as for all subjects with the disease of interest.
One important advantage of the case-cohort study design is that the same subcohort can
be used for studying different diseases, whereas for designs such as the nested case-control
design, new matching of cases and controls is needed for different diseases [Langholz and
Thomas, 1990; Wacholder et al., 1991].
Many methods have been proposed for case-cohort data under the proportional haz-
ards model. Prentice [1986] and Self and Prentice [1988] studied a pseudo-likelihood ap-
proach, which is a modification of the partial likelihood method [Cox, 1975] that weights
the contributions of the cases and subcohort differently. To improve the efficiency of the
pseudo-likelihood estimator, Chen and Lo [1999] and Chen [2001b] studied different classes
of estimating equations and used a local type of average as weight, respectively. Borgan
et al. [2000] proposed using time-varying weights, and Kulich and Lin [2004] developed a
class of weighted estimators by using all available covariate data for the full cohort. Breslow
and Wellner [2007] considered the semiparametric model using inverse probability weighted
methods with two-phase stratified samples. Various other semiparametric survival models
have also been modified to accommodate case-cohort studies [e.g. Chen, 2001a; Chen and
Zucker, 2009; Kong et al., 2004; Kulich and Lin, 2000a; Lu and Tsiatis, 2006].
Taking advantage of the case-cohort design, several diseases are often studied using the
same subcohort. In such situations, the information on the expensive exposure measure
is available on the subcohort as well as any subjects with any of the diseases of interest.
For example, in the Busselton Health Study, two case-cohort studies were conducted to
investigate the effect of serum ferritin on coronary heart disease and on stroke, respectively
[Knuiman et al., 2003]. Serum ferritin was measured on the subcohort, a random sample of
the cohort, as well as in all subjects with coronary heart disease and/or stroke. Typically,
the coronary heart disease analysis would not include any exposure information collected
on stroke patients not in the subcohort, and vice versa. In this paper, we develop more
efficient estimators for a single disease outcome, which can effectively use all available
exposure information. Because it is often of interest to compare the effect of a risk factor
on different diseases, we propose a more efficient version of the Kang and Cai [2009] test of
association across multiple diseases.
3.2 Model definitions and assumptions
Suppose that there are n independent subjects in a cohort study with K diseases of
interest. Let Tik denote the potential failure time and Cik denote the potential censoring
time for disease k of subject i. Let Xik = min(Tik,Cik) denote the observed time, ∆ik =
I(Tik ≤ Cik) the indicator for failure, and Nik(t) = I(Xik ≤ t,∆ik = 1) and Yik(t) = I(Xik ≥ t)
the counting and at-risk processes for disease k of subject i, respectively, where I(⋅) is the
indicator function. Let Zik(t) be a p × 1 vector of possibly time-dependent covariates for
disease k of subject i at time t. The time-dependent covariates are assumed to be external
[Kalbfleisch and Prentice, 2002]. Let τ denote the end of study time. We assume that Tik is
independent of Cik given the covariates Zik and follows the multiplicative intensity process
[Cox, 1972]
λik{t ∣ Zik(t)} = Yik(t)λ0k(t)eβT0 Zik(t), (3.1)
23
where λ0k(t) is an unspecified baseline hazard function for disease k of subject i and β0 is
p-dimensional vector of fixed and unknown parameters. Model (3.1) can incorporate disease-
specific effect model, λik{t ∣ Z∗ik(t)} = Yik(t)λ0k(t)eβTk Z∗ik(t), as a special case. Specifically, we
define βT0 = (βT1 , . . . , βTk , . . . , βTK) and Zik(t)T = [0Ti1, . . . ,0Ti(k−1),{Z∗ik(t)}T ,0Ti(k+1), . . . ,0TiK],
letting 0T be a 1 × p zero vector. Then we have βT0 Zik(t) = βTk Z∗ik(t).
Assume that there are n˜ subjects in the subcohort. Let ξi be an indicator for subcohort
membership, i.e. ξi = 1 denotes that subject i is selected into the subcohort and ξi = 0
denotes otherwise. Let α˜ = pr(ξi = 1) = n˜/n denote the selection probability of subject
i into the subcohort. The covariates Zik(t) (0 ≤ t ≤ τ) are measured for subjects in the
subcohort and those with any disease of interest.
3.2.1 Estimation for univariate failure time
First, we consider the situation in which only one disease is of interest, but covariate
information is available for subjects with other diseases. In the Busselton Health study, for
example, this corresponds to the situation in which we are interested in the effect of serum
ferritin on coronary heart disease with additional serum ferritin measurements available on
subjects outside the subcohort who had stroke.
In this situation, the observable information is {Xik,∆ik, ξi, Zik(t),0 ≤ t ≤ Xik} when
ξi = 1 or ∆ik = 1, and is (Xik,∆ik, ξi) when ξi = 0 and ∆ik = 0 (k = 1, . . . ,K). If we are
interested in disease k and ignore the covariate information collected on subjects with other
diseases, we can use Borgan et al. [2000]’s estimator with time-varying weights. Specifically,
the estimator is the solution to
Ûk(β) ≡ n∑
i=1∫ τ0
⎧⎪⎪⎨⎪⎪⎩Zik(t) − Ŝ
(1)
k (β, t)
Ŝ
(0)
k (β, t)
⎫⎪⎪⎬⎪⎪⎭dNik(t) = 0, (3.2)
where Ŝ
(d)
k (β, t) = n−1∑ni=1 ρik(t)Yik(t)Zik(t)⊗deβTZik(t) for d = 0,1 and 2 with a⊗0 = 1,
a⊗1 = a, and a⊗2 = aaT , and the time-varying weight ρik(t) = ∆ik + (1 −∆ik)ξiαˆ−1k (t) with
αˆk(t) = ∑ni=1 ξi(1 −∆ik)Yik(t)/{∑ni=1(1 −∆ik)Yik(t)}. Here αˆk(t), an estimator for the true
selection probability α˜, is the proportion of the sampled censored subjects for disease k
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among censored subjects who remain in the risk set at time t for disease k. This estimator
does not use the covariate information from subjects outside the subcohort who had other
diseases.
To use the collected covariate information on subjects who are outside the subcohort
and have other diseases, we consider the pseudo-partial likelihood score equations
Ũk(β) = n∑
i=1∫ τ0
⎧⎪⎪⎨⎪⎪⎩Zik(t) − S̃
(1)
k (β, t)
S̃
(0)
k (β, t)
⎫⎪⎪⎬⎪⎪⎭dNik(t) = 0, (3.3)
where
S̃
(d)
k (β, t) = n−1 n∑
i=1ψik(t)Yik(t)Zik(t)⊗deβTZik(t) (d = 0,1,2),
ψik(t) = ⎧⎪⎪⎨⎪⎪⎩1 −
K∏
j=1(1 −∆ij)
⎫⎪⎪⎬⎪⎪⎭ +
K∏
j=1(1 −∆ij)ξiα̃−1k (t),
and α̃k(t) = ∑ni=1 ξi{∏Kj=1(1 − ∆ij)}Yik(t)/∑ni=1{∏Kj=1(1 − ∆ij)}Yik(t). Here α̃k(t) is the
proportion of sampled subjects among subjects who do not have any diseases and are
remaining in the risk set at time t. Our proposed weight for disease k is ψik(t) = 1 when
∆ij = 1 for some j, and ψik(t) = α̃−1k (t) when ξi = 1 and ∆ij = 0 for all j (j = 1, . . . , k).
This weight takes the failure status of the other diseases into consideration, and thus our
proposed estimator will use the available covariate information for other diseases.
3.2.2 Estimation for multivariate failure time
For multivariate failure time data in case-cohort studies, Kang and Cai [2009] proposed
the pseudo-likelihood score equations
ÛM(β) ≡ n∑
i=1
K∑
k=1∫ τ0
⎧⎪⎪⎨⎪⎪⎩Zik(t) − Ŝ
(1)
k (β, t)
Ŝ
(0)
k (β, t)
⎫⎪⎪⎬⎪⎪⎭dNik(t) = 0, (3.4)
with the corresponding solution denoted βˆM .
As with Borgan et al. [2000]’s estimator, when calculating the contribution of disease
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k in the estimating equation, the quantity Ŝ
(d)
k (β, t) does not use the covariate informa-
tion collected on subjects with other diseases outside the subcohort. In order to improve
efficiency, we consider the pseudo-likelihood score equations with new weights
ŨM(β) ≡ n∑
i=1
K∑
k=1∫ τ0
⎧⎪⎪⎨⎪⎪⎩Zik(t) − S̃
(1)
k (β, t)
S̃
(0)
k (β, t)
⎫⎪⎪⎬⎪⎪⎭dNik(t) = 0. (3.5)
When there is only a single disease of interest, i.e. K = 1, (3.5) reduces to (3.3). Let β̃M
denote the solution of equation (3.5). We estimate the baseline cumulative hazard function
for disease k using a Breslow–Aalen type estimator Λ̃M0k(β̃M , t), where
Λ̃M0k(β, t) = ∫ t
0
∑ni=1 dNik(u)
nS̃
(0)
k (β,u) . (3.6)
3.3 Asymptotic properties
3.3.1 Asymptotic properties of β˜M and Λ˜M0k(β˜M , t)
Because the estimators for the univariate failure time are special cases of those for the
multivariate failure time, we present results only for the multivariate case. We make the
following assumptions:
(a) (Ti,Ci, Zi, i = 1, . . . , n) are independently and identically distributed, where
Ti = (Ti1, . . . , TiK)T , Ci = (Ci1, . . . ,CiK)T , and Zi = (Zi1, . . . , ZiK)T ;
(b) pr{Yik(t) = 1} > 0 for t ∈ [0, τ] , i = 1, . . . , n and k = 1, . . . ,K;
(c) ∣Zik(0)∣+ ∫ τ0 ∣dZik(t)∣ <Dz <∞ for i = 1, . . . , n and k = 1, . . . ,K almost surely, where Dz
is a constant;
(d) for d = 0,1,2, there exists a neighborhood B of β0 such that s(d)k (β, t) are continuous
functions and supt∈(0,τ),β∈B ∥S(d)k (β, t)−s(d)k (β, t)∥→ 0 in probability, where S(d)k (β, t) =
n−1∑ni=1 Yik(t)Zik(t)⊗deβTZik(t);
(e) the matrix Ak(β0) = ∫ τ0 vk(β0, t)s(0)k (β0, t)λ0k(t)dt is positive definite for k = 1, . . . ,K,
where vk(β, t) = s(2)k (β, t)/s(0)k (β, t) − ek(β, t)⊗2 and ek(β, t) = s(1)k (β, t)/s(0)k (β, t);
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(f) for all β ∈ B, t ∈ [0, τ], and k = 1, . . . ,K, S(1)k (β, t) = ∂S(0)k (β, t)/∂β, and S(2)k (β, t) =
∂2S
(0)
k (β, t)/(∂β∂βT ), where S(d)k (β, t), d = 0,1,2 are continuous functions of β ∈ B
uniformly in t ∈ [0, τ] and are bounded on B × [0, τ], and s(0)k is bounded away from
zero on B × [0, τ];
(g) for all k = 1, . . . ,K, ∫ τ0 λ0k(t)dt <∞; and
(h) limn→∞ α˜ = α, where α˜ = n˜/n and α is a positive constant.
We summarize the asymptotic results in the following theorems and provide the proofs
in Section 3.3.2.
Theorem 1. Under regularity conditions (a)–(h), β˜M converges in probability to β0 and
n1/2(β˜M −β0) converges in distribution to a mean zero normal distribution with covariance
matrix A(β0)−1Σ(β0)A(β0)−1, where
A(β) = K∑
k=1Ak(β), Σ(β) = VI(β) + 1 − αα VII(β),
VI(β) = E { K∑
k=1W1k(β)}
⊗2
, VII(β) = E { K∑
k=1∫ τ0 Ω1k(β, t)dΛ0k(t)}
⊗2
,
Wik(β) = ∫ τ
0
{Zik(t) − eik(β, t)}dMik(t),
Ωik(β, t) = K∏
j=1(1 −∆ij)
⎡⎢⎢⎢⎢⎣Qik(β, t) −
Yik(t)E{∏Kj=1(1 −∆1j)Q1k(β, t)}
E{∏Kj=1(1 −∆1j)Y1k(t)}
⎤⎥⎥⎥⎥⎦ ,
Qik(β, t) = Yik(t){Zik(t) − ek(β, t)}eβTZik(t).
The covariance matrix Σ(β0) consists of two parts: VI(β0) is a contribution to the
variance from the full cohort, and VII(β0) is due to sampling the subcohort from the full
cohort.
We summarize the asymptotic properties of the proposed baseline cumulative hazard
estimator Λ˜M0k(β˜M , t) in the next theorem.
Theorem 2. Under regularity conditions (a)–(h), Λ˜M0k(β˜M , t) is a consistent estimator
of Λ0k(t) in t ∈ [0, τ] and H(t) = {H1(t), . . . ,HK(t)}T = [n1/2{Λ˜M01(β˜M , t) − Λ01(t)}, . . . ,
n1/2{Λ˜M0K(β˜M , t) −Λ0K(t)}]T converges weakly to the Gaussian process H(t) = {H1(t), . . . ,
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HK(t)}T in D[0, τ]K with mean zero and the following covariance function Rjk(t, s) be-
tween Hj(t) and Hk(s) for j ≠ k
Rjk(t, s)(β0) = E{η1j(β0, t)η1k(β0, s)} + 1 − α
α
E{ζ1j(β0, t)ζ1k(β0, s)},
where
ηik(β, t) = lk(β, t)TA(β)−1 K∑
m=1Wim(β, t) + ∫ t0 1s(0)k (β,u)dMik(u),
ζik(β, t) = lk(β, t)TA(β)−1 K∑
m=1∫ τ0 Ωim(β,u)dΛ0m(u)
+ K∏
j=1(1 −∆ij)∫ t0 Yik(u)
⎡⎢⎢⎢⎢⎣eβTZik(u) −
E{∏Kj=1(1 −∆1j)eβTZ1k(u)Y1k(u)}
E{∏Kj=1(1 −∆1j)Y1k(u)}
⎤⎥⎥⎥⎥⎦ dΛ0k(u)s(0)k (β,u) ,
and lk(β, t)T = −∫ t
0
ek(β,u)dΛ0k(u).
3.3.2 Proofs of Theorems
Under the assumptions in Section 3.3.1, we will provide the proofs for the main theorems.
We denote
S
(d)
k (β, t) = n−1 n∑
i=1Yik(t)Zik(t)⊗deβTZik(t)
Wik(β) = ∫ τ
0
(Zik(t) − eik(β, t))dMik(t),
Mik(t) = Nik(t) − ∫ t
0
Yik(u)eβ0Zik(u)λ0k(u)du,
Ωik(β, t) = K∏
j=1(1 −∆ij)
⎡⎢⎢⎢⎢⎣Qik(β, t) −
Yik(t)E[∏Kj=1(1 −∆1j)Q1k(β, t)]
E[∏Kj=1(1 −∆1j)Y1k(t)]
⎤⎥⎥⎥⎥⎦ ,
Qik(β, t) = Yik(t)(Zik(t) − ek(β, t))eβZik(t)
∥f∥ = sup
t
∣f(t)∣, ∥d∥ = max
i
∣di∣, ∥D∥ = max
ij
∣Dij ∣
where f is a function, d is a vector, and D is a matrix.
The following lemmas play important roles for proving theorems.
lemma 1. Let Hn(t) and Wn(t) be two sequences of bounded process. If we assume that
the following conditions (1), (2), and (3) hold for some constant τ where
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(1) sup0≤t≤τ ∥Hn(t) −H(t) ∥→p 0 for some bounded process H(t),
(2) Hn(t) is monotone on [0, τ] and
(3) Wn(t) converges to zero-mean process with continuous sample paths, then
sup
0≤t≤τ ∥ ∫ t0 {Hn(s) −H(s)}dWn(s) ∥→p 0, sup0≤t≤τ ∥ ∫ t0 Wn(s)d{Hn(s) −H(s)} ∥→p 0
The above lemma is a extension of lemma 1 from Lin et al. [2000]. To prove the
asymptotic properties for case-cohort studies, the following lemma will be used frequently
and is an extension of the proposition from Kulich and Lin [2000a] and details of proof is
given by Lemma 2 in Kang and Cai [2010].
lemma 2. Let Bi(t), i = 1, . . . , n be independent and identically distributed real-valued
random process on [0, τ] and denote random process vector, B(t) = [B1(t), . . . ,Bn(t)] with
EBi(t) ≡ µB(t), var Bi(0) < ∞, and var Bi(τ) < ∞. Let ξ = [ξ1, . . . , ξn] be random
vector containing n˜ ones and n − n˜ zeros with each permutation equally likely. Let ξ be
independent of B(t). Suppose that almost all paths of Bi(t) have finite variation. Then
n−1/2∑ni=1 ξi{Bi(t) − µB(t)} converges weakly in l∞[0, τ] to a zero-mean Gaussian process,
and n−1∑ni=1 ξi{Bi(t) − µB(t)} converges in probability to zero uniformly in t.
Since we select subcohort members by using simple random sampling without replace-
ment, the condition of random vector ξ of above lemma is satisfied. For finite sample
n < ∞, we can express µB(t) = n−1∑ni=1Bi(t) and thus n−1/2∑ni=1 ξi{Bi(t) − µBi(t)} =
n−1/2∑ni=1 ξi{Bi(t) − n−1∑ni=1Bi(t)} = n−1/2∑ni=1{ξi − n˜n}Bi(t) = n−1/2α˜∑ni=1{ ξiα˜ − 1}Bi(t).
First, we consider the asymptotic properties of time-varying sampling probability es-
timator α˜k(t) = ∑ni=1 ξi{∏Kj=1(1 − ∆ij)}Yik(t)/∑ni=1{∏Kj=1(1 − ∆ij)}Yik(t) for true selection
probability α˜. For each k, it follows from the Taylor expansion series as
α˜−1k (t) − α˜−1 = − 1
α∗(t)2 {α˜k(t) − α˜},
where α∗(t) is on the line segment between α˜k(t) and α˜.
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Set Bi(t) = {∏Kj=1(1−∆ij)}Yik(t)∑ni=1{∏Kj=1(1−∆ij)}Yik(t) . Since ∏Kj=1(1−∆ij) and Yik(t) are bounded functions
in t, {∏Kj=1(1 − ∆ij)}Yik(t) is also a bounded function and the finite sum of its has finite
variation. Thus, Bi(t) has finite variation
Also it is easy to show E[Bi(t)] = n−1∑ni=1Bi(t) = n−1∑ni=1 {∏Kj=1(1−∆ij)}Yik(t)∑ni=1{∏Kj=1(1−∆ij)}Yik(t) = n−1 =
µB , Var[Bi(0)] <∞, and Var[Bi(τ)] <∞. So,
α˜k(t) − α˜ = ∑ni=1 ξi(∏Kj=1(1 −∆ij))Yik(t)∑ni=1(∏Kj=1(1 −∆ij))Yik(t) −
n∑
i=1
ξi
n
= n∑
i=1 ξi
⎡⎢⎢⎢⎢⎣
(∏Kj=1(1 −∆ij))Yik(t)∑ni=1(∏Kj=1(1 −∆ij))Yik(t) − 1n
⎤⎥⎥⎥⎥⎦= n∑
i=1 ξi [Bi(t) − µB]
We can express α˜k(t)− α˜ = ∑ni=1 α˜( ξiα˜ − 1) (∏Kj=1(1−∆ij))Yik(t)∑ni=1(∏Kj=1(1−∆ij))Yik(t) , and thus n1/2(α˜−1k (t)− α˜−1)
can be written as
α˜
α∗(t)2 ⋅ n∑ni=1∏Kj=1(1 −∆ij)Yik(t) ⋅ n−1/2{
n∑
i=1(1 − ξiα˜ )
K∏
j=1(1 −∆ij)Yik(t)} (3.7)
1
n ∑ni=1{∏Kj=1(1−∆ij)}Yik(t) converges in probability uniformly to E[{∏Kj=1(1−∆1j)}Y1k(t)]
by Glivenko-Cantelli lemma. Since {∏Kj=1(1−∆ij)}Yik(t) is bounded and monotone function
in t, n−1/2{∑ni=1( ξiα˜ −1)∏Kj=1(1−∆ij)Yik(t)} converges weakly to zero-mean Gaussian process
in the view of lemma 2. This follows from lemma 2 that n−1{∑ni=1( ξiα˜ −1)∏Kj=1(1−∆ij)Yik(t)}
converges to zero in probability uniformly in t. Thus, α˜k(t) and α˜ converge to the same
limit uniformly in t. This ensures that α∗(t) also converges to the same limit as α˜ uniformly
in t.
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By Slutsky’s theorem and above results, (3.7) can be written as
n1/2(α˜−1k (t) − α˜−1) = 1
α˜E(∏Kj=1(1 −∆1j)Y1k(t))n−1/2
⎧⎪⎪⎨⎪⎪⎩
n∑
i=1(1 − ξiα˜ )
K∏
j=1(1 −∆ij)Yik(t)
⎫⎪⎪⎬⎪⎪⎭
+ ⎡⎢⎢⎢⎢⎣ α˜α∗(t)2 ⋅ n∑ni=1∏Kj=1(1 −∆ij)Yik(t) − 1α˜E(∏Kj=1(1 −∆1j)Y1j(t))
⎤⎥⎥⎥⎥⎦
× n−1/2 ⎧⎪⎪⎨⎪⎪⎩
n∑
i=1(1 − ξiα˜ )
K∏
j=1(1 −∆ij)Yik(t)
⎫⎪⎪⎬⎪⎪⎭
= 1
α˜E(∏Kj=1(1 −∆1j)Y1k(t))n−1/2
⎧⎪⎪⎨⎪⎪⎩
n∑
i=1(1 − ξiα˜ )
K∏
j=1(1 −∆ij)Yik(t)
⎫⎪⎪⎬⎪⎪⎭+ op(1) (3.8)
The above properties will be used in some proofs. Here is the proof of theorem 1.
The proof of Theorem 1 We first show the consistency of β˜M . Denote ŨMn = n−1ŨM .
By Taylor expansion series, β˜M can be written as
β˜M = β0 + [−∂ŨMn (β0)
∂β0
]−1 ŨMn (β0) + op(1) (3.9)
Based on the extension of Fourtz [1977], if the following conditions are satisfied
(I)
∂ŨMn (β)
∂βT
exists and is continuous in an open neighborhood B of β0,
(II)
∂ŨMn (β)
∂βT
is negative definite with probability going to one as n →∞,
(III) -
∂ŨMn (β)
∂βT
converges to A(β0) in probability uniformly for β in an open neighborhood
about β0,
(IV) ŨMn (β) converges to 0 in probability,
then, we can show that β˜M converges to β0 in probability. Note that
∂ŨMn (β)
∂βT
= − 1
n
n∑
i=1
K∑
k=1∫ τ0 Ṽk(β, t)dNik(t),
where Ṽk(β, t) = S̃(2)k (β, t)S̃(0)k (β, t) − S̃(1)k (β, t)⊗2
S̃
(0)
k (β, t)2 . (3.10)
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Since
∂ŨMn (β)
∂βT
has the form (3.10) and each component, S̃
(d)
k (β, t) for d=0,1,2 are continuous,
(I) is satisfied.
In order to show that conditions (II) and (III) are satisfied, we first will show ∥ (−∂ŨMn (β)
∂βT
)−
A(β) ∥ converge to zero in probability uniformly in β ∈ B as n→∞.
Let dMik(t) = dNik(t) − Yik(t)eβ0Zik(t)λ0k(t)dt. We have
∥ (−∂ŨMn (β)
∂βT
) −A(β) ∥
= ∥ K∑
k=1∫ τ0 {Ṽk(β, t) − vk(β, t) + vk(β, t)} 1nd
n∑
i=1Nik(t) − ∫ τ0 vk(β0, t)s(0)k (β0, t)λ0k(t)dt ∥
≤ ∥ K∑
k=1∫ τ0 {Ṽk(β, t) − vk(β, t)} 1nd
n∑
i=1Nik(t) ∥
+ ∥ K∑
k=1∫ τ0 vk(β, t) 1nd
n∑
i=1Nik(t) − ∫ τ0 vk(β, t)s(0)k (β, t)λ0k(t)dt ∥
≤ ∥ K∑
k=1∫ τ0 {Ṽk(β, t) − vk(β, t)} 1nd
n∑
i=1Nik(t) ∥
+ ∥ K∑
k=1∫ τ0 vk(β, t) 1nd
n∑
i=1{Mik(t) + Yik(t)eβTZik(t)Λ0k(t)} − vk(β, t)s(0)k (β, t)λ0k(t)dt ∥
Since S
(0)
k (β, t) = n−1∑ni=1 Yik(t)eβTZik(t), it follows that
∥ (−∂ŨMn (β)
∂βT
) −A(β) ∥
≤ ∥ K∑
k=1∫ τ0 {Ṽk(β, t) − vk(β, t)} 1nd
n∑
i=1Nik(t) ∥ (3.11)
+ ∥ K∑
k=1∫ τ0 vk(β, t) 1nd
n∑
i=1Mik(t) ∥ (3.12)
+ ∥ K∑
k=1∫ τ0 vk(β, t){S(0)k (β, t) − s(0)k (β, t)}λ0k(t)dt ∥ (3.13)
We will show that each of three terms in above inequality converges to zero uniformly in
β ∈ B. First, the term in (3.11) will be shown to converges to zero in probability as n→∞.
To show this, first we need to show that
sup
t∈[0,τ]β∈B ∥ Ṽk(β, t) − vk(β, t) ∥→ 0 as n→∞ for k = 1, . . . ,K.
32
Since Ṽk(β, t) is a function of S̃(d)k (β, t), d = 0,1,2, supt∈(0,τ),β∈B ∥S(d)k (β, t)−s(d)k (β, t)∥→p 0
based on condition (d), and s
(0)
k (β, t) is bounded away from zero base on condition (f), it
suffices to show that
sup
t∈[0,τ]β∈B ∥ S̃(d)k (β, t) − S(d)k (β, t) ∥→ 0 as n→∞ for k = 1, . . . ,K and d = 0,1,2.
Note that S̃
(d)
k (β, t) = n−1∑ni=1ψik(t)Yik(t)Zik(t)⊗deβTZik(t), where ψik(t) = 1 − (∏Kj=1(1 −
∆ij)) +∏Kj=1(1 −∆ij)ξiα̃−1k (t) for d = 0,1,2. One can write
S̃
(d)
k (β, t) − S(d)k (β, t)= n−1 n∑
i=1{ψik(t) − 1}Yik(t)Zik(t)⊗deβTZik(t)
= 1
n
n∑
i=1{1 − (
K∏
j=1(1 −∆ij)) +
K∏
j=1(1 −∆ij)ξiα̃−1k (t) − 1}Yik(t)Zik(t)⊗deβTZik(t)
= 1
n
n∑
i=1{
K∏
j=1(1 −∆ij)ξiα̃−1k (t) − (
K∏
j=1(1 −∆ij))}Yik(t)Zik(t)⊗deβTZik(t)
= 1
n
n∑
i=1(ξiα˜ − 1)
K∏
j=1(1 −∆ij)Zik(t)⊗deβTZik(t)Yik(t)
+ 1
n
n∑
i=1(α˜−1k (t) − α˜−1)ξi
K∏
j=1(1 −∆ij)Zik(t)⊗deβTZik(t)Yik(t)
and then
∥ S̃(d)k (β, t) − S(d)k (β, t) ∥≤ ∥ 1
n
n∑
i=1(ξiα˜ − 1)
K∏
j=1(1 −∆ij)Zik(t)⊗deβTZik(t)Yik(t) ∥ (3.14)
+ ∣α˜−1k (t) − α˜−1∣ 1n n∑i=1 ξi
K∏
j=1(1 −∆ij)∣Zik(t)⊗d∣eβTZik(t)Yik(t) (3.15)
Based on condition (c), the total variation of ∏Kj=1(1 −∆ij)Zik(t)⊗deβTZik(t)Yik(t) is finite
on [0, τ]. By lemma 2, the term in (3.14) converges to zero in probability uniformly in
t. Since it was shown that (α˜−1k (t) − α˜−1) converges to zero in probability uniformly in t
and 1n ∑ni=1 ξi∏Kj=1(1−∆ij)∣Zik(t)⊗d∣eβTZik(t)Yik(t) converges to α˜E[∏Kj=1(1−∆1j)∣Z1k(t)⊗d∣
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×eβTZ1k(t)Y1k(t)] in probability uniformly in t, the term in (3.15) converges to zero in
probability uniformly. Thus, S̃
(d)
k (β, t)−S(d)k (β, t) converges to zero. Combining this result
with condition (d), we can show that
sup
t∈[0,τ],β∈B ∥ S̃(d)k (β, t) − s(d)k (β, t) ∥→ 0 as n→∞ for k = 1, . . . ,K and d = 0,1,2. (3.16)
Since s
(0)
k is bounded way from zero based by condition (f), we can also show that supt∈[0,τ],β∈B∥ S̃(0)k (β, t)−1 − s(0)k (β, t)−1 ∥→ 0 as n → ∞ for k = 1, . . . ,K. Combining these results,
Ṽk(β, t) converges to vk(β, t) in probability uniformly in t and β. Moreover, by Lenglart
inequality (Andersen and Gill [1982], p1115), there exists n0 such that for n ≥ n0 for any δ,
η > 0,
P [n−1N¯k(τ) > η] ≤ δ
η
+ P [∫ τ
0
S
(0)
k (β0; t)λ0k(t)dt > δ],
where N¯k(t) = ∑ni=1Nik(t).
Based on condition (d), P [∫ τ0 S(0)k (β0; t)λ0k(t)dt > δ] converges to zero as n → ∞ for
δ > ∫ τ0 s(0)k (β0; t)λ0k(t)dt and then limη↑∞ limn→∞ P [n−1N¯k(τ) > η] = 0. Therefore, the term
in (3.11) converges to zero in probability uniformly in β ∈ B as n→∞.
For the quantity in (3.12), ∫ τ0 vk(β, t) 1nd∑ni=1Mik(t) is a local square integrable martin-
gale. By the Lenglart inequality(Andersen and Gill [1982], p1115), it can be shown that,
for all δ, η > 0,
P [∥ 1
n
∫ τ
0
{vk(β, t)}jj′M¯k(t)∥ > η] ≤ δ
η2
+ P [ 1
n
∫ τ
0
{vk(β, t)}2jj′S(0)k (β; t)λ0k(t)dt > δ] ,
where M¯k(t) = ∑ni=1Mik(t) and subscript jj′ indicates (jj′) element of matrix vk(β, t).
Based on boundedness conditions (d), (f), and (g), the second term on right side in the
above inequality converges to zero in probability, uniformly in β ∈ B for any δ as n → ∞.
Then it follows that one on the left side converges to zero in probability, uniformly in β ∈ B
as n→∞. Hence, the quantity in (3.12) converges to zero in probability, uniformly in β ∈ B
as n→∞.
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Due to boundedness of supt,β {vk(β, t)} based on conditions (d) and (e), Λ0k(t) for k =
1, . . . ,K based on condition (g), and uniform convergence of S̃
(0)
k (β, t) to s(0)k (β, t), the term
in (3.13) converges to zero in probability uniformly in β ∈ B as n→∞. Therefore, all three
terms in (3.11), (3.12), and (3.13) converge to zero in probability uniformly. Consequently,
we have
−∂ŨMn (β)
∂βT
→p A(β) as n→∞ uniformly in β ∈ B
and consequently (II) and (III) are satisfied.
To show that (IV) is satisfied, we will examine the asymptotic behavior of n−1/2ŨMn (β0).
We can decompose n−1/2ŨM(β0) into two parts such that
n−1/2ŨM(β0) = n−1/2 n∑
i=1
K∑
k=1∫ τ0
⎧⎪⎪⎨⎪⎪⎩Zik(t) − S̃
(1)
k (β0, t)
S̃
(0)
k (β0, t)
⎫⎪⎪⎬⎪⎪⎭dNik(t)
= n−1/2 n∑
i=1
K∑
k=1∫ τ0
⎧⎪⎪⎨⎪⎪⎩Zik(t) − S
(1)
k (β0, t)
S
(0)
k (β0, t)
⎫⎪⎪⎬⎪⎪⎭dNik(t) (3.17)
+ n−1/2 n∑
i=1
K∑
k=1∫ τ0
⎧⎪⎪⎨⎪⎪⎩S
(1)
k (β0, t)
S
(0)
k (β0, t) −
S̃
(1)
k (β0, t)
S̃
(0)
k (β0, t)
⎫⎪⎪⎬⎪⎪⎭dNik(t). (3.18)
The quantity in (3.17) is the pseudo partial likelihood score function for full cohort and can
be written as
(3.17) = n−1/2 n∑
i=1
K∑
k=1∫ τ0
⎧⎪⎪⎨⎪⎪⎩Zik(t) − S
(1)
k (β, t)
S
(0)
k (β0, t)
⎫⎪⎪⎬⎪⎪⎭dMik(t)
= n−1/2 n∑
i=1
K∑
k=1∫ τ0 {Zik(t) − ek(β0, t)}dMik(t)
+ n−1/2 n∑
i=1
K∑
k=1∫ τ0
⎧⎪⎪⎨⎪⎪⎩ek(β0, t) − S
(1)
k (β0, t)
S
(0)
k (β0, t)
⎫⎪⎪⎬⎪⎪⎭dMik(t).
We can show that (3.17) was asymptotically equivalent to n−1/2∑ni=1∑Kk=1 Wik(β0) where
Wik(β) = ∫ τ0 (Zik(t) − eik(β, t))dMik(t) (Spiekerman and Lin [1998], Clegg et al. [1999]).
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Since dMik(t) = dNik(t) − Yik(t)eβ0Zik(t)dΛ0k(t), (3.18) can decompose into two parts:
n−1/2 n∑
i=1
K∑
k=1∫ τ0
⎧⎪⎪⎨⎪⎪⎩S
(1)
k (β0, t)
S
(0)
k (β0, t) −
S̃
(1)
k (β0, t)
S̃
(0)
k (β0, t)
⎫⎪⎪⎬⎪⎪⎭dNik(t)
= K∑
k=1∫ τ0
⎧⎪⎪⎨⎪⎪⎩S
(1)
k (β0, t)
S
(0)
k (β0, t) −
S̃
(1)
k (β0, t)
S̃
(0)
k (β0, t)
⎫⎪⎪⎬⎪⎪⎭d{n−1/2
n∑
i=1Mik(t)} (3.19)
+ n−1/2 K∑
k=1∫ τ0
⎧⎪⎪⎨⎪⎪⎩S
(1)
k (β0, t)
S
(0)
k (β0, t) −
S̃
(1)
k (β0, t)
S̃
(0)
k (β0, t)
⎫⎪⎪⎬⎪⎪⎭
n∑
i=1Yik(t)eβ0Zik(t)dΛ0k(t). (3.20)
Based on the assumed model, M1k(t), . . . ,Mnk(t) are identically independently dis-
tributed zero-mean random variables for fixed t. Mik(t) is of bounded variation since
M2ik(0) < ∞ and M2ik(τ) < ∞ are satisfied based on conditions (c) and (g). From the ex-
ample of 2.11.16 of Van Der Vaart and Wellner (1996, p215), n−1/2∑ni=1Mik(t) converges
weakly to a zero-mean Gaussian process, say PMk(t).
To establish that PMk(t) has continuous sample paths, we will use Kolmogorov-Centsov
theorem. If conditions of Kolmogorov-Centsov theorem E[{PMk(t)−PMk(s)}4] ≤D∗z ∣t−s∣2
and E[{PMk(t) − PMk(s)}2] ≤ D˜z ∣t − s∣ for all t ≥ s are satisfied, then we can show thatPMk(t) has continuous sample paths. Note that E[{PMk(t) − PMk(s)}2] = E[PMk(t)2] -
2E[PMk(t)PMk(s)] + E[PMk(s)2] = E[PMk(t)2] - E[PMk(s)2] due to E[PMk(t)PMk(s)]
= E[PMk(s)2] for t ≥ s. Since E[PMk(t)2] = E[n−1∑ni=1Mik(t)2] = E[Mik(t)2] =
E[∫ t0 Yik(u)eβT0 Zik(u)λ0k(u)du], E[PMk(t)2] - E[PMk(s)2] = E[∫ ts Yik(u)eβT0 Zik(u)λ0k(u) du] ≤
eDzE[∫ ts λ0k(u)du] = D˜z(Λ0k(t) − Λ0k(s)) based on condition (c) where D˜z = eDz . There
exists constant C such that Λ0k(t)−Λ0k(s) ≤ C(t− s) for t ≥ s since Λ0k(.) is differentiable
and λ0k(.) is bounded in [0, τ]. Thus E{PMk(t)−PMk(s)}2 ≤ D˜cz(t−s) where D˜cz = D˜z×C.
For fixed t, PMk(t) is a zero-mean random normal variable. Then, PMk(t)−PMk(s) is also
a zero-mean random normal variable for fixed t and s. Consequently, {PMk(t) −PMk(s)}2
is a random chi-square variable for fixed t and s. We can express E[{PMk(t)−PMk(s)}4] =
Var{PMk(t) − PMk(s)}2 + E{(PMk(t) − PMk(s))2}2 = 3{E(PMk(t) − PMk(s))2}2 due to
Var{PMk(t) −PMk(s)}2 = 2E[{PMk(t) −PMk(s)}2] from the property of chi-square distri-
bution. Therefore, E{PMk(t)−PMk(s)}4 = 3{E(PMk(t)−PMk(s))2}2 ≤D∗z ∣t−s∣2 for some
constant D∗z . Since the two conditions are satisfied, it follows that PMk(t) has continuous
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sample paths from Kolmogorov-Centsov theorem.
Based on conditions (c), (d), and (f), there exists N∗ such that n > N∗ S(1)k (β, t) and
S
(0)
k (β, t) are of bounded variations and S(0)k (β, t) is bounded away from zero. Thus S(1)k (β,t)S(0)
k
(β,t)
is of bounded variation when n > N∗. By using f ′(x)/f(x) = [log f(x)]′ ≅ F ∗1 (t) − F ∗2 (t)
where F ∗1 (t) and F ∗1 (t) are bounded, monotone and nonnegative functions in t, it can
be written as
S
(1)
k
(β,t)
S
(0)
k
(β,t) = Z∗k1(t) − Z∗k2(t) where Z∗k1(t) and Z∗k2(t) are bounded, monotone
and nonnegative functions in t. Hence,
S
(1)
k
(β,t)
S
(0)
k
(β,t) is a sum of two monotone functions in t.
Similarly, we can show that
S˜
(1)
k
(β,t)
S˜
(0)
k
(β,t) is of bounded variation due to conditions (c) and (f)
and the result of (3.16) by the same manner. Moreover, we can write that
S˜
(1)
k
(β,t)
S˜
(0)
k
(β,t) is also a
sum of two monotone functions in t. Based on condition (d) and the result of (3.16), it can
be shown that
S
(1)
k
(β,t)
S
(0)
k
(β,t) and S˜
(1)
k
(β,t)
S˜
(0)
k
(β,t) converge to the same limit uniformly. Thus, it follows
from lemma 1 that
K∑
k=1∫ τ0
⎧⎪⎪⎨⎪⎪⎩S
(1)
k (β, t)
S
(0)
k (β, t) −
S˜
(1)
k (β, t)
S˜
(0)
k (β, t)
⎫⎪⎪⎬⎪⎪⎭n−1/2
n∑
i=1dMik(t)
= K∑
k=1∫ τ0
⎧⎪⎪⎨⎪⎪⎩S
(1)
k (β, t)
S
(0)
k (β, t) −
s
(1)
k (β, t)
s
(0)
k (β, t)
⎫⎪⎪⎬⎪⎪⎭n−1/2
n∑
i=1dMik(t)
− K∑
k=1∫ τ0
⎧⎪⎪⎨⎪⎪⎩ S˜
(1)
k (β, t)
S˜
(0)
k (β, t) −
s
(1)
k (β, t)
s
(0)
k (β, t)
⎫⎪⎪⎬⎪⎪⎭n−1/2
n∑
i=1dMik(t)→ 0 as n→∞.
Therefore, the term in (3.19) converges to 0 in probability uniformly in t.
We have shown that n−1/2∑ni=1Mik(t) converges weakly to a zero-mean Gaussian process
with continuous sample paths. To show that S̃
(d)
k (β, t) and S(d)k (β, t) converges to the same
limit in probability, we will show that n1/2{S(d)k (β, t)− S̃(d)k (β, t)} converges to a zero mean
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Gaussian process. It can be expressed as
n1/2 {S(d)k (β, t) − S˜(d)k (β, t)}
= n−1/2 { n∑
i=1Zik(t)⊗deβTZik(t)Yik(t) −
n∑
i=1ψik(t)Zik(t)⊗deβTZik(t)Yik(t)}
= n−1/2{ n∑
i=1
K∏
j=1(1 −∆ij)Zik(t)⊗deβTZik(t)Yik(t)
− n∑
i=1
K∏
j=1(1 −∆ij)ξiα˜−1k (t)Zik(t)⊗deβTZik(t)Yik(t)}
= n−1/2 n∑
i=1(α˜−1 − α˜−1k (t))
K∏
j=1(1 −∆ij)ξiZik(t)⊗deβTZik(t)Yik(t)
+ n−1/2 n∑
i=1(1 − ξiα˜ )
K∏
j=1(1 −∆ij)Zik(t)⊗deβTZik(t)Yik(t)
= n−1 n∑
i=1
⎧⎪⎪⎨⎪⎪⎩ 1α˜E(∏Kj=1(1 −∆ij)Y1k(t)) 1√n
⎧⎪⎪⎨⎪⎪⎩
n∑
p=1(ξpα˜ − 1)
K∏
j=1(1 −∆pj)Ypk(t)
⎫⎪⎪⎬⎪⎪⎭
⎫⎪⎪⎬⎪⎪⎭
× ξi K∏
j=1(1 −∆ij)Zik(t)⊗deβTZik(t)Yik(t)
+ n−1/2 n∑
i=1(1 − ξiα˜ )
K∏
j=1(1 −∆ij)Zik(t)⊗deβTZik(t)Yik(t) + op(1) (by plugging in (4.6))
= n−1/2 n∑
i=1(ξiα˜ − 1) ⋅ ∏
K
j=1(1 −∆ij)Yik(t)
E(∏Kj=1(1 −∆1j)Y1k(t))
⎧⎪⎪⎨⎪⎪⎩n−1
n∑
p=1
ξp
α˜
K∏
j=1(1 −∆pj)Zpk(t)⊗deβTZpk(t)Ypk(t)
⎫⎪⎪⎬⎪⎪⎭
+ n−1/2 n∑
i=1(1 − ξiα˜ )
K∏
j=1(1 −∆ij)Zik(t)⊗deβTZik(t)Yik(t) + op(1).
Since n−1∑np=1 ξpα˜ ∏Kj=1(1 −∆pj)Zpk(t)⊗deβTZpk(t)Ypk(t) converges to E(∏Kj=1(1 −∆1j)
Z1k(t)⊗deβTZ1k(t)Y1k(t)) in probability uniformly in t, it can be written as
n1/2 {S(d)k (β, t) − S˜(d)k (β, t)}
= n−1/2 n∑
i=1(1 − ξiα˜ )
K∏
j=1(1 −∆ij)Yik(t)
× ⎧⎪⎪⎨⎪⎪⎩Zik(t)⊗deβTZik(t) −
E(∏Kj=1(1 −∆1j)Z1k(t)⊗deβTZ1k(t)Y1k(t))
E(∏Kj=1(1 −∆1j)Y1k(t))
⎫⎪⎪⎬⎪⎪⎭ + op(1) (3.21)
By lemma 2, n1/2{S(d)k (β, t)− S̃(d)k (β, t)} converges weakly to a zero-mean Gaussian process
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since we setBi(t) =∏Kj=1(1−∆ij)Yik(t){Zik(t)⊗deβTZik(t)−E(∏Kj=1(1−∆1j)Z1k(t)⊗deβT Z1k(t)Y1k(t))E(∏Kj=1(1−∆1j)Y1k(t)) }
with Var(Bi(0)) < ∞ and Var(Bi(τ)) < ∞ . Consequently, S̃(d)k (β, t) and S(d)k (β, t) con-
verges to the same limit in probability.
To investigate the asymptotic properties of the quantity in (3.20), it can be decomposed
into two parts:
n−1/2 K∑
k=1∫ τ0
⎧⎪⎪⎨⎪⎪⎩S
(1)
k (β, t)
S
(0)
k (β, t) −
S˜
(1)
k (β, t)
S˜
(0)
k (β, t)
⎫⎪⎪⎬⎪⎪⎭
n∑
i=1Yik(t)eβ0Zik(t)dΛ0k(t)
= n1/2 K∑
k=1∫ τ0
⎧⎪⎪⎨⎪⎪⎩S(1)k (β, t) − S(0)k (β, t) ⋅ S˜
(1)
k (β, t)
S˜
(0)
k (β, t)
⎫⎪⎪⎬⎪⎪⎭dΛ0k(t)
= n1/2 K∑
k=1∫ τ0 {S(1)k (β, t) − S˜(1)k (β, t)}dΛ0k(t) − {S(0)k (β, t) − S˜(0)k (β, t)} S˜
(1)
k (β, t)
S˜
(0)
k (β, t)dΛ0k(t)= n1/2 K∑
k=1∫ τ0 {S(1)k (β, t) − S˜(1)k (β, t)}dΛ0k(t)
− n1/2 K∑
k=1∫ τ0 {S(0)k (β, t) − S˜(0)k (β, t)} ek(β, t)dΛ0k(t) + op(1) (3.22)
The last quantity in (3.22) holds since
S˜
(1)
k
(β,t)
S˜
(0)
k
(β,t) converges to ek(β, t) in probability uni-
formly in t, n1/2{S(d)k (β, t) − S̃(d)k (β, t)} d = 0,1 converges weakly to a zero-mean Gaussian
process, and Λ0k(t) is bounded on t ∈ [0, τ].
Plugging the quantity in (3.21) into equation (3.22), we have
n−1/2 K∑
k=1∫ τ0
⎧⎪⎪⎨⎪⎪⎩S
(1)
k (β, t)
S
(0)
k (β, t) −
S˜
(1)
k (β, t)
S˜
(0)
k (β, t)
⎫⎪⎪⎬⎪⎪⎭
n∑
i=1Yik(t)eβ0Zik(t)dΛ0k(t)
= n−1/2 K∑
k=1
n∑
i=1∫ τ0 (1 − ξiα˜ )
K∏
j=1(1 −∆ij)Yik(t)
× [Zik(t)eβTZik(t) − E(∏Kj=1(1 −∆1j)Z1k(t)eβTZ1k(t)Y1k(t))
E(∏Kj=1(1 −∆1j)Y1k(t))
− {eβTZik(t) − E(∏Kj=1(1 −∆1j)eβTZ1k(t)Y1k(t))
E(∏Kj=1(1 −∆1j)Y1k(t)) }ek(β, t)]dΛ0k(t) + op(1)
= n−1/2 K∑
k=1
n∑
i=1∫ τ0 (1 − ξiα˜ )
K∏
j=1(1 −∆ij){Yik(t)[Zik(t) − ek(β, t)]eβTZ1k(t)dΛ0k(t)
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− Yik(t) ⋅ E(∏Kj=1(1 −∆1j)Y1k(t)[Z1k(t) − ek(β, t)]eβTZ1k(t))
E(∏Kj=1(1 −∆1j)Y1k(t)) dΛ0k(t)} + op(1)
= n−1/2 K∑
k=1
n∑
i=1∫ τ0 (1 − ξiα˜ )
K∏
j=1(1 −∆ij){Qik(β, t) − Yik(t)E(∏
K
j=1(1 −∆1j)Q1k(β, t))
E(∏Kj=1(1 −∆1j)Y1k(t)) }× dΛ0k(t) + op(1) (3.23)
where Qik(β, t) = Yik(t)(Zik(t) − ek(β, t))eβZik(t).
We have shown that the term in (3.17) is asymptotically equivalent to n−1/2∑ni=1∑Kk=1
Wik(β, t) and the term in (3.18) is asymptotically equivalent to n−1/2∑Kk=1∑ni=1 ∫ τ0 (1 −
ξi
α˜ )∏Kj=1(1 −∆ij){Qik(β, t) − Yik(t)E(∏Kj=1(1−∆1j)Q1k(β,t))E(∏Kj=1(1−∆1j)Y1k(t)) }dΛ0k(t).
Therefore, n−1/2ŨM(β0) is asymptotically equivalent to
n−1/2 n∑
i=1
K∑
k=1Wik(β0) + n−1/2
n∑
i=1
K∑
k=1∫ τ0 (1 − ξiα˜ )Ωik(β0, t)dΛ0k(t), (3.24)
where Ωik(β, t) =∏Kj=1(1 −∆ij){Qik(β, t) − Yik(t)E(∏Kj=1(1−∆1j)Q1k(β,t))E(∏Kj=1(1−∆1j)Y1k(t)) } .
By Spiekerman and Lin [1998] and Clegg et al. [1999], the first term of (3.24) converges
weakly to a zero-mean normal vector with covariance matrix VI(β0) = E[∑Kk=1W1k(β0)]⊗2.
The second term of (3.24) is asymptotically zero-mean normal vector with covariance matrix
1−α
α VII(β0) = 1−αα E [∑Kk=1 ∫ τ0 Ωik(β0, t)dΛ0k(t)]⊗2 by Ha´jek [1960]’s central limit theorem for
finite sampling.
In addition, n−1/2∑ni=1∑Kk=1Wik(β0) and n−1/2∑ni=1∑Kk=1 ∫ τ0 (1− ξiα˜ )Ωik(β0, t)dΛ0k(t) are
independent since
Cov (n−1/2 n∑
i=1
K∑
k=1Wik(β0), n−1/2
n∑
i=1
K∑
k=1(1 − ξiα˜ )∫ τ0 Ωik(β0, t)dΛ0k(t))
= E {n−1 n∑
i=1
K∑
k=1Wik(β0)
n∑
i=1
K∑
k=1(1 − ξiα˜ )∫ τ0 Ωik(β0, t)dΛ0k(t)}
= E {E (n−1 n∑
i=1
K∑
k=1Wik(β0)
n∑
i=1
K∑
k=1(1 − ξiα˜ )∫ τ0 Ωik(β0, t)dΛ0k(t)∣F(τ))}
= E {n−1 n∑
i=1
K∑
k=1Wik(β0)
n∑
i=1
K∑
k=1E (1 − ξiα˜ ∣F(τ))∫ τ0 Ωik(β0, t)dΛ0k(t)} = 0,
where {F(t), t ≥ 0} is filtration.
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Combining all the above results, n−1/2ŨM(β0) converges weakly to zero-mean normal
vector with covariance matrix Σ(β0) = VI(β0) + 1−αα VII(β0). Consequently, n−1ŨM(β0)
converges to zero in probability. Therefore, β˜M converges to β0 in probability and is a
consistent estimator of β0 by satisfying conditions (I), (II), (III), and (IV) (theorem 2 of
Fourtz [1977]).
In addition to the consistency of β˜M , it follows from Taylor expansion, it can be written
as
n1/2(β˜M − β0) = [A(β0)]−1n−1/2ŨM(β0). (3.25)
Therefore, n1/2(β˜M −β0) converges weakly zero-mean normal vector with covariance matrix
A(β0)−1Σ(β0)A(β0)−1.
The proof of Theorem 2 Note that
Λ̃M0k(β˜M , t) = ∫ t
0
∑ni=1 dNik(u)
nS˜
(0)
k (β˜M , u) = ∫
t
0
∑ni=1 dMik(u)
nS˜
(0)
k (β˜M , u) + ∫
t
0
S
(0)
k (β0, u)dΛ0k(u)
S˜
(0)
k (β˜M , u)
We can decompose n1/2{Λ̃M0k(β˜M , t) −Λ0k(t)} into four parts:
n1/2{Λ̃M0k(β˜M , t) −Λ0k(t)}
= n1/2∫ t
0
⎛⎝ 1nS˜(0)k (β˜M , u) − 1nS˜(0)k (β0, u)
⎞⎠d n∑i=1Mik(u)
+ n1/2∫ t
0
⎛⎝ 1S˜(0)k (β˜M , u) − 1S˜(0)k (β0, u)
⎞⎠S(0)k (β0, u)dΛ0k(u)
+ n−1/2∫ t
0
1
S˜
(0)
k (β0, u)d
n∑
i=1Mik(u)
+ n1/2∫ t
0
⎛⎝S
(0)
k (β0, u) − S˜(0)k (β0, u)
S˜
(0)
k (β0, u)
⎞⎠dΛ0k(u) (3.26)
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By Taylor expansion, it can be written as
1
S˜
(0)
k (β˜M , u) − 1S˜(0)k (β0, u) = −
S˜
(1)
k (β∗, u)
S˜
(0)
k (β∗, u)2 (β˜M − β0)
where β∗ is on the line segment between β˜M and β0. Plugging into the first term in (3.26),
we have
∫ t
0
⎛⎝− S˜
(1)
k (β∗, u)
S˜
(0)
k (β∗, u)2
⎞⎠(β˜M − β0){n−1/2d n∑i=1Mik(u)} , (3.27)
where β∗ is on the line segment between β˜M and β0. Due to consistency of β˜M , β∗ also
converges to β0 in probability uniformly. Since S˜
(0)
k (β∗, u) and S˜(1)k (β∗, u) are of bounded
variations and S˜
(0)
k (β∗, u) is bounded away from 0, S˜(1)k (β∗,u)S˜(0)
k
(β∗,u)2 is of bounded variation and
can be written as sum of two monotone functions in t. In addition, it is shown consistency of
β˜M , weak convergence of n−1/2d∑ni=1Mik(u) to zero-mean Gaussian process with continuous
sample paths, and the uniform convergence of S˜
(0)
k (β∗, u) and S˜(1)k (β∗, u). Therefore, by
lemma 1, the quantity in (4.23) converges to zero in probability uniformly in t.
The second term in (3.26), by Taylor expansion series, can be written as
n1/2∫ t
0
⎛⎝− S˜
(1)
k (β∗, u)
S˜
(0)
k (β∗, u)2
⎞⎠(β˜M − β0)S(0)k (β0, t)dΛ0k(u)
Since β˜M and β∗ converge to β0 in probability uniformly in t, S˜(0)k (β∗, u) and S˜(0)k (β0, u)
converges to s
(0)
k (β0, t) in probability uniformly. Also, S˜(1)k (β∗, u) →p s(1)k (β0, t). Since
dΛ0k(u) is bounded, we can show that
n1/2∫ t
0
⎛⎝− S˜
(1)
k (β∗, u)
S˜
(0)
k (β∗, u)2
⎞⎠(β˜M − β0)S(0)k (β0, u)dΛ0k(u) = n1/2lk(β, t)T (β˜M − β0) + op(1),
where lk(β, t)T = ∫ t0 −ek(β,u)dΛ0k(u) and ek(β0, u) = s(1)k (β0, u)/s(0)k (β0, u).
Since S˜
(0)
k (β0, u) converges to s(0)k (β0, u) in probability uniformly and s(0)k (β0, u) is
bounded away from 0, we have S˜
(0)
k (β0, u)−1 →p s(0)k (β0, u)−1. In addition,n−1/2d∑ni=1Mik(u)
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converges to zero-mean Gaussian process with continuous sample paths. Hence, the third
term in (3.26) can be written as
∫ t
0
1
S˜
(0)
k (β0, u) {n−1/2d
n∑
i=1Mik(u)} = ∫ t0 1s(0)k (β0, u) {n−1/2d
n∑
i=1Mik(u)} + op(1)
Due to uniform convergence of S˜
(0)
k (β0, u)−1 to s(0)k (β0, u)−1 where s(0)k (β0, u) is bounded
away from 0 and plug (3.21) into the last term in (3.26), we have
n1/2∫ t
0
⎛⎝S
(0)
k (β0, u) − S˜(0)k (β0, u)
S˜
(0)
k (β0, u)
⎞⎠dΛ0k(u)
= 1√
n
n∑
i=1(1 − ξiα˜ )
K∏
j=1(1 −∆ij)
× ∫ t
0
Yik(u)⎧⎪⎪⎨⎪⎪⎩eβTZik(u) −
E(∏Kj=1(1 −∆1j)eβTZ1k(u)Y1k(u))
E(∏Kj=1(1 −∆1j)Y1k(u))
⎫⎪⎪⎬⎪⎪⎭ dΛ0k(u)s(0)k (β0, u) + op(1)
Combining all the results, we have
n1/2{Λ̃M0k(β˜M , t) −Λ0k(t)}
= n1/2lk(β, t)T (β˜M − β0) + ∫ t
0
1
s
(0)
k (β0, u) {n−1/2d
n∑
i=1Mik(u)}
+ 1√
n
n∑
i=1(1 − ξiα˜ )
K∏
j=1(1 −∆ij)∫ t0 Yik(u)
⎧⎪⎪⎨⎪⎪⎩eβTZik(u) −
E(∏Kj=1(1 −∆1j)eβTZ1k(u)Y1k(u))
E(∏Kj=1(1 −∆1j)Y1k(u))
⎫⎪⎪⎬⎪⎪⎭× dΛ0k(u)
s
(0)
k (β0, u) + op(1) (3.28)
Recall (3.25):
n1/2(β˜M − β0)
= A(β0)−1 {n−1/2 n∑
i=1
K∑
m=1Wim(β0) + n−1/2
n∑
i=1(1 − ξiα˜ )
K∑
m=1∫ τ0 Ωim(β0, t)dΛ0m(t)} + op(1),
where Wik(β) = ∫ τ0 {Zik(t) − ek(β, t)}dMik(t) and
Ωik(β, t) =∏Kj=1(1 −∆ij){Qik(β, t) −Yik(t)E(∏Kj=1(1−∆1j)Q1k(β,t))E(∏Kj=1(1−∆1j)Y1k(t)) } .
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Using the above equation, we have
n1/2{Λ̃M0k(β˜M , t) −Λ0k(t)}
= n−1/2 n∑
i=1[
⎧⎪⎪⎨⎪⎪⎩lk(β, t)TA(β0)−1
K∑
m=1Wim(β0) + ∫ t0 1s(0)k (β0, u)dMik(u)
⎫⎪⎪⎬⎪⎪⎭
+ (1 − ξi
α˜
){lk(β, t)TA(β0)−1 K∑
m=1∫ τ0 Ωim(β0, t)dΛ0m(t)
+ K∏
j=1(1 −∆ij)∫ t0 Yik(u)
⎧⎪⎪⎨⎪⎪⎩eβTZik(u) −
E(∏Kj=1(1 −∆1j)eβTZ1k(u)Y1k(u))
E(∏Kj=1(1 −∆1j)Y1k(u))
⎫⎪⎪⎬⎪⎪⎭ dΛ0k(u)s(0)k (β0, u)}]+ op(1)
= n−1/2 n∑
i=1ηik(β0, t) + n−1/2
n∑
i=1(1 − ξiα˜ )ζik(β0, t) + op(1),
where
ηik(β0, t) = lk(β, t)TA(β0)−1 K∑
m=1Wim(β0) + ∫ t0 1s(0)k (β0, u)dMik(u) and
ζik(β0, t) = lk(β, t)TA(β0)−1 K∑
m=1∫ τ0 Ωim(β0, t)dΛ0m(t)
+ K∏
j=1(1 −∆ij)∫ t0 Yik(u)
⎧⎪⎪⎨⎪⎪⎩eβTZik(u) −
E(∏Kj=1(1 −∆1j)eβTZ1k(u)Y1k(u))
E(∏Kj=1(1 −∆1j)Y1k(u))
⎫⎪⎪⎬⎪⎪⎭ dΛ0k(u)s(0)k (β0, u) .
Let H(t) = (H(1)(t) + H(2)(t)) where H(1)(t) = (H(1)1 (t), . . . ,H(1)K (t))T , H(2)(t) =(H(2)1 (t), . . . ,H(2)K (t))T , H(1)k (t)T = n−1/2∑ni=1 ηik(β0, t), and H(2)k (t)T = n−1/2∑ni=1(1 −
ξi
α˜ )ζik(β0, t). Then, by theorem 2 of Spiekerman and Lin [1998], H(1)(t) = (H(1)1 (t), . . . ,
H
(1)
K (t))T converges weakly to Gaussian process H(1)(t) = (H(1)1 (t), . . . , H(1)K (t))T whose
mean is zero and covariance functions betweenH(1)j (t) andH(1)k (s) is E{η1j(β0, t), η1k(β0, s)}
for t, s ∈ [0, τ] in D[0, τ]K .
We will show weak convergence of H(2)(t) to a zero-mean Gaussian process H(2)(t).
s
(0)
k (β, t) and E(∏Kj=1(1−∆1j)Y1k(t)) are bounded away from zero, lk(β, t)T , eβTZ1k(t)Y1k(t),
E(∏Kj=1(1 − ∆1j)eβTZ1k(t)Y1k(t)), and dΛ0k(t) are of bounded variations based on con-
ditions (b), (c), (d), and (f); A(β0) is positive definite based on (e). Hence, it fol-
lows from Cramer-Wold device and lemma 2 that the finite dimensional distribution of
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H(2)(t) is asymptotically same as that of H(2)(t) for any finite number of time point(t1, . . . , tL). Moreover, we need to show H(2)(t) has tightness. It suffices to show the
marginal tightness of H
(2)
k (t) for each k since space D[0, τ]K is equipped with the uni-
form metric. By applying lemma 2, the marginal tightness follows to H
(2)
k (t). Combining
all the results, H(2)(t) = (H(2)1 (t), . . . ,H(2)K (t))T converges weakly to Gaussian processH(2)(t) = (H(2)1 (t), . . . ,H(2)K (t))T whose mean is zero and covariance functions betweenH(2)j (t) and H(2)k (s) is 1−αα E{ζ1j(β0, t), ζ1k(β0, s)} for t, s ∈ [0, τ] in D[0, τ]K .
H(1)(t) and H(2)(s) are independent since
Cov(H(1)(t),H(2)(s))
= Cov(n−1/2 n∑
i=1ηik(β0, t), n−1/2
n∑
i=1(1 − ξiα˜ )ζik(β0, s))= E(n−1 n∑
i=1ηik(β0, t)
n∑
i=1(1 − ξiα˜ )ζik(β0, s))= E(E{n−1 n∑
i=1ηik(β0, t)
n∑
i=1(1 − ξiα˜ )ζik(β0, s)∣F(t)})= E(n−1 n∑
i=1ηik(β0, t)
n∑
i=1E{(1 − ξiα˜ )∣F(t)}ζik(β0, s))= 0
Therefore, H(t) = (H(1)(t) +H(2)(t)) converges weakly to zero-mean Gaussian processH(t) = (H(1)(t) + H(2)(t)) in D[0, τ]K whose covariance function between H(2)j (t) andH(2)k (s) is E{η1j(β0, t), η1k(β0, s)} + 1−αα E{ζ1j(β0, t), ζ1k(β0, s)}.
3.4 Simulations
We conducted simulation studies to examine the performance of the proposed methods
and to compare them with the Borgan et al. [2000] method for univariate outcomes and the
Kang and Cai [2009] method for multiple outcomes. We also compared separate analysis
with joint analysis. Suppose case-cohort studies have been conducted for diseases 1 and 2.
Then covariate information is collected for the subcohort and all the subjects with disease
1 and/or 2. We generated bivariate failure times from the Clayton–Cuzick model [Clayton
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and Cuzick, 1985] with the conditional survival function
S(t1, t2 ∣ Z1, Z2) = {exp{∫ t10 λ01(t) expβ1Z1 dt}/θ + exp{∫ t20 λ02(t) expβ2Z2 dt}/θ −1}−θ ,
where λ0k(t) and βk (k = 1,2) are the baseline hazard function and the effect of a covariate
for disease k, respectively, and θ is the association parameter between the failure times of the
two diseases. Kendall’s tau is τθ = (2θ + 1)−1. Smaller Kendall’s tau values represent lower
correlation between T1 and T2. Values of 0⋅1, 4, and 10 are used for θ, with corresponding
Kendall’s tau values 0⋅83, 0⋅11, and 0⋅05, respectively. We set the baseline hazard functions
λ01(t) ≡ 2 and λ02(t) ≡ 4. We consider the situation Z1 = Z2 = Z, where Z is generated from
a Bernouilli distribution with pr(Z = 1) = 0⋅5. Censoring times are simulated from a uniform
distribution [0, u], where u depends on the specified level of the censoring probability. We
set the event proportions of approximately 8% and 20% for k = 1, and 14% and 35% for
k = 2. The corresponding u values are 0⋅08 and 0⋅22, respectively, for β1 = 0⋅1; they are 0⋅06
and 0⋅16 for β1 = log 2. The sample size of the full cohort is set to be n = 1000. We create
the subcohort by simple random sampling and consider subcohort sizes of 100 and 200. For
each configuration, 2000 simulations were conducted.
In the first set of simulations, we consider the case that disease 1 is of primary interest.
We compare the performance of our proposed estimator with the estimator of Borgan et al.
[2000]. Table 3.1 summarizes the results. We see that both methods are approximately
unbiased. The average of the estimated standard error of the proposed estimator is close
to the empirical standard deviation, and the coverage rate of the 95% confidence interval is
close to the nominal level. As expected, the variation of the estimators in general decreases
as the subcohort size increases. Our proposed estimators have smaller variance relative to
the estimators of Borgan et al. [2000] in all cases. This shows that the extra information
collected on subjects with the other disease helps to increase efficiency. The efficiency gain
is larger in situations with larger event proportions, smaller subcohort sizes and lower cor-
relation. We also considered disease 2 with β2 = log 2 and conducted additional simulations
to compare our proposed estimator with those of Prentice [1986], Self and Prentice [1988],
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Table 3.1: Simulation result for a single disease outcome: β1 = log(2) = 0.693
Event Size of The proposed method Borgan et al.’s method
proportion subcohort τθ β˜1 SE SD CR βˆ1 SE SD CR SRE
8% 100 0⋅83 0⋅706 0⋅32 0⋅32 94 0⋅705 0⋅33 0⋅33 94 1⋅04
0⋅11 0⋅718 0⋅31 0⋅32 94 0⋅719 0⋅33 0⋅33 94 1⋅07
0⋅05 0⋅708 0⋅32 0⋅32 94 0⋅705 0⋅33 0⋅33 94 1⋅06
200 0⋅83 0⋅715 0⋅28 0⋅28 95 0⋅716 0⋅28 0⋅28 95 1⋅02
0⋅11 0⋅704 0⋅28 0⋅28 95 0⋅705 0⋅28 0⋅29 95 1⋅03
0⋅05 0⋅697 0⋅28 0⋅27 95 0⋅698 0⋅28 0⋅28 95 1⋅05
20% 100 0⋅83 0⋅703 0⋅25 0⋅25 94 0⋅704 0⋅26 0⋅27 95 1⋅13
0⋅11 0⋅694 0⋅23 0⋅23 94 0⋅694 0⋅26 0⋅27 95 1⋅31
0⋅05 0⋅700 0⋅23 0⋅23 94 0⋅701 0⋅26 0⋅26 95 1⋅29
200 0⋅83 0⋅693 0⋅20 0⋅20 95 0⋅692 0⋅21 0⋅21 95 1⋅10
0⋅11 0⋅696 0⋅19 0⋅19 95 0⋅699 0⋅21 0⋅21 95 1⋅17
0⋅05 0⋅694 0⋅19 0⋅19 95 0⋅695 0⋅21 0⋅21 95 1⋅26
SE, average standard errors; SD, sample standard deviation; CR, coverage rate (%) of the
nominal 95% confidence intervals; SRE= SD2c/SD2p, sample relative efficiency, where SDc
and SDp are the sample standard deviation for the Borgan et al. [2000]’s method and the
proposed method, respectively.
Kalbfleisch and Lawless [1988], and Barlow [1994]. Similar results were obtained but are
not presented in the paper due to space limitations.
In the second set of simulations, we are interested in the joint analysis of the two diseases.
We fit the following models:
λik(t ∣ Zi) = Yik(t)λ0k(t)eβkZi (k = 1,2; i = 1, . . . , n).
We compare the performance of the proposed estimator with the estimator of Kang and
Cai [2009]. Table 3.2 provides summary statistics for the estimator of β1 for different
combinations of event proportion, subcohort sample size, and correlation. The estimates
from both methods are nearly unbiased, and their estimated standard errors are close to
the empirical standard deviations. Our method is more efficient than that of Kang and
Cai [2009]. The efficiency gain is very limited when the event proportion is small. Higher
efficiency gains are associated with smaller subcohort sizes. Estimates for β2 are not shown
in Table 3.2, but the overall performance is similar to that of β1.
We also compared separate analysis of the two diseases with the joint analysis using the
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Table 3.2: Simulation result for multiple disease outcomes: [β1, β2] = [0.1, 0.7]
Event Size of The proposed method Kang & Cai’s method SRE
proportion subcohort τθ β˜
M
1 SE SD CR βˆ
M
1 SE SD CR βˆ1[8%,14%] 100 0⋅83 0⋅099 0⋅31 0⋅30 95 0⋅101 0⋅32 0⋅31 95 1⋅07
0⋅11 0⋅101 0⋅30 0⋅30 95 0⋅098 0⋅32 0⋅32 95 1⋅13
0⋅05 0⋅109 0⋅30 0⋅31 94 0⋅111 0⋅32 0⋅33 94 1⋅11
200 0⋅83 0⋅106 0⋅26 0⋅27 95 0⋅105 0⋅27 0⋅27 95 1⋅04
0⋅11 0⋅096 0⋅26 0⋅26 94 0⋅096 0⋅27 0⋅27 94 1⋅05
0⋅05 0⋅098 0⋅26 0⋅27 94 0⋅098 0⋅27 0⋅27 94 1⋅05[20%,35%] 100 0⋅83 0⋅098 0⋅23 0⋅24 94 0⋅094 0⋅26 0⋅27 94 1⋅24
0⋅11 0⋅099 0⋅22 0⋅22 94 0⋅097 0⋅26 0⋅26 95 1⋅42
0⋅05 0⋅095 0⋅22 0⋅22 94 0⋅101 0⋅26 0⋅27 95 1⋅44
200 0⋅83 0⋅103 0⋅19 0⋅19 94 0⋅104 0⋅20 0⋅21 95 1⋅19
0⋅11 0⋅098 0⋅18 0⋅18 95 0⋅097 0⋅20 0⋅20 95 1⋅29
0⋅05 0⋅098 0⋅18 0⋅18 95 0⋅100 0⋅20 0⋅20 96 1⋅31
SE, average standard errors; SD, sample standard deviation; CR, coverage rate (%) of the
nominal 95% confidence intervals; SRE= SD2e/SD2p, sample relative efficiency, where SDe
and SDp are the sample standard deviation for the Kang and Cai [2009]’s method and the
proposed method, respectively.
Table 3.3: Comparison between separate and joint analysis: β1 = log 2, Pr(∆ = 1)=0.2
Separate analysis
Size of The proposed weight Borgan at al.’s method
subcohort τθ β˜1 SE SD βˆ1 SE SD
100 0⋅83 0⋅713 0⋅244 0⋅245 0⋅716 0⋅263 0⋅265
0⋅11 0⋅702 0⋅226 0⋅236 0⋅705 0⋅262 0⋅270
0⋅05 0⋅700 0⋅226 0⋅232 0⋅710 0⋅263 0⋅268
200 0⋅83 0⋅703 0⋅196 0⋅194 0⋅704 0⋅206 0⋅206
0⋅11 0⋅697 0⋅186 0⋅193 0⋅699 0⋅205 0⋅213
0⋅05 0⋅698 0⋅186 0⋅187 0⋅702 0⋅206 0⋅209
Joint analysis
Size of The proposed weight Kang and Cai’s method
subcohort τθ β˜
M
1 SE SD βˆ
M
1 SE SD
100 0⋅83 0⋅711 0⋅243 0⋅245 0⋅713 0⋅262 0⋅264
0⋅11 0⋅701 0⋅226 0⋅235 0⋅701 0⋅261 0⋅267
0⋅05 0⋅700 0⋅225 0⋅231 0⋅707 0⋅262 0⋅266
200 0⋅83 0⋅703 0⋅195 0⋅194 0⋅703 0⋅205 0⋅205
0⋅11 0⋅696 0⋅186 0⋅193 0⋅697 0⋅205 0⋅212
0⋅05 0⋅698 0⋅186 0⋅187 0⋅700 0⋅205 0⋅209
SE, average standard errors; SD, sample standard deviation.
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Table 3.4: Type I error and power (%) in separate and joint analyses: Pr(∆ = 1)=0.2
Type I error (β1 = β2 = log 2) Power (β1 = 0⋅1, β2 = 0⋅7)
Size of Separate analysis Joint analysis Separate analysis Joint analysis
subcohort τθ P BR P KC P BR P KC
100 0⋅83 0⋅6 0⋅6 6⋅3 6⋅7 49 42 90 78
0⋅11 0⋅8 1⋅7 5⋅9 5⋅9 56 42 83 61
0⋅05 1⋅2 2⋅1 5⋅1 5⋅6 59 43 81 61
200 0⋅83 0⋅2 0⋅3 5⋅2 5⋅8 80 72 98 94
0⋅11 1⋅6 1⋅9 5⋅4 5⋅4 77 65 89 78
0⋅05 1⋅8 2⋅5 5⋅3 5⋅4 79 68 90 79
P, the proposed weight; BR, the method of Borgan et al. [2000]; KC, the method of Kang
and Cai [2009].
proposed method. Data were generated satisfying the following model:
λk(t ∣ Z1, Z2) = λ0k(t)eβkZ+β3Z∗ (k = 1,2),
where β1 represents the effect of Z on the risk of disease 1, β2 represents the effect of Z
on the risk of disease 2, and β3 represents the common effect of Z
∗ for both diseases. We
set β1 = β2 = log 2 and β3 = 0⋅1. Table 3.3 summarizes the results for β1. The sample
standard deviations of Kang & Cai’s estimator in the joint analysis are slightly smaller
than Borgan’s estimator in the separate analysis. The sample standard deviations of the
proposed estimators are similar in the joint and separate analyses, and they are smaller
than Kang & Cai’s and Borgan’s estimators, respectively. Conclusions for the estimator of
β2 are similar. We also conducted hypothesis tests for H0 ∶ β1 = β2. Table 3.4 presents the
Type I error rates and power of the tests at the 0⋅05 significance level. The tests under
the separate analysis treat the two estimates, βˆ1 and βˆ2, as from two independent samples.
Type I error rates from separate analyses are much lower than 5% while those from the
joint analysis are close to 5%. The settings for power analysis are the same as before except
that β1 = 0⋅1 and β2 = 0⋅7. Tests based on the proposed methods are more powerful than
those based on Kang & Cai’s and Borgan’s methods, and the joint analysis produces more
powerful tests than the separate analysis.
49
3.5 Data analysis
We apply the proposed method to analyze data from the Busselton Health Study [Cullen,
1972; Knuiman et al., 2003], conducted in the south-west of Western Australia, and intended
to evaluate the association between coronary heart disease and stroke and their risk factors.
General health information for adult participants was obtained by questionnaire every three
years from 1966 to 1981. This study population consists of 1612 men and women aged
40-89 who participated in 1981 and were free of coronary heart disease or stroke at that
time. Coronary heart disease event is defined as hospital admission, any procedure, or
death related to coronary heart disease. Stroke event is defined as hospital admission, any
procedure, or death from stroke. The outcomes of interest were time to the first coronary
heart disease event and time to the first stroke event. The event time for a subject was
considered censored if the subject was free of that event type by December 31, 1998 or lost
to follow-up during the study period.
One of the main interests of the study was to compare the effect of serum ferritin on
coronary heart disease with its effect on stroke. To reduce cost and preserve stored serum,
case-cohort sampling was used. Serum ferritin was measured for all the subjects with
coronary heart disease and/or stroke as well as those in the subcohort. We conduct a joint
analysis of the two diseases. In our analysis, the full cohort consists of 1210 subjects with
viable blood serum samples, which includes 174 subjects with only coronary heart disease,
75 with only stroke, and 43 with both diseases. The subcohort consisted of 334 disease-
free subjects, 61 with only coronary heart disease, 36 with only stroke, and 19 with both
diseases. The total number of assayed sera samples was 626. If a subject was censored and
free of both events at the censoring time, then the censoring times for the two disease events
were the same. Two subjects died due to both coronary heart disease and stroke, for whom
the times for both events were the same. No other subjects died at the first diagnosis of
either disease. For this study, it is reasonable to assume, as in the original study [Knuiman
et al., 2003], that censoring was conditionally independent of the event processes.
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Table 3.5: Analysis results for the Busselton Health Study
Proposed method Kang & Cai method
Variables β˜M SE HR 95% CI βˆM SE HR 95% CI
log(ferritin) on CHD 0⋅145 0⋅0897 1⋅16 (0⋅97, 1⋅38) 0⋅092 0⋅0949 1⋅10 (0⋅91, 1⋅32)
log(ferritin) on Stroke 0⋅172 0⋅1219 1⋅19 (0⋅93, 1⋅51) 0⋅186 0⋅1304 1⋅20 (0⋅93, 1⋅56)
Age 0⋅071 0⋅0069 1⋅07 (1⋅06, 1⋅09) 0⋅069 0⋅0070 1⋅07 (1⋅06, 1⋅09)
Triglycerides 0⋅239 0⋅0484 1⋅27 (1⋅16, 1⋅40) 0⋅232 0⋅0541 1⋅26 (1⋅13, 1⋅40)
BPT 0⋅423 0⋅1633 1⋅53 (1⋅11, 2⋅10) 0⋅408 0⋅1727 1⋅50 (1⋅07, 2⋅11)
CHD, coronary heart disease; BPT, Blood pressure treatment; SE, standard error; HR,
hazard ratio; CI, confidence interval.
We fit the following model
λk(t ∣ Z1, Z2, Z3, Z4) = λ0k(t)eβ1kZ1+β2kZ2+β3kZ3+β4kZ4 (k = 1,2),
where Z1, Z2, Z3, and Z4 denote the logarithm of serum ferritin level, age in years, triglyc-
erides in millimoles per liter, and whether subjects had blood pressure treatment, respec-
tively. We then tested H0 ∶ β21 = β22, β31 = β32, β41 = β42 based on the proposed method,
and the p-value is 0⋅138. Therefore, we fit the final model
λk(t ∣ Z1, Z2, Z3, Z4) = λ0k(t)eβ1kZ1+β2Z2+β3Z3+β4Z4 (k = 1,2).
Table 3.5 summarizes the results of the final fit. With a 1 unit increase in the logarithm
of the serum ferritin level, the hazard ratio for coronary heart disease risk is increased by
16% and for stroke risk by 19%. When we tested H0 ∶ β11 = β12, H0 was not rejected with
the p-value = 0⋅823. We also fit the same model using Kang and Cai [2009]’s method. The
standard errors for the effects of the logarithm of the serum ferritin level are slightly larger,
0⋅0949 for coronary heart disease and 0⋅1304 for stroke.
3.6 Concluding remarks
When disease rates are low, the efficiency gain of the proposed method is not large.
When the event rates are low, the number of cases is small, and consequently, the amount
of extra information is small. In the case of common diseases, sampling all cases in the
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traditional case-cohort design with multiple diseases limits applications [Breslow and Well-
ner, 2007]. Instead, a generalized case-cohort design [Cai and Zeng, 2007] in which cases
are sampled can be considered. Extending the proposed weights to this general case merits
further investigation.
In our proposed estimation framework, time-dependent covariates can be allowed. How-
ever, estimation generally requires one to know the entire history of time-dependent co-
variates. In many follow-up studies, this may not be true. One commonly used approach
for handling time-dependent covariates is to consider the last-value-carry-forward, but this
could introduce bias. A more sensible approach is to consider the joint modeling of survival
times and longitudinal covariates via shared random effects, which has not been studied for
case-cohort data.
When studying multiple diseases, different diseases may be competing risks for the same
subject. In a competing risks situation, a subject can only experience at most one event; in
the situation we considered, a subject can still experience the other events. Consequently, in
the competing risks situation, a subject is at risk for all types of events simultaneously and
will not be at risk for any other events as soon as one event occurs. Our approach in this
paper can be adapted to competing risks by modifying the at-risk process and the weight
function, but analysis will be based on the cause-specific hazards as studied in Sorensen
and Andersen [2000].
The current method is based on estimating equations, which improves the estimation
efficiency by incorporating a refined weight function for the risk set. However, it is not
semiparametric efficient. To derive the most efficient estimator, we need to specify the joint
distribution of the correlated failure times from the same subject and consider nonparamet-
ric maximum likelihood estimation based on the joint likelihood function for case-cohort
sampling. This may be very challenging, especially when expensive covariates are continu-
ous. This is an interesting topic which warrants future research.
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Chapter 4
Stratified case-cohort studies with nonrare
events
4.1 Introduction
Case-cohort study design is an economical means for large cohort studies since it can
be expensive to assemble covariate information for all cohort members [Prentice, 1986]. To
conduct case-cohort design, there are two sampling steps. First, a random sample from
the full cohort, named the subcohort, is selected via simple random sampling. Second, we
sample subjects having diseases of interest outside the subcohort. The covariate information
on the exposure is obtained for the subcohort members as well as sampled cases or failures.
In biomedical studies some covariate information is often available for all subjects in the
cohort such as age or gender and these covariate information could be used to define strata
variables. Under the situation, the subcohort can be selected via stratified random sampling
based on strata variables, which could lead to more powerful and efficient case-cohort study
than unstratified case-cohort study using simple random sampling of the subcohort [Borgan
et al., 2000]. Kulich and Lin [2004] and Samuelsen et al. [2007] proposed stratified case-
cohort design by using the covariate data outside the case-cohort sample and using local
averaging method, respectively.
For case-cohort studies with a single disease outcome as well as multivariate disease
outcomes, extensive progress has been made. From unstratified case-cohort data, Pren-
tice [1986] proposed a pseudo-likelihood approach, Self and Prentice [1988] proposed the
inference of a slightly modified pseudo-likelihood estimator, and Barlow [1994] developed a
robust estimator of the variance with a time-varying weight. For multivariate failure time
outcomes, Lu and Shih [2006] proposed estimation for case-cohort studies for clustered fail-
ure time. In order to be able to compare the effects of a risk factor on different diseases,
Kang and Cai [2009] developed the estimation procedure based on the joint analysis in
generalized case-cohort studies. By using stratum variables, stratified case-cohort design
with a single disease outcome has been studied [Borgan et al., 2000; Kulich and Lin, 2000a,
2004].
Aforementioned methods were considered in traditional case-cohort design when diseases
are infrequent. However, in many biomedical studies, the disease rate may not be low or the
number of cases is large. Under the situation, Cai and Zeng [2007] proposed the generalized
case-cohort design by selecting a subset of all cases or failures. When stratum variables are
available for all cohort members, Kang and Cai [2010] considered stratified generalized case-
cohort design by using stratified random sampling of the subcohort and cases. For example,
the Atherosclerosis Risk in Communities (ARIC) study is to investigate the association
between high-sensitivity C-reactive protein (hs-CRP) and incident diabetes events. Since
the disease rate of incident diabetes is 11.2% and frozen biologic specimen from which hs-
CRP can be measured should be conserved, selecting all subjects with incident diabetes is
prohibited. To preserve frozen biologic specimen and save cost, the generalized case-cohort
study was conducted by sampling a subset of diabetes cases. Based on age (≤ 55, > 55),
gender, and race, the subcohort and a subset of diabetes cases were selected via stratified
sampling.
When it is of interest to study the effect of one risk factor on multiple diseases, several
case-cohort studies were conducted separately. For example, another case-cohort study for
association between hs-CRP and incident coronary heart diseases (CHD) had been con-
ducted in the ARIC study [Ballantyne et al., 2004]. In this study, hs-CRP information was
available on the subcohort as well as all incident coronary heart diseases. When construct-
ing estimating equations for diabetes in generalized stratified case-cohort studies, hs-CRP
information for subjects collected from CHD cases was not used. This motivates us to con-
sider a different approach which can utilize all available exposure information in generalized
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stratified case-cohort studies.
In this paper, we develop estimation procedure for generalized stratified case-cohort
study design with a single disease outcome as well as multiple disease outcomes by using all
available exposure information. In section 4.2, we propose models and estimation procedures
for the proposed methods. Section 4.3 summarizes asymptotic properties to be proved for
the proposed estimators and section 4.4 reports some simulation results. In section 4.5,
we apply our proposed methods to data from the ARIC study. In section 4.6, concluding
remarks are provided.
4.2 Model and estimation
4.2.1 Model
Suppose that there are n independent subjects and K diseases of interest in a cohort
which can divided into L mutually exclusive strata using information available for all the
cohort members. Suppose that the total size of cohort n is partitioned into nl intervals for
l = 1, . . . , L. Let Tlik be the failure time, Clik the potential censoring time, and Zlik(t) be
a p × 1 possibly time-dependent covariates vector for disease k of subject i in stratum l.
Let Xlik = min(Tlik,Clik) denote the observed time, ∆lik = I(Tlik ≤ Clik) the indicator for
failure, Nlik(t) = I(Xlik ≤ t,∆lik = 1) the counting process for the observed failure time, and
Ylik(t) = I(Xlik ≥ t) the at risk indicator for disease k of subject i in stratum l, where I(.)
is the indicator function.
We assume that all the time-dependent covariates are external [Kalbfleisch and Prentice,
2002] and Tlik is independent of Clik for given possibly time-dependent covariates Zlik(t).
Let τ denote the end of study time. For disease k of subject i in stratum l, the hazard
function λlik(.) associated with Zlik(t) is given by
λlik{t∣Zlik(t)} = Ylik(t)λ0k(t)eβT0 Zlik(t), (4.1)
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where λ0k(t) is an unspecified baseline hazard function for disease k of subject i in stra-
tum l and β0 is p-dimensional fixed and unknown parameters. Model(4.1) can incorpo-
rate disease-type-specific effect model λlik{t∣Z∗lik(t)} = Ylik(t) λ0k(t)eβTk Z∗lik(t) as a special
case. Specifically, we define βT0 = (βT1 , . . . , βTk , . . . , βTK) and Zlik(t)T = (0Tli1, . . . ,0Tli(k−1),{Z∗lik(t)}T ,0Tli(k+1), . . . ,0TliK) where 0T is 1 × p zero vector. We have βT0 Zlik(t) = βTk Z∗lik(t).
Since obtaining Z for all the subjects in the cohort can be very expensive, a generalized
case-cohort design is often used where a subcohort and a sample of disease cases from each
stratum are selected to measure Z’s values. Let Vik denote the discrete random variable
for indicating stratum for subject i with disease k. The stratum variable is assumed to be
independent of Tlik given Zlik(t) [Kulich and Lin, 2004].
Under generalized case-cohort design with stratified sampling, subjects in the subcohort
are assumed to be selected by stratified random sampling. Specifically, we select a fixed
size n˜l subjects from nl subjects in stratum l into the subcohort by using simple random
sampling without replacement. Let the total size of the subcohort be n˜ = ∑Ll=1 n˜l and α˜l =
Pr(ξli = 1) = n˜l/nl be the selection probability of subject i in stratum l into the subcohort,
where ξli = 1 denotes that subject i in stratum l is selected into the subcohort and ξli = 0
denotes otherwise. After sampling the subcohort, stratified random samples of cases outside
of the subcohort for each disease outcome are drawn. Specifically, for disease k in stratum
l, we select m˜lk cases outside of the subcohort using simple random sampling without
replacement. Let γ˜lk = Pr (ηlik = 1∣∆lik = 1, ξli = 0) = m˜lk/(nlk − n˜lk) denote the selection
probability of subjects among non-subcohort members with disease k in stratum l, where
ηlik is the indicator for whether subject i with disease k in stratum l among non-subcohort
members is sampled, nlk and n˜lk denote the number of subjects with disease k in the cohort
and in the subcohort in stratum l, respectively. For k ≠ k′ or l ≠ l′, (ηl1k, . . . , ηlnlk) is
independent of (ηl′1k′ , . . . , ηl′nlk′); however, (ηl1k, . . . , ηlnlk) are correlated because of the
sampling scheme.
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4.2.2 Estimation
The observable information for subject i is (Xlik,∆lik, Zlik(t), Vik,0 ≤ t ≤ Xlik) when
ξli = 1 or ηlik = 1 and (Xlik,∆lik, Vik) when ξli = 0 and ηlik = 0 (k = 1, . . . ,K). If we ignore
the covariate information available for the sampled subjects with other diseases outside of
the subcohort, the relative risk parameter β0 can be estimated by the weighted estimating
equation, UˆKC(β) = 0 [Kang and Cai, 2010] where
UˆKC(β) = L∑
l=1
nl∑
i=1
K∑
k=1∫ τ0 wlik(t)
⎧⎪⎪⎨⎪⎪⎩Zlik(t) − Sˆ
(1)
k (β, t)
Sˆ
(0)
k (β, t)
⎫⎪⎪⎬⎪⎪⎭dNlik(t), (4.2)
Sˆ
(d)
k (β, t) = n−1∑Ll=1∑nli=1wlik(t)Ylik(t)Zlik(t)⊗deβTZlik(t) for d = 0,1 and 2 and wlik(t) is
a time-varying weight function which has the follow form: wlik(t) = (1 − ∆lik)ξliαˆ−1lk (t) +
∆likξli+∆lik(1−ξli)ηlikγˆ−1lk (t), where αˆlk(t) = ∑nli=1(1−∆lik)ξliYlik(t)/{∑nli=1(1−∆lik)Ylik(t)},
γˆlk(t) = ∑nli=1 ∆lik(1 − ξli)ηlikYlik(t)/{∑nli=1 ∆lik(1 − ξli)Ylik(t)}. Note that we can set K = 1
in (4.2) if we are interested in only one disease. If γˆlk(t) for all k is 1, then the generalized
stratified case-cohort design is reduced to the traditional stratified case-cohort design whose
the weight function ρlik(t) = (1 −∆lik)ξliαˆ−1lk (t) +∆lik.
Note that Sˆ
(d)
k (β, t) only uses the covariate information collected for the subcohort and
the subset of subjects with disease k outside of the subcohort. In other words, covariate
information collected on the subset of subjects with other diseases outside the subcohort
is ignored when calculating Sˆ
(d)
k (β, t) in the estimating equation. To make use of available
information about other diseases, we propose the proposed weight with two types of diseases
(i.e. K = 2). The key idea in the proposed weight function with two types of diseases is
that the weight for one type of the disease uses the covariate information collected on
the selected subjects with the other type of the disease. Specifically, subcohort subjects
without any disease (i.e. ∏2j=1(1 −∆lij)ξli = 1) are weighted by α˜lk(t)−1, the inverse of the
estimated selection probabilities, while subjects with disease 1 or disease 2 in the subcohort
(i.e. {1 −∏2j=1(1 − ∆lij)}ξli = 1) are weighted by 1. To use the information collected on
the sampled subjects with disease 2, the sampled non-subcohort subjects with disease 1
(i.e. ∆li1(1 − ξli)ηli1 = 1) can be decomposed into two groups: those with only disease
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1 (i.e. ∆li1(1 − ∆li2)(1 − ξli)ηli1 = 1) and those with both disease 1 and disease 2 (i.e.
∆li1∆li2(1−ξli)ηli1 = 1). The sampled subjects in the first group (i.e. ∆li1(1−∆li2)(1−ξli) =
1) are weighted by γ˜l1k(t)−1, the inverse of their estimated sampling probabilities. Similarly,
the sampled non-subcohort subjects with disease 2 can also be decomposed into two groups:
those with only disease 2 (i.e. ∆li1(1−∆li2)(1−ξli)ηli2 = 1) and those with both disease (i.e.
∆li1∆li2(1 − ξli)ηli2 = 1). Those with only disease 2 are weighted by γ˜l2k(t)−1, the inverse
of their estimated sampling probabilities. For those sampled non-subcohort subjects with
both diseases, they can be weighted by either γ˜−1l3k(t) or γ˜−1l4k(t), the inverse of the estimated
sampling probability based on disease 1 and disease 2, respectively. We take the average
of ∆li1∆li2(1 − ξli)ηli1γ˜−1l3k(t) and ∆li1∆li2(1 − ξli)ηli2γ˜−1l4k(t) as the weight for this group.
Therefore, the proposed weight with two types of diseases has the following form:
pilik(t) = Π2j=1(1 −∆lij)ξliα˜−1lk (t) + {1 −Π2j=1(1 −∆lij)} ξli
+ ∆li1(1 −∆li2)(1 − ξli)ηli1γ˜−1l1k(t) + (1 −∆li1)∆li2(1 − ξli)ηli2γ˜−1l2k(t)
+ 1
2
∆li1∆li2(1 − ξli)ηli1γ˜−1l3k(t) + 12∆li1∆li2(1 − ξli)ηli2γ˜−1l4k(t), (4.3)
where
α˜lk(t) = ∑nli=1 Π2j=1(1 −∆lij)ξliYlik(t)∑nli=1 Π2j=1(1 −∆lij)Ylik(t) , γ˜l1k(t) = ∑
nl
i=1 ∆li1(1 −∆li2)(1 − ξli)ηli1Ylik(t)∑nli=1 ∆li1(1 −∆li2)(1 − ξli)Ylik(t)
γ˜l2k(t) = ∑nli=1(1 −∆li1)∆li2(1 − ξli)ηli2Ylik(t)∑nli=1(1 −∆li1)∆li2(1 − ξli)Ylik(t) , γ˜l3k(t) = ∑
nl
i=1 ∆li1∆li2(1 − ξli)ηli1Ylik(t)∑nli=1 ∆li1∆li2(1 − ξli)Ylik(t)
γ˜l4k(t) = ∑nli=1 ∆li1∆li2(1 − ξli)ηli2Ylik(t)∑nli=1 ∆li1∆li2(1 − ξli)Ylik(t) .
Note that if all cases outside the subcohort are selected, the weight functions in (4.28)
reduce to φlik(t) =∏Kj=1(1 −∆lij)ξliα˜−1lk (t) + {1 −∏Kj=1(1 −∆lij)}.
Using the proposed weight functions in (4.28), we propose the following weighted esti-
mating functions for the estimation of the regression coefficient:
U˜G(β) = L∑
l=1
nl∑
i=1
K∑
k=1∫ τ0 pilik(t)
⎧⎪⎪⎨⎪⎪⎩Zlik(t) − S˜
(1)
k (β, t)
S˜
(0)
k (β, t)
⎫⎪⎪⎬⎪⎪⎭dNlik(t), (4.4)
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where S˜
(d)
k (β, t) = n−1∑Ll=1∑nli=1 pilik(t)Ylik(t)Zlik(t)⊗deβTZlik(t) for d = 0,1 and 2. The
solution to U˜G(β) = 0 is defined to be the estimator β˜G for the regression parameter β0.
A Breslow-Aalen type estimator of the baseline hazard cumulative hazard function is
Λ˜0k(β˜G, t) which is given by
Λ˜0k(β, t) = ∫ t
0
∑Ll=1∑nli=1 pilik(u)dNlik(u)
nS˜
(0)
k (β,u) .
4.3 Asymptotic properties
In this section, we summarize the asymptotic properties for the proposed methods. We
will show the asymptotic properties of the proposed estimator only for two types of diseases.
The other situations can be proved similarly. We make the following assumptions:
(a) {Tli,Cli, Zli}, i = 1, . . . , n and l = 1, . . . , L are independent and identically distributed
where Tli = (Tli1, . . . , TliK)T , Cli = (Cli1, . . . ,CliK)T , and Zli = (Zli1, . . . , ZliK)T ;
(b) P{Ylik(t) = 1} > 0 for t ∈ [0, τ] , i = 1, . . . , n, l = 1, . . . , L and k = 1,2;
(c) ∣Zlik(0)∣ + ∫ τ0 ∣dZlik(t)∣ < Dz < ∞, i = 1, . . . , n, l = 1, . . . , L and k = 1,2 almost surely
and Dz is a constant;
(d) (Asymptotic stability) For d = 0,1,2, there exists a neighborhood B of β0 such that
s
(d)
k (β, t) are continuous functions and supt∈[0,τ],β∈B ∥S(d)k (β, t)−s(d)k (β, t)∥ pÐ→ 0 where
S
(d)
k (β, t) = n−1∑Ll=1∑nli=1 Ylik(t)Zlik(t)⊗deβTZlik(t);
(e) The matrix Ak(β0) = ∫ τ0 vk(β0, t)s(0)k (β0, t)λ0k(t)dt is positive definite for k = 1,2
where vk(β, t) = s(2)k (β, t)/s(0)k (β, t) − ek(β, t)⊗2 and ek(β, t) = s(1)k (β, t)/s(0)k (β, t);
(f) (Asymptotic regularity) For all β ∈ B, t ∈ [0, τ], and k = 1,2, S(1)k (β, t) = ∂∂βS(0)k (β, t),
and S
(2)
k (β, t) = ∂2∂β∂β′ S(0)k (β, t), where S(d)k (β, t), d = 0,1,2 are continuous functions
of β ∈ B uniformly in t ∈ [0, τ] and are bounded on B × [0, τ], s(0)k is bounded away
from zero on B × [0, τ];
(g) (Finite interval) For all k = 1,2, ∫ τ0 λ0k(t)dt <∞;
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To show the desired asymptotic properties for generalized case-cohort samples, the following
conditions are also needed:
(h) For all l = 1, . . . , L, limnl→∞ α˜l = αl, where α˜l = n˜l/nl and α is a positive constant.
(i) limnl→∞ γ˜l1 = limnl→∞ γ˜l3 = γl1, limnl→∞ γ˜l2 = limnl→∞ γ˜l4 = γl2 where γ˜l1 = Pr[ηli1 =
1∣∆li1(1−∆li2) = 1, ξli = 0] = m˜l,10/(nl,10− n˜l,10), m˜l,10 denotes the number of sampled
non-subcohort subjects in the lth stratum with only disease 1, but not disease 2 (i.e.
∆li1(1−∆li2) = 1), nl,10 and n˜l,10 denote the number of subjects with only diseases 1,
but not disease 2 (i.e. ∆li1(1−∆li2) = 1) in the cohort and the subcohort in lth stratum,
respectively, γ˜l2 = Pr[ηli2 = 1∣(1 − ∆li1)∆li2 = 1, ξli = 0] = m˜l,01/(nl,01 − n˜l,01), m˜l,01
denotes the number of sampled non-subcohort subjects in the lth stratum with only
disease 2, but not disease 1 (i.e. (1−∆li1)∆li2 = 1), nl,01 and n˜l,01 denote the number
of subjects with only diseases 2, but not disease 1 (i.e. (1−∆li1)∆li2 = 1) in the cohort
and the subcohort in lth stratum, respectively, γ˜l3 = Pr[ηli1 = 1∣∆li1∆li2 = 1, ξli = 0] =
m˜l,111/(nl,11 − n˜l,11), m˜l,111 denotes the number of non-subcohort subjects with both
disease 1 and disease 2 who are sampled with respect to disease 1 in the lth stratum,
nl,11 and n˜l,11 denote the number of subjects with both diseases 1 and disease 2 in
the cohort and the subcohort in lth stratum, respectively, γ˜l4 = Pr[ηli2 = 1∣∆li1∆li2 =
1, ξli = 0] = m˜l,112/(nl,11 − n˜l,11), m˜l,112 denotes the number of non-subcohort subjects
with both disease 1 and disease 2 who are sampled with respect to disease 2 in the
lth stratum, and γlk is a positive constant on (0,1] for all k = 1,2 and l = 1, . . . , L.
(j) limn→∞ nl/n=ql, where ql is a positive constant on (0,1) for all l = 1, . . . , L.
We summarize the asymptotic properties of β˜G in the following theorem.
Theorem 3. Under the regularity conditions (a)-(j), β˜G converges in probability to β0 and
n1/2(β˜G−β0) is asymptotically normally distributed with mean zero and with the covariance
matrix
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A(β0)−1ΣG(β0)A(β0)−1, where
A(β) = 2∑
k=1Ak(β), ΣG(β) =
L∑
l=1 ql[VI,l(β) + 1 − αlαl VII,l(β) + (1 − αl)
2∑
k=1VIII,lk(β)],
VI,l(β) = El[ 2∑
k=1Ql1k(β)]⊗2,
VII,l(β)
= Varl[ 2∏
j=1(1 −∆l1j)
2∑
k=1∫ τ0 [Rl1k(β, t) − Yl1k(t)El(∏
2
j=1(1 −∆l1j)Rl1k(β, t))
El(∏2j=1(1 −∆l1j)Yl1k(t)) ]dΛ0k(t)],
VIII,lk(β)
= Pr(Θl10)1 − γl1
γl1
Varl(Ql1k(β) − ∫ τ
0
Yl1k(t)El{dQl1k(β, t)∣Θl10, ξl1 = 0}
El{Yl1k(t)∣Θl10} ∣Θl10, ξl1 = 0)+ Pr(Θl01)1 − γl2
γl2
Varl(Ql1k(β) − ∫ τ
0
Yl1k(t)El{dQl1k(β, t)∣Θl01, ξl1 = 0}
El{Yl1k(t)∣Θl01} ∣Θl01, ξl1 = 0)+ 1
4
Pr(Θl11)1 − γl1
γl1
Varl(Ql1k(β) − ∫ τ
0
Yl1k(t)El{dQl1k(β, t)∣Θl11, ξl1 = 0}
El{Yl1k(t)∣Θl11} ∣Θl11, ξl1 = 0)+ 1
4
Pr(Θl11)1 − γl2
γl2
Varl(Ql1k(β) − ∫ τ
0
Yl1k(t)El{dQl1k(β, t)∣Θl11, ξl1 = 0}
El{Yl1k(t)∣Θl11} ∣Θl11, ξl1 = 0),
Qlik(β) = ∫ τ
0
{Zlik − ek(β, t)}dMlik(t),Θljk = {(∆l11 = j and ∆l12 = k)},
Rlik(β, t) = Ylik(t)[Zlik(t) − ek(β, t)]eβTZlik(t).
Note that ΣG(β) consists of three parts. The first part VI,l(β) is a contribution to
the variance from the full cohort, the second part VII,l(β) and the last part VIII,lk(β) are
due to sampling the subcohort from the full cohort and due to sampling a portion of cases
in non-subcohort. For cohort studies, the second and last part vanish and their variance
is only first part VI,l(β). If traditional stratified case-cohort studies are conducted, then
the last part goes to zero and so the first and second parts are remained. For unstratified
generalized case-cohort studies (i.e. L = 1 and ql = 1), variance consists of VI,1(β), VII,1(β),
and VIII,1k(β).
We summarize the asymptotic property of the proposed baseline cumulative hazard
estimator Λ˜0k(β˜G, t).
Theorem 4. Under the regularity conditions (a)-(j), Λ˜0k(β˜G, t) is a consistent estimator of
Λ0k(t) in t ∈ [0, τ] and P (t) = [P1(t), P2(t)]T = [n1/2(Λ˜01(β˜G, t)−Λ01(t)), n1/2(Λ˜02(β˜G, t)−
Λ02(t))]T converges weakly to the Gaussian process P(t) = {P1(t),P2(t)}T in D[0, τ]K
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with mean zero and the following covariance function Pjk(t, s) between Pj(t) and Pk(s) for
j ≠ k.
Pjk(t, s)(β0) = L∑
l=1 ql[El{vl1j(β0, t)vl1k(β0, s)}+ 1 − αl
αl
El{ζl1j(β0, t)ζl1k(β0, s)} +El{ϕl1j(β0, t)ϕl1k(β0, s)}],
where
vlik(β, t) = lk(β, t)TA(β)−1 2∑
m=1Qlim(β, t) + ∫ t0 1s(0)k (β,u)dMlik(u),
ζlik(β, t) = lk(β, t)TA(β)−1 2∑
m=1∫ τ0 Ωlim(β,u)dΛ0m(u)
+ 2∏
j=1(1 −∆lij)∫ t0 Ylik(u){eβTZlik(u) − El(∏
K
j=1(1 −∆l1j)eβTZl1k(u)Yl1k(u))
El(∏Kj=1(1 −∆l1j)Yl1k(u)) } dΛ0k(u)s(0)k (β,u) ,
ϕlik(β, t) = lk(β, t)TA(β)−1 2∑
m=1(1 − ξli)[∆li1(1 −∆li2)(ηli1γ˜l1 − 1)B(1)lim(β, t∣Θl10)+(1 −∆li1)∆li2(ηli2
γ˜l2
− 1)B(1)lim(β, t∣Θl01) + 12∆li1∆li2{(ηli1γ˜l1 − 1)B(1)lim(β, t∣Θl11)+(ηli2
γ˜l2
− 1)B(1)lim(β, t∣Θl11)}] + (1 − ξli)[∆li1(1 −∆li2)(ηli1γ˜l1 − 1)B(2)lik (β, t∣Θl10)+(1 −∆li1)∆li2(ηli2
γ˜l2
− 1)B(2)lik (β, t∣Θl01) + 12∆li1∆li2{(ηli1γ˜l1 − 1)B(2)lik (β, t∣Θl11)+(ηli2
γ˜l2
− 1)B(2)lik (β, t∣Θl11)}],
B
(1)
lik (β, t∣Θljm) = ∫ t
0
1
s
(0)
k (β,u)[dMlik(u) − Ylik(u)
E{dMl1k(u)∣Θljm, ξli = 0}
E{Yl1k(u)∣Θljm} ],
B
(2)
lik (β, t∣Θljm) = Qlik(β) − ∫ t
0
Ylik(u)E{dQl1k(β,u)∣Θljm, ξli = 0}
E{Yl1k(β,u)∣Θljm} ,
lk(β, t)T = −∫ t
0
ek(β,u)dΛ0k(u),Θljk = {∆li1 = j and ∆li2 = k}.
The proofs for Theorem 3 and 4 are provided in Appendix.
We summarize the asymptotic efficiency for unstratified case-cohort studies (i.e. L =
1) with two types of diseases (i.e. K = 2). Note that the covariance matrix for β˜G,
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A(β0)−1ΣG(β0)A(β0)−1 involves the first derivative of the weighted estimating functions
A(β0) and the asymptotic variance of the weighted estimating functions, ΣG(β0).
Theorem 5. Under the condition E[w2111 − pi211]E[w2112 − pi211] > (ρE[w111w112 − pi211])2, the
asymptotic variance for our proposed method A(β0)−1ΣG(β0)A(β0)−1 is smaller than that
for Kang and Cai [2010]’s method, where
E1[w2111 − pi211] = (1 − α1)p2 [1 + α1α1 (1 − p1) + 3p14 { 1γ11 + 1γ12 } − 1γ12 ] ,
E1[w2112 − pi211] = (1 − α1)p1 [1 + α1α1 (1 − p2) + 3p24 { 1γ11 + 1γ12 } − 1γ11 ] ,
E1[w111w112 − pi211] = (1 − α1) [p1{1 − 1γ11 } + p2{1 − 1γ12 } + p1p2{34( 1γ11 + 1γ12 ) − 1}] ,
ρ = Corr(Q111(β),Q112(β)), α1 = pr(ξ11 = 1), p1 = pr(∆111 = 1), p2 = pr(∆112 = 1),
γ11 = pr(η111 = 1∣∆111(1 − ξ11) = 1), γ12 = pr(η112 = 1∣∆112(1 − ξ11) = 1).
Specifically, smaller α1 induces larger (1+α1)/α1, which dominates other contributions
in E[w2111−pi211]E[w2112−pi211]. The quantity (ρE[w111w112−pi211])2 depends on the selection
probability of a subset of cases γ11 and γ12 for fixed the disease rates p1 and p2. This indi-
cates that in situations where the subcohort size is smaller and the selected case proportion
is higher, the proposed method produce more efficient estimates over that of Kang & Cai’s
method.
If we consider the simple situation such as p1 = p2 = p, γ11 = γ12 = γ, and ρ = 1, specific
conditions to lead larger power are 0 < p < 23 , 12 − 34p < γ < 1 − 32p, 0 < α1 < γ(1 − 32p − γ)−1.
4.3.1 Proofs of Theorems
Under the assumptions in Section 4.3, we will outline the proofs for the main theorems.
Before we prove theorems, we consider the asymptotic properties of time-varying sam-
pling probability estimator α˜lk(t) = ∑nli=1 ξli[∏2j=1(1−∆lij)]Ylik(t)/∑nli=1[∏2j=1(1−∆lij)]Ylik(t).
For each k, by the Taylor expansion series of α˜−1lk (t) around α˜l,
α˜−1lk (t) − α˜−1l = − 1
α∗l (t)2 {α˜lk(t) − α˜l}, (4.5)
63
where α∗l (t) is on the line segment between α˜lk(t) and α˜l.
We can express α˜lk(t) − α˜l = ∑nli=1 α˜l{ ξliα˜l − 1} {∏2j=1(1−∆lij)}Ylik(t)∑nli=1(∏2j=1(1−∆lij))Ylik(t) , and thus (4.5) can
be written as
n
1/2
l (α˜−1lk (t) − α˜−1l )= α˜l
α∗(t)2 ⋅ nl∑nli=1∏2j=1(1 −∆lij)Ylik(t)n−1/2l {
nl∑
i=1(1 − ξliα˜l )
2∏
j=1(1 −∆lij)Ylik(t)}
By Glivenko-Cantelli lemma, n−1l ∑nli=1[∏2j=1(1 − ∆lij)]Ylik(t) converges in probability
uniformly to El[(∏2j=1(1−∆l1j))Yl1k(t)], where El[(∏2j=1(1−∆l1j))Yl1k(t)] is bounded away
from zero by condition (b). In view of lemma 2, n−1l {∑nli=1( ξliα˜l − 1)∏2j=1(1 − ∆lij)Ylik(t)}
converges to zero in probability uniformly in t since ∏2j=1(1 − ∆lij)Ylik(t) is bounded and
monotone in t. Therefore, α˜lk(t) − α˜l = ∑nli=1 α˜l{ ξliα˜l −1}{∏2j=1(1−∆lij)}Ylik(t)∑nli=1(∏2j=1(1−∆lij))Ylik(t) converges to zero in
probability uniformly in t. Thus, α˜lk(t) and α˜l converge to the same limit in probability
uniformly in t, which ensures α∗l (t) also converges to the same limit as α˜l. By Slutsky’s
theorem and above results, we get
n
1/2
l [α˜−1lk (t) − α˜−1l ] = 1α˜lEl[∏2j=1(1 −∆l1j)Yl1k(t)]n−1/2l
⎧⎪⎪⎨⎪⎪⎩
nl∑
i=1(1 − ξliα˜l )
2∏
j=1(1 −∆lij)Ylik(t)
⎫⎪⎪⎬⎪⎪⎭+ ⎡⎢⎢⎢⎣ α˜lα∗l (t)2 ⋅ nl∑nli=1∏2j=1(1 −∆lij)Ylik(t) − 1α˜lEl[∏2j=1(1 −∆l1j)Yl1j(t)]
⎤⎥⎥⎥⎦
× n−1/2l ⎧⎪⎪⎨⎪⎪⎩
nl∑
i=1(1 − ξliα˜l )
2∏
j=1(1 −∆lij)Ylik(t)
⎫⎪⎪⎬⎪⎪⎭
= 1
α˜lEl[∏2j=1(1 −∆l1j)Yl1k(t)]n−1/2l
⎧⎪⎪⎨⎪⎪⎩
nl∑
i=1(1 − ξliα˜l )
2∏
j=1(1 −∆lij)Ylik(t)
⎫⎪⎪⎬⎪⎪⎭+ op(1) (4.6)
Due to the sampling of cases, we consider the asymptotic properties for time-varying sam-
pling probability estimators γ˜l1k(t), γ˜l2k(t), γ˜l3k(t), and γ˜l4k(t) in (4.3). For each k, by
Taylor expansion of γ˜l1k(t) around γ˜l1, it can be written as
γ˜−1l1k(t) − γ˜−1l1 = − 1
γ∗l1(t)2 (γ˜l1k(t) − γ˜l1), (4.7)
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where γ∗l1(t) is on the line segment between γ˜l1k(t) and γ˜l1. By similar arguments for α˜l,
(4.7) can be written as
n
1/2
l (γ˜−1l1k(t) − γ˜−1l1 )= γ˜l1
γ∗l1k(t)2 nl∑nli=1 ∆li1(1 −∆li2)(1 − ξli)Ylik(t)n−1/2l
nl∑
i=1(1 − ηli1γ˜l1 )∆li1(1 −∆li2)(1 − ξli)Ylik(t).
By Glivenko-Cantelli lemma, n−1l ∑nli=1 ∆li1(1−∆li2)(1−ξli)Ylik(t) converges to (1−αl)El[∆l11(1−∆l12)Yl1k(t)] which is bounded away from 0 based on condition (b). In view of lemma
2, n−1l ∑nli=1(1 − ηli1γ˜l1k )∆li1(1 − ∆li2)(1 − ξli)Ylik(t) converges to 0 in probability uniformly
in t since ∆li1(1 − ∆li2)(1 − ξli)Ylik(t) is bounded and monotone function in t. Thus,
γ˜l1k(t) − γ˜l1 = ∑nli=1 γ˜l1( ηli1γ˜l1 −1)∆l11(1−∆l12)Yl1k(t)∑nli=1 ∆l11(1−∆l12)Yl1k(t) converges to zero in probability uniformly in
t. Hence, γ˜l1k(t) and γ˜l1 converge to same limit uniformly in t. This means that γ∗l1k(t)
also converges to same limit uniformly as γ˜l1. Combining above the results, it follows from
Slutsky’s theorem that
n
1/2
l (γ˜−1l1k(t) − γ˜−1l1 )= 1
γ˜l1(1 − αl)El[∆l11(1 −∆l12)Yl1k(t)]n−1/2l { nl∑i=1(1 − ηli1γ˜l1k )∆li1(1 −∆li2)(1 − ξli)Ylik(t)}+ [ γ˜l1
γ˜2l1k(t) nl∑nli=1 ∆li1(1 −∆li2)(1 − ξli)Ylik(t) − 1γ˜l1(1 − αl)El[∆l11(1 −∆l12)Yl1k(t)]]×n−1/2l { nl∑
i=1(1 − ηli1γ˜l1 )∆li1(1 −∆li2)(1 − ξli)Ylik(t)}= 1
γ˜l1(1 − αl)El[∆l11(1 −∆l12)Yl1k(t)]×n−1/2l { nl∑
i=1(1 − ηli1γ˜l1 )∆li1(1 −∆li2)(1 − ξli)Ylik(t)} + op(1). (4.8)
Similarly, we can show that
n
1/2
l (γ˜−1l2k(t) − γ˜−1l2 ) = 1γ˜l2(1 − αl)El[(1 −∆l11)∆l12Yl1k(t)]× n−1/2l { nl∑
i=1(1 − ηli2γ˜l2 )(1 −∆li1)∆li2(1 − ξli)Ylik(t)} + op(1), (4.9)
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n
1/2
l (γ˜−1l3k(t) − γ˜−1l3 ) = 1γ˜l3(1 − αl)El[∆l11∆l12Yl1k(t)]× n−1/2l { nl∑
i=1(1 − ηli1γ˜l3 )∆li1∆li2(1 − ξli)Ylik(t)} + op(1), (4.10)
n
1/2
l (γ˜−1l4k(t) − γ˜−1l4 ) = 1γ˜l4(1 − αl)El[∆l11∆l12Yl1k(t)]× n−1/2l { nl∑
i=1(1 − ηli2γ˜l4 )∆1i∆li2(1 − ξli)Ylik(t)} + op(1). (4.11)
The above properties will be used in the proofs. The following is the proof of theorem 3.
Proof of Theorem 3
We first show the consistency of β˜G. Denote ŨGn = n−1ŨG. By Taylor expansion series,
β˜G can be written as
β˜G = β0 + [−∂ŨGn (β0)
∂β0
]−1 ŨGn (β0) + op(1) (4.12)
Based on the extension of Fourtz [1977], if (I), (II), (III),and (IV) conditions are satisfied
(I)
∂ŨGn (β)
∂βT
exists and is continuous in an open neighborhood B of β0
(II)
∂ŨGn (β)
∂βT
is negative definite with probability going to one as n →∞
(III) -
∂ŨGn (β)
∂βT
converges to A(β0) in probability uniformly for β in an open neighborhood
about β0
(IV) ŨGn (β) converges to 0 in probability
then, we can show that β˜G converges to β0 in probability. Note that
∂ŨGn (β)
∂βT
= − 1
n
L∑
l=1
nl∑
i=1
2∑
k=1∫ τ0 pilik(t)Ṽk(β, t)dNlik(t) where
Ṽk(β, t) = S̃(2)k (β, t)S̃(0)k (β, t) − S̃(1)k (β, t)⊗2
S̃
(0)
k (β, t)2 . (4.13)
By continuity of each component in (4.13) and condition (f), (I) is satisfied.
In order to show that conditions (II),(III) are satisfied, we will show ∥ (−∂ŨGn (β)
∂βT
) −
A(β) ∥ converges to zero in probability uniformly in β ∈ B as n → ∞, where A(β) =
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∑2k=1 ∫ τ0 vk(β, t)s(0)k (β, t), λ0k(t)dt.
By Andersen and Gill [1982], it can be written as
∥ (−∂ŨGn (β)
∂βT
) −A(β) ∥
= ∥ 2∑
k=1∫ τ0 Ṽk(β, t) 1nd
L∑
l=1
nl∑
i=1pilik(t)Nlik(t) −
2∑
k=1∫ τ0 vk(β0, t)s(0)k (β0, t)λ0k(t)dt ∥
≤ ∥ 2∑
k=1∫ τ0 {Ṽk(β, t) − vk(β, t)} 1nd
L∑
l=1
nl∑
i=1Nlik(t) ∥
+ ∥ 2∑
k=1∫ τ0 {Ṽk(β, t) − vk(β, t)} 1nd
L∑
l=1
nl∑
i=1{pilik(t) − 1}Nlik(t) ∥
+ ∥ 2∑
k=1∫ τ0 vk(β, t) 1nd
L∑
l=1
nl∑
i=1Mlik(t) ∥
+ ∥ 2∑
k=1∫ τ0 vk(β, t) 1nd
L∑
l=1
nl∑
i=1{pilik(t) − 1}Mlik(t) ∥
+ ∥ 2∑
k=1∫ τ0 vk(β, t){S(0)k (β, t) − s(0)k (β, t)}λ0k(t)dt ∥ (4.14)
We can show that each term in (4.14) converges to zero uniformly in β ∈ B. To show that
the first term in (4.14) converges to zero in probability, we need to show that
sup
t∈[0,τ]β∈B ∥ Ṽk(β, t) − vk(β, t) ∥ pÐ→ 0 as n→∞ for k = 1,2
which suffices to show that
sup
t∈[0,τ]β∈B ∥ S̃(d)k (β, t) − S(d)k (β, t) ∥→ 0 as n pÐ→∞ for k = 1,2 and d = 0,1,2
It can be written as
S̃
(d)
k (β, t) − S(d)k (β, t)= 1
n
L∑
l=1
nl∑
i=1(ξliα˜l − 1)
2∏
j=1(1 −∆lij)Zlik(t)⊗deβTZlik(t)Yik(t)
+ 1
n
L∑
l=1
nl∑
i=1(α˜−1lk (t) − α˜−1l )ξli
2∏
j=1(1 −∆lij)Zlik(t)⊗deβTZlik(t)Ylik(t)
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+ 1
n
L∑
l=1
nl∑
i=1(ηi1γ˜l1 − 1)∆li1(1 −∆li2)(1 − ξli)Zlik(t)⊗deβTZlik(t)Ylik(t)
+ 1
n
L∑
l=1
nl∑
i=1(γ˜−1l1k(t) − γ˜−1l1 )ηli1∆li1(1 −∆li2)(1 − ξli)Zlik(t)⊗deβTZlik(t)Ylik(t)
+ 1
n
L∑
l=1
nl∑
i=1(ηli2γ˜l2 − 1) (1 −∆li1)∆li2(1 − ξli)Zlik(t)⊗deβTZlik(t)Ylik(t)
+ 1
n
L∑
l=1
nl∑
i=1(γ˜−1l2k(t) − γ˜−1l2 )ηli2(1 −∆li1)∆li2(1 − ξli)Zlik(t)⊗deβTZlik(t)Ylik(t)
+ 1
n
L∑
l=1
nl∑
i=1
1
2
(ηli1
γ˜l3
− 1)∆li1∆li2(1 − ξli)Zlik(t)⊗deβTZlik(t)Ylik(t)
+ 1
n
L∑
l=1
nl∑
i=1
1
2
(γ˜−1l3k(t) − γ˜−1l3 )ηli1∆li1∆li2(1 − ξli)Zlik(t)⊗deβTZlik(t)Ylik(t)
+ 1
n
L∑
l=1
nl∑
i=1
1
2
(ηli2
γ˜l4
− 1)∆li1∆li2(1 − ξli)Zlik(t)⊗deβTZlik(t)Ylik(t)
+ 1
n
L∑
l=1
nl∑
i=1
1
2
(γ˜−1l4k(t) − γ˜−1l4 )ηli2∆li1∆li2(1 − ξli)Zlik(t)⊗deβTZlik(t)Ylik(t) (4.15)
By using the result of (4.6), the first and the second terms in (4.15) can be written as
1
n
L∑
l=1
nl∑
i=1(ξliα˜l − 1)
2∏
j=1(1 −∆lij)Zlik(t)⊗deβTZlik(t)Yik(t)
+ 1
n
L∑
l=1
nl∑
i=1(α˜−1lk (t) − α˜−1l )ξli
2∏
j=1(1 −∆lij)Zlik(t)⊗deβTZlik(t)Ylik(t)
= 1
n
L∑
l=1
nl∑
i=1(ξliα˜l − 1)
2∏
j=1(1 −∆lij)Zlik(t)⊗deβTZlik(t)Yik(t)
+ 1
n
L∑
l=1
nl∑
i=1( 1α˜lEl[∏2j=1(1 −∆l1j)Yl1k(t)]n−1l
⎧⎪⎪⎨⎪⎪⎩
nl∑
m=1(1 − ξlmα˜l )
2∏
j=1(1 −∆lmj)Ylmk(t)
⎫⎪⎪⎬⎪⎪⎭× ξli 2∏
j=1(1 −∆lij)Zlik(t)⊗deβTZlik(t)Ylik(t) + op(1)
= 1
n
L∑
l=1
nl∑
i=1(ξliα˜l − 1)
2∏
j=1(1 −∆lij)Zlik(t)⊗deβTZlik(t)Ylik(t)
+ 1
n
L∑
l=1
nl∑
i=1(1 − ξliα˜l )
2∏
j=1(1 −∆lij) Ylik(t)El[∏2j=1(1 −∆l1j)Yl1k(t)]
× {n−1l nl∑
m=1
ξlm
α˜l
2∏
j=1(1 −∆lmj)Ylmk(t)Zlmk(t)⊗deβTZlmk(t)} + op(1).
By lemma 2, n−1l ∑nlm=1 ξlmα˜l ∏2j=1(1 −∆lmj)Ylmk(t)Zlmk(t)⊗deβTZlmk(t) converges to
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El[∏2j=1(1 − ∆l1j)Yl1k(t)Zl1k(t)⊗deβTZl1k(t)] in probability uniformly in t. Thus, the first
and second terms are asymptotically equivalent to
1
n
L∑
l=1
nl∑
i=1(ξliα˜l − 1)
2∏
j=1(1 −∆lij)Ylik(t)
× [Zlik(t)⊗deβTZlik(t) − El[∏2j=1(1 −∆l1j)Yl1k(t)Zl1k(t)⊗deβTZl1k(t)]
El[∏2j=1(1 −∆l1j)Yl1k(t)] ].
Similarly, the third and forth terms can be written as
1
n
L∑
l=1
nl∑
i=1(ηi1γ˜l1 − 1)∆li1(1 −∆li2)(1 − ξli)Zlik(t)⊗deβTZlik(t)Ylik(t)
+ 1
n
L∑
l=1
nl∑
i=1
1
γ˜l1(1 − αl)El[∆l11(1 −∆l12)Yl1k(t)]
× n−1l { nl∑
m=1(1 − ηlm1γ˜l1 )∆lm1(1 −∆lm2)(1 − ξlm)Ylmk(t)}× ηli1∆li1(1 −∆li2)(1 − ξli)Zlik(t)⊗deβTZlik(t)Ylik(t) + op(1)
= 1
n
L∑
l=1
nl∑
i=1(ηi1γ˜l1 − 1)∆li1(1 −∆li2)(1 − ξli)Zlik(t)⊗deβTZlik(t)Ylik(t)
+ 1
n
L∑
l=1
nl∑
i=1(1 − ηli1γ˜l1 )(1 − ξli)∆li1(1 −∆li2) Ylik(t)El[∆l11(1 −∆l12)Yl1k(t)]× {n−1l nl∑
m=1 ∆lm1(1 −∆lm2)(1 − ξlm)(1 − αl) ηlm1γ˜l1 Ylmk(t)Zlmk(t)⊗deβTZlmk(t)} + op(1)
It follows from lemma 2, n−1l ∑nlm=1 ∆lm1(1 − ∆lm2) (1−ξlm)(1−αl) ηlm1γ˜l1 Ylmk(t)Zlmk(t)⊗deβTZlmk(t)
converges to El[Yl1k(t)Zl1k(t)⊗deβTZl1k(t)∣Θl10, ξ1l = 0] in probability uniformly in t. Thus,
the third and fourth terms can be written as
1
n
L∑
l=1
nl∑
i=1(ηi1γ˜l1 − 1)∆li1(1 −∆li2)(1 − ξli)Ylik(t)
× [Zlik(t)⊗deβTZlik(t) − El[Yl1k(t)Zl1k(t)⊗deβTZl1k(t)∣Θl10, ξ1l = 0]
El[Yl1k(t)∣Θl10] ] + op(1).
By using similar arguments, the fifth to the last terms can be written as
1
n
L∑
l=1
nl∑
i=1(ηli2γ˜l2 − 1) (1 −∆li1)∆li2(1 − ξli)Ylik(t)
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× [Zlik(t)⊗deβTZlik(t) − El[Yl1k(t)Zl1k(t)⊗deβTZl1k(t)∣Θl01, ξ1l = 0]
El[Yl1k(t)∣Θl01] ]
+ 1
2n
L∑
l=1
nl∑
i=1((ηli1γ˜l3 − 1) + (ηli2γ˜l4 − 1))∆li1∆li2(1 − ξli)Ylik(t)
× [Zlik(t)⊗deβTZlik(t) − El[Yl1k(t)Zl1k(t)⊗deβTZl1k(t)∣Θl11, ξ1l = 0]
El[Yl1k(t)∣Θl11] ] + op(1).
Combining all the results, we have
n1/2{S̃(d)k (β, t) − S(d)k (β, t)}= n−1/2 L∑
l=1
nl∑
i=1(ξliα˜l − 1)
2∏
j=1(1 −∆lij)Ylik(t)
× [Zlik(t)⊗deβTZlik(t) − El[∏2j=1(1 −∆l1j)Yl1k(t)Zl1k(t)⊗deβTZl1k(t)]
El[∏2j=1(1 −∆l1j)Yl1k(t)] ]
+ n−1/2 L∑
l=1
nl∑
i=1(ηi1γ˜l1 − 1)∆li1(1 −∆li2)(1 − ξli)Ylik(t)
× [Zlik(t)⊗deβTZlik(t) − El[Yl1k(t)Zl1k(t)⊗deβTZl1k(t)∣Θl10, ξ1l = 0]
El[Yl1k(t)∣Θl10] ]
+ n−1/2 L∑
l=1
nl∑
i=1(ηli2γ˜l2 − 1) (1 −∆li1)∆li2(1 − ξli)Ylik(t)
× [Zlik(t)⊗deβTZlik(t) − El[Yl1k(t)Zl1k(t)⊗deβTZl1k(t)∣Θl01, ξ1l = 0]
El[Yl1k(t)∣Θl01] ]
+ n−1/2 1
2
L∑
l=1
nl∑
i=1(ηli1γ˜l3 − 1)∆li1∆li2(1 − ξli)Ylik(t)
× [Zlik(t)⊗deβTZlik(t) − El[Yl1k(t)Zl1k(t)⊗deβTZl1k(t)∣Θl11, ξ1l = 0]
El[Yl1k(t)∣Θl11] ]
+ n−1/2 1
2
L∑
l=1
nl∑
i=1(ηli2γ˜l4 − 1)∆li1∆li2(1 − ξli)Ylik(t)
× [Zlik(t)⊗deβTZlik(t) − El[Yl1k(t)Zl1k(t)⊗deβTZl1k(t)∣Θl11, ξ1l = 0]
El[Yl1k(t)∣Θl11] ] + op(1)
By lemma 2 and condition (h) and (i), for d = 0,1, and 2, n1/2{S̃(d)k (β, t) − S(d)k (β, t)}
converges weakly to zero-mean Gaussian process. Hence, S̃
(d)
k (β, t)−S(d)k (β, t) converges to
zero in probability uniformly in t based on the condition (d) and then it can be shown that
sup
t∈[0,τ]β∈B ∥ S̃(d)k (β, t) − s(d)k (β, t) ∥→ 0 as n→∞ for k = 1,2 and d = 0,1,2 (4.16)
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Combining all the results, Ṽk(β, t) converges to vk(β, t) in probability uniformly in t and β
since s
(0)
k (β, t) is bounded way from zero by condition (f).
By Lenglart inequality(Andersen and Gill [1982], p1115), there exists n0 such that for
n ≥ n0 for any δ, η > 0,
P [n−1N¯k(τ) > η] ≤ δ
η
+ P [∫ τ
0
S
(0)
k (β0; t)λ0k(t)dt > δ],
where N¯k(t) = ∑Ll=1∑nli=1Nlik(t).
Based on condition (d), P [∫ τ0 S(0)k (β0; t)λ0k(t)dt > δ] converges to zero as n → ∞ for
δ > ∫ τ0 s(0)k (β0; t)λ0k(t)dt and then limη↑∞ limn→∞ P [n−1N¯k(τ) > η] = 0. Therefore, the first
term in (4.14) converges to zero in probability, uniformly in β ∈ B as n→∞. It follows from
lemma 2 that the second and fourth terms in (4.14) can be shown to converge to zero in
probability uniformly in t.
The third term in (4.14), ∫ τ0 vk(β, t) 1nd∑Ll=1∑nli=1Mlik(t) is a local square integrable
martingale. By the Lenglart inequality(Andersen and Gill [1982], p1115), it can be shown
that for all δ, η > 0,
P [∥ 1
n
∫ τ
0
{vk(β, t)}jj′M¯k(t)∥ > η] ≤ δ
η2
+ P [ 1
n
∫ τ
0
{vk(β, t)}2jj′S(0)k (β; t)λ0k(t)dt > δ] ,
where M¯k(t) = ∑Ll=1∑nli=1Mlik(t) and subscript jj′ indicates (jj′) element of matrix vk(β, t).
Due to boundedness conditions (d),(f),and (g), the second term on right side of the above
inequality converges to zero in probability, uniformly in β ∈ B for any δ as n→∞. Then it
follows that one on the left side of inequality converges to zero in probability, uniformly in
β ∈ B as n→∞. Hence, the third term in (4.14) converges to zero in probability, uniformly
in β ∈ B as n→∞.
Due to the boundedness of supt,β {vk(β, t)}, Λ0k(t) for k = 1,2 based on conditions
(d),(e), and (g) and uniform convergence of S˜
(0)
k to s
(0)
k , the last term in (4.14) converges
to zero in probability uniformly β ∈ B as n → ∞. All five terms in (4.14) converge to zero
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in probability uniformly. Thus, by condition (e), we have
−∂ŨGn (β)
∂βT
pÐ→ A(β) as n→∞ uniformly in β ∈ B
and, consequently, (II) and (III) are satisfied.
If we show that n−1/2ŨGn (β) is asymptotically normally distributed, it can be shown
that ŨGn (β) converges to zero in probability. Then, (IV) also will be satisfied. Therefore,
we can show that β˜G converges to β0 in probability and is a consistent estimator of β0 by
satisfying (I),(II),(III), and (IV)( Fourtz [1977] theorem 2). We will show the asymptotic
properties of n−1/2ŨGn (β0). We can decompose n−1/2ŨG(β0) into two parts such that
n−1/2ŨG(β0) = n−1/2 L∑
l=1
nl∑
i=1
2∑
k=1∫ τ0 pilik(t)
⎧⎪⎪⎨⎪⎪⎩Zik(u) − S̃
(1)
k (β0, t)
S̃
(0)
k (β0, t)
⎫⎪⎪⎬⎪⎪⎭dNlik(t)
= n−1/2 L∑
l=1
nl∑
i=1
2∑
k=1∫ τ0 pilik(t)
⎧⎪⎪⎨⎪⎪⎩Zik(u) − S̃
(1)
k (β0, t)
S̃
(0)
k (β0, t)
⎫⎪⎪⎬⎪⎪⎭dMlik(t)
+ n−1/2 L∑
l=1
nl∑
i=1
2∑
k=1∫ τ0 pilik(t)
⎧⎪⎪⎨⎪⎪⎩Zlik(u) − S̃
(1)
k (β0, t)
S̃
(0)
k (β0, t)
⎫⎪⎪⎬⎪⎪⎭Ylik(t)eβT0 Zlik(t)dΛ0k(t) (4.17)
The second term in (4.17) vanishes to zero since it follows from condition (g) that
n−1/2 L∑
l=1
nl∑
i=1
2∑
k=1∫ τ0 pilik(t)
⎧⎪⎪⎨⎪⎪⎩Zlik(t) − S̃
(1)
k (β0, t)
S̃
(0)
k (β0, t)
⎫⎪⎪⎬⎪⎪⎭Ylik(t)eβT0 Zlik(t)dΛ0k(t)
= n−1/2 L∑
l=1
2∑
k=1∫ τ0 {
nl∑
i=1pilik(t)Zlik(u)Ylik(t)eβT0 Zlik(t)
− nl∑
i=1pilik(t) S̃
(1)
k (β0, t)
S̃
(0)
k (β0, t)Ylik(t)eβ
T
0 Zlik(t)}dΛ0k(t)
= n−1/2 L∑
l=1
2∑
k=1∫ τ0
⎧⎪⎪⎨⎪⎪⎩S̃(1)k (β0, t) − S̃
(1)
k (β0, t)
S̃
(0)
k (β0, t) S̃(0)(β0, t)
⎫⎪⎪⎬⎪⎪⎭dΛ0k(t).
Then, it can be written as
n−1/2ŨG(β0) = n−1/2 L∑
l=1
nl∑
i=1
2∑
k=1∫ τ0 pilik(t)
⎧⎪⎪⎨⎪⎪⎩Zlik(t) − S̃
(1)
k (β0, t)
S̃
(0)
k (β0, t)
⎫⎪⎪⎬⎪⎪⎭dMlik(t)
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= n−1/2 L∑
l=1
nl∑
i=1
2∑
k=1∫ τ0 pilik(t)
⎧⎪⎪⎨⎪⎪⎩Zlik(t) − s
(1)
k (β0, t)
s
(0)
k (β0, t) +
s
(1)
k (β0, t)
s
(0)
k (β0, t) −
S̃
(1)
k (β0, t)
S̃
(0)
k (β0, t)
⎫⎪⎪⎬⎪⎪⎭dMlik(t)
= n−1/2 L∑
l=1
nl∑
i=1
2∑
k=1∫ τ0
⎧⎪⎪⎨⎪⎪⎩Zlik(t) − s
(1)
k (β0, t)
s
(0)
k (β0, t)
⎫⎪⎪⎬⎪⎪⎭dMlik(t)
+ n−1/2 L∑
l=1
nl∑
i=1
2∑
k=1∫ τ0
⎧⎪⎪⎨⎪⎪⎩s
(1)
k (β0, t)
s
(0)
k (β0, t) −
S̃
(1)
k (β0, t)
S̃
(0)
k (β0, t)
⎫⎪⎪⎬⎪⎪⎭dMlik(t)
+ n−1/2 L∑
l=1
nl∑
i=1
2∑
k=1∫ τ0 (pilik(t) − 1)
⎧⎪⎪⎨⎪⎪⎩Zlik(t) − s
(1)
k (β0, t)
s
(0)
k (β0, t)
⎫⎪⎪⎬⎪⎪⎭dMlik(t)
+ n−1/2 L∑
l=1
nl∑
i=1
2∑
k=1∫ τ0 (pilik(t) − 1)
⎧⎪⎪⎨⎪⎪⎩s
(1)
k (β0, t)
s
(0)
k (β0, t) −
S̃
(1)
k (β0, t)
S̃
(0)
k (β0, t)
⎫⎪⎪⎬⎪⎪⎭dMlik(t) (4.18)
By Spiekerman and Lin [1998], it can be shown that the first part in (4.18) was asymp-
totically equivalent to n−1/2∑Ll=1∑nli=1∑2k=1Qlik(β0).
Next we will show that the second and last terms in (4.18) converge to zero in probability,
uniformly in t. First, the second term in (4.18) can be written as
2∑
k=1∫ τ0
⎧⎪⎪⎨⎪⎪⎩s
(1)
k (β0, t)
s
(0)
k (β0, t) −
S̃
(1)
k (β0, t)
S̃
(0)
k (β0, t)
⎫⎪⎪⎬⎪⎪⎭{n−1/2d
L∑
l=1
nl∑
i=1Mlik(t)}
Note that Ml1k(t), . . . ,Mlnk(t) is identically and independently distributed zero-mean ran-
dom variables and n−1/2∑Ll=1∑nli=1Mlik(t) is a sum of i.i.d. zero-mean random variables for
fixed t. Mlik(t) is of bounded variation since M2lik(0) < ∞ and M2lik(τ) < ∞ are satisfied
based on conditions (c) and (g). From the example of 2.11.16 of van der Vaart and Wellner
[1996](p215), n−1/2∑Ll=1∑nli=1Mlik(t) converges weakly to a zero-mean Gaussian process, sayPMk(t).
To establish the existence of stochastic processes with continuous sample paths, we will
use Kolmogorov-Centsov theorem. If conditions of Kolmogorov-Centsov theorem E{PMk(t)−PMk(s)}4 ≤D∗z ∣t−s∣2 and E{PMk(t)−PMk(s)}2 ≤ D˜z ∣t−s∣ for all t ≥ s are satisfied, then we
can show that PMk(t) has continuous sample paths. Since EPMk(t)2 = E[n−1∑nli=1Mlik(t)2]
= EMlik(t)2 = E[∫ t0 Yik(u)eβT0 Zlik(u)λ0k(u)du], E{PMk(t) −PMk(s)}2 = EPMk(t)2 -
2EPMk(t)PMk(s) + EPMk(s)2 =EPMk(t)2 - EPMk(s)2 = E[∫ ts Yik(u)eβT0 Zlik(u)λ0k(u)du] ≤
eDzE[∫ ts λ0k(u)du] = D˜z(Λ0k(t) −Λ0k(s)) based on condition (c). There exists constant C
73
such that Λ0k(t) − Λ0k(s) ≤ C(t − s) for t ≥ s since Λ0k(.) is differentiable and λ0k(.) is
bounded in [0, τ]. Thus E{PMk(t) −PMk(s)}2 ≤ D˜cz(t − s). For fixed t, PMk(t) is random
normal variable. Therefore, we have E{PMk(t) − PMk(s)}4 = Var(PMk(t) − PMk(s))2 +
E{(PMk(t) −PMk(s))2}2 = 3 {E(PMk(t) −PMk(s))2}2 ≤D∗cz ∣t − s∣2.
Since two conditions are satisfied, it follows that PMk(t) has continuous sample path
from Kolmogorov-Centsov theorem. Based on conditions (c), (d), and (f), it can be shown
that S̃
(1)
k (β, t) and S̃(0)k (β, t) are of bounded variations and specially S̃(0)k (β, t) is bounded
away from zero. Thus
S̃
(1)
k
(β,t)
S̃
(0)
k
(β,t) is of bounded variation and can be written as S̃
(1)
k
(β,t)
S̃
(0)
k
(β,t) =
Gk1−Gk1 where both Gk1 and Gk2 are nonnegative, monotone functions in t, and bounded.
Therefore,
S̃
(1)
k
(β,t)
S̃
(0)
k
(β,t) is the sum of two monotone functions. By the result in (4.16), it can be
shown that supt∈[0,τ]β∈B ∥ S˜(1)k (β,t)
S˜
(0)
k
(β,t) − s(1)k (β,t)s(0)
k
(β,t) ∥ pÐ→ 0. By lemma 1, the second term in (4.18)
converges to zero in probability uniformly in t as n→∞.
By using similar arguments, the last term in (4.18) can be shown to converge to zero in
probability uniformly in t.
The third term in (4.18) can be decomposed such that
n−1/2 L∑
l=1
nl∑
i=1
2∑
k=1∫ τ0 (pilik(t) − 1)
⎧⎪⎪⎨⎪⎪⎩Zlik(t) − s
(1)
k (β0, t)
s
(0)
k (β0, t)
⎫⎪⎪⎬⎪⎪⎭dMlik(t)
= n−1/2 L∑
l=1
nl∑
i=1
2∑
k=1∫ τ0
2∏
j=1(1 −∆lij)(ξliα˜l − 1)
⎧⎪⎪⎨⎪⎪⎩Zlik(t) − s
(1)
k (β0, t)
s
(0)
k (β0, t)
⎫⎪⎪⎬⎪⎪⎭dMlik(t)
+ n−1/2 L∑
l=1
nl∑
i=1
2∑
k=1∫ τ0 (α˜−1lk (t) − α˜−1l )ξli
2∏
j=1(1 −∆lij)
⎧⎪⎪⎨⎪⎪⎩Zlik(t) − s
(1)
k (β0, t)
s
(0)
k (β0, t)
⎫⎪⎪⎬⎪⎪⎭dMlik(t)
+ n−1/2 L∑
l=1
nl∑
i=1
2∑
k=1∫ τ0 ∆li1(1 −∆li2)(1 − ξl1)(ηli1γ˜l1 − 1)
⎧⎪⎪⎨⎪⎪⎩Zlik(t) − s
(1)
k (β0, t)
s
(0)
k (β0, t)
⎫⎪⎪⎬⎪⎪⎭dMlik(t)
+ n−1/2 L∑
l=1
nl∑
i=1
2∑
k=1∫ τ0 ∆li1(1 −∆li2)(1 − ξl1)(γ˜−1l1k(t) − γ˜−1l1 )ηli1
⎧⎪⎪⎨⎪⎪⎩Zlik(t) − s
(1)
k (β0, t)
s
(0)
k (β0, t)
⎫⎪⎪⎬⎪⎪⎭dMlik(t)
+ n−1/2 L∑
l=1
nl∑
i=1
2∑
k=1∫ τ0 (1 −∆li1)∆li2(1 − ξl1)(ηli2γ˜l2 − 1)
⎧⎪⎪⎨⎪⎪⎩Zlik(t) − s
(1)
k (β0, t)
s
(0)
k (β0, t)
⎫⎪⎪⎬⎪⎪⎭dMlik(t)
+ n−1/2 L∑
l=1
nl∑
i=1
2∑
k=1∫ τ0 (1 −∆li1)∆li2(1 − ξl1)(γ˜−1l2k(t) − γ˜−1l2 )ηli2
⎧⎪⎪⎨⎪⎪⎩Zlik(t) − s
(1)
k (β0, t)
s
(0)
k (β0, t)
⎫⎪⎪⎬⎪⎪⎭dMlik(t)
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+ n−1/2 1
2
L∑
l=1
nl∑
i=1
2∑
k=1∫ τ0 ∆li1∆li2(1 − ξl1)(ηli1γ˜l3 − 1)
⎧⎪⎪⎨⎪⎪⎩Zlik(t) − s
(1)
k (β0, t)
s
(0)
k (β0, t)
⎫⎪⎪⎬⎪⎪⎭dMlik(t)
+ n−1/2 1
2
L∑
l=1
nl∑
i=1
2∑
k=1∫ τ0 ∆li1∆li2(1 − ξl1)(γ˜−1l3k(t) − γ˜−1l3 )ηli1
⎧⎪⎪⎨⎪⎪⎩Zlik(t) − s
(1)
k (β0, t)
s
(0)
k (β0, t)
⎫⎪⎪⎬⎪⎪⎭dMlik(t)
+ n−1/2 1
2
L∑
l=1
nl∑
i=1
2∑
k=1∫ τ0 ∆li1∆li2(1 − ξl1)(ηli2γ˜l4 − 1)
⎧⎪⎪⎨⎪⎪⎩Zlik(t) − s
(1)
k (β0, t)
s
(0)
k (β0, t)
⎫⎪⎪⎬⎪⎪⎭dMlik(t)
+ n−1/2 1
2
L∑
l=1
nl∑
i=1
2∑
k=1∫ τ0 ∆li1∆li2(1 − ξl1)(γ˜−1l4k(t) − γ˜−1l4 )ηli2
⎧⎪⎪⎨⎪⎪⎩Zlik(t) − s
(1)
k (β0, t)
s
(0)
k (β0, t)
⎫⎪⎪⎬⎪⎪⎭dMlik(t)
(4.19)
By using the result in (4.6), the second term in (4.19) is asymptotically equivalent to
= n−1/2 L∑
l=1
nl∑
i=1
2∑
k=1∫ τ0
2∏
j=1(1 −∆lij)(1 − ξliα˜l )Ylik(t) 1El[∏2j=1(1 −∆l1j)Yl1k(t)]
× ⎧⎪⎪⎨⎪⎪⎩n−1l
nl∑
m=1
ξli
α˜l
2∏
j=1(1 −∆lmj)(Zlmk(t) − s
(1)
k (β0, t)
s
(0)
k (β0, t))dMlmk(t)
⎫⎪⎪⎬⎪⎪⎭
= n−1/2 L∑
l=1
nl∑
i=1
2∑
k=1∫ τ0
2∏
j=1(1 −∆lij)(1 − ξliα˜l )Ylik(t) 1El[∏2j=1(1 −∆l1j)Yl1k(t)]
× ⎧⎪⎪⎨⎪⎪⎩n−1l
nl∑
m=1
ξli
α˜l
2∏
j=1(1 −∆lmj)(Zlmk(t) − s
(1)
k (β0, t)
s
(0)
k (β0, t))(dNlmk(t) − Ylmk(t)eβ
TZlmk(t)dΛ0k(t))⎫⎪⎪⎬⎪⎪⎭ .
(4.20)
Since the term related with dNlmk(t) in (4.20) does not contribute to ∏2j=1(1 −∆lmj), we
have
n−1/2 L∑
l=1
nl∑
i=1
2∑
k=1∫ τ0
2∏
j=1(1 −∆lij)(ξliα˜l − 1)Ylik(t) 1El[∏2j=1(1 −∆l1j)Yl1k(t)]
× ⎧⎪⎪⎨⎪⎪⎩n−1l
nl∑
m=1
ξli
α˜l
2∏
j=1(1 −∆lmj)(Zlmk(t) − s
(1)
k (β0, t)
s
(0)
k (β0, t))Ylmk(t)eβ
TZlmk(t)dΛ0k(t)⎫⎪⎪⎬⎪⎪⎭
= n−1/2 L∑
l=1
nl∑
i=1
2∑
k=1∫ τ0
2∏
j=1(1 −∆lij)(ξliα˜l − 1)Ylik(t)
× El[∏2j=1(1 −∆l1j)Yl1k(t)Rl1k(t)]
El[∏2j=1(1 −∆l1j)Yl1k(t)] dΛ0k(t) + op(1).
If follows from the result of (4.8) and lemma 2 that the fourth term in (4.19) can be written
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as
= n−1/2 L∑
l=1
nl∑
i=1
2∑
k=1∫ τ0 ∆li1(1 −∆li2)(1 − ξl1)ηli1 1γ˜l1(1 − αl)El[∆l11(1 −∆l12)Yl1k(t)]× n−1l { nl∑
m=1(1 − ηlm1γ˜l1 )∆lm1(1 −∆lm2)(1 − ξlm)Ylmk(t)}{Zlik(t) − ek(β0, t)}dMlik(t)
= n−1/2 L∑
l=1
nl∑
i=1
2∑
k=1∫ τ0 ∆li1(1 −∆li2)(1 − ηli1γ˜l1 )Ylik(t)× El[∆l11(1 −∆l12)(Zl1k(t) − ek(β0, t))dMl1k(t)]
El[∆l11(1 −∆l12)Yl1k(t)] + op(1)
By similar arguments, the sixth, eighth, and tenth terms are asymptotically equivalent to
n−1/2 L∑
l=1
nl∑
i=1
2∑
k=1∫ τ0 (1 −∆li1)∆li2(1 − ξli)(1 − ηli2γ˜l2 )Ylik(t)El[dQl1k(β, t)∣Θl01, ξl1 = 0]El[Yl1k(t)∣Θl01]
+ n−1/2 1
2
L∑
l=1
nl∑
i=1
2∑
k=1∫ τ0 ∆li1∆li2(1 − ξli)(1 − ηli1γ˜l3 )Ylik(t)El[dQl1k(β, t)∣Θl11, ξl1 = 0]El[Yl1k(t)∣Θl11]
+ n−1/2 1
2
L∑
l=1
nl∑
i=1
2∑
k=1∫ τ0 ∆li1∆li2(1 − ξli)(1 − ηli2γ˜l4 )Ylik(t)El[dQl1k(β, t)∣Θl11, ξl1 = 0]El[Yl1k(t)∣Θl11] .
Combining all the results, the third term in (4.18) is asymptotically equivalent to
n−1/2 L∑
l=1
nl∑
i=1
2∑
k=1∫ τ0
2∏
j=1(1 −∆lij)(ξliα˜l − 1)[Rlik(t)
− Ylik(t)El[∏2j=1(1 −∆l1j)Yl1k(t)Rl1k(t)]
El[∏2j=1(1 −∆l1j)Yl1k(t)]] dΛ0k(t)
+ n−1/2 L∑
l=1
nl∑
i=1
2∑
k=1 ∆li1(1 −∆li2)(ηli1γ˜l1 − 1)[Qlik(β0) − ∫ τ0 Ylik(t)El[dQl1k(β0, t)∣Θl10, ξl1 = 0]El[Yl1k(t)∣Θl10] ]
+ n−1/2 L∑
l=1
nl∑
i=1
2∑
k=1(1 −∆li1)∆li2(ηli2γ˜l2 − 1)[Qlik(β0) − ∫ τ0 Ylik(t)El[dQl1k(β0, t)∣Θl01, ξl1 = 0]El[Yl1k(t)∣Θl01] ]
+ n−1/2 1
2
L∑
l=1
nl∑
i=1
2∑
k=1 ∆li1∆li2(ηli1γ˜l3 − 1)[Qlik(β0) − ∫ τ0 Ylik(t)El[dQl1k(β0, t)∣Θl11, ξl1 = 0]El[Yl1k(t)∣Θl11] ]
+ n−1/2 1
2
L∑
l=1
nl∑
i=1
2∑
k=1 ∆li1∆li2(ηli2γ˜l4 − 1)[Qlik(β0) − ∫ τ0 Ylik(t)El[dQl1k(β0, t)∣Θl11, ξl1 = 0]El[Yl1k(t)∣Θl11] ]
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Therefore, n−1/2ŨG(β0) is asymptotically equivalent to
n−1/2 L∑
l=1
nl∑
i=1
2∑
k=1Qlik(β0)
+ n−1/2 L∑
l=1
nl∑
i=1
2∑
k=1(ξliα˜l − 1)∫ τ0
2∏
j=1(1 −∆lij){Rlik(t)
− Ylik(t)El[∏2j=1(1 −∆l1j)Rl1k(t)]
El[∏2j=1(1 −∆l1j)Yl1k(t)] }dΛ0k(t)
+ n−1/2 L∑
l=1
nl∑
i=1
2∑
k=1(1 − ξli){∆li1(1 −∆li2)(ηli1γ˜l1 − 1)[Qli1(β0)− ∫ τ
0
Ylik(t)El[dQl1k(β, t)∣Θl10, ξl1 = 0]
El[Yl1k(t)∣Θl10] ]+ (1 −∆li1)∆li2(ηli2
γ˜l2
− 1)[Qlik(β) − ∫ τ
0
Ylik(t)El[dQl1k(β0, t)∣Θl01, ξl1 = 0]
El[Yl1k(t)∣Θl01] ]+ 1
2
∆li1∆li2(ηli1
γ˜l3
− 1)[Qlik(β0) − ∫ τ
0
Ylik(t)El[dQl1k(β0)∣Θl11, ξl1 = 0]
El[Yl1k(t)∣Θl11] ]+ 1
2
∆li1∆li2(ηli2
γ˜l4
− 1)[Qlik(β) − ∫ τ
0
Ylik(t)E[dQl1k(β0)∣Θl11, ξl1 = 0]
El[Yl1k(t)∣Θl11] ]}. (4.21)
By Spiekerman and Lin [1998], it can be shown that the first term in (4.21) converges
to weakly to a zero-mean normal vector with covariance VI,l(β0) = El[∑2k=1Ql1k(β0)]⊗2.
The second term in (4.21) is asymptotically zero-mean normal vector with covariance
matrix 1−αlαl VII,l(β0) = 1−αlαl Varl(∏2j=1(1−∆l1j)∑2k=1 ∫ τ0 [Rl1k(β0, t)−Yl1kE(∏2j=1(1−∆l1j)Rl1k(β0,t))El(∏2j=1(1−∆l1j)Yl1k(t)) ]
dΛ0k(t)) by Ha´jek [1960]’s central limit theorem for finite sampling.
It follows from Ha´jek [1960]’s central limit theorem for finite sampling and Cramer-
Wold devices that the third term to the last term in (4.21) converges to weakly a zero-mean
normal vector with covariance (1 − αl)∑2k=1 VIII,lk(β0) where
VIII,lk(β)
= Pr(Θl10)1 − γl1
γl1
Var(Ql1k(β) − ∫ τ
0
Yl1k(t)E{dQl1k(β, t)∣Θl10, ξl1 = 0}
E{Yl1k(t)∣Θl10} ∣Θl10, ξl1 = 0)+ Pr(Θl10)1 − γl2
γl2
Var(Ql1k(β) − ∫ τ
0
Yl1k(t)El{dQl1k(β, t)∣Θl01, ξl1 = 0}
El{Yl1k(t)∣Θl01} ∣Θl10, ξl1 = 0)+ 1
4
Pr(Θl11)1 − γl1
γl1
Var(Ql1k(β) − ∫ τ
0
Yl1k(t)E{dQl1k(β, t)∣Θl11, ξ1 = 0}
E{Yl1k(t)∣Θl11} ∣Θl11, ξl1 = 0)+ 1
4
Pr(Θl11)1 − γl2
γl2
Varl(Ql1k(β) − ∫ τ
0
Yl1k(t)E{dQl1k(β, t)∣Θl11, ξl1 = 0}
E{Yl1k(t)∣Θl11} ∣Θl11, ξl1 = 0)
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since four components are independent.
In addition, n−1/2∑Ll=1∑nli=1∑2k=1Qlik(β0) and n−1/2∑Ll=1∑nli=1∑2k=1(1 − ξliα˜l ) ∫ τ0 ∏2j=1(1 −
∆lij)Llik(t)dΛ0k(t) where Llik(t) = Rlik(t) − Ylik(t)El[∏2j=1(1−∆l1j)Rl1k(t)]El[∏2j=1(1−∆l1j)Yl1k(t)] are independent
since
Covl
⎛⎝n−1/2l nl∑i=1
2∑
k=1Qlik(β0), n−1/2l
nl∑
i=1
2∑
k=1(ξliα˜l − 1)∫ τ0
2∏
j=1(1 −∆lij)Llik(t)dΛ0k(t)⎞⎠
= E ⎧⎪⎪⎨⎪⎪⎩n−1l
nl∑
i=1
2∑
k=1Qlik(β0)
nl∑
i=1
2∑
k=1(ξliα˜l − 1)∫ τ0
2∏
j=1(1 −∆lij)Llik(t)dΛ0k(t)⎞⎠
= E ⎧⎪⎪⎨⎪⎪⎩E ⎛⎝n−1l
nl∑
i=1
2∑
k=1Qlik(β0)
nl∑
i=1
2∑
k=1(ξliα˜l − 1)∫ τ0
2∏
j=1(1 −∆lij)Llik(t)dΛ0k(t)∣F(τ)⎞⎠
⎫⎪⎪⎬⎪⎪⎭
= E ⎧⎪⎪⎨⎪⎪⎩n−1l
nl∑
i=1
2∑
k=1Qlik(β0)
nl∑
i=1
2∑
k=1El ((ξliα˜l − 1)∣F(τ))∫ τ0
2∏
j=1(1 −∆lij)Llik(t)dΛ0k(t)
⎫⎪⎪⎬⎪⎪⎭ = 0
By using similar arguments, n−1/2∑Ll=1∑nli=1∑2k=1Qlik(β0) and the third to the last term in
(4.21) are independent. Since ξli and ηlik for k = 1,2 are independent, n−1/2∑Ll=1∑nli=1∑2k=1( ξliα˜l −
1) ∫ τ0 ∏2j=1(1−∆lij)Llik(t)dΛ0k(t) and the third to the last term in (4.21) are independent.
Combining all the results, n−1/2ŨG(β0) converges weakly to zero-mean normal vector with
covariance matrix ΣG(β) where
ΣG(β) = L∑
l=1 ql{VI,l(β) + 1 − αlαl VII,l(β) + (1 − αl)
2∑
k=1VIII,lk(β)},
VI,l(β) = El[ 2∑
k=1Ql1k(β)]⊗2,
VII,l(β)
= Varl( 2∏
j=1(1 −∆l1j)
2∑
k=1∫ τ0 [Rl1k(β, t) − Yl1k(t)El(∏
2
j=1(1 −∆l1j)Rl1k(β, t))
El(∏2j=1(1 −∆l1j)Yl1k(t)) ]dΛ0k(t)),
VIII,lk(β)
= Pr(Θl10)1 − γl1
γl1
Varl[Ql1k(β) − ∫ τ
0
Yl1k(t)E{dQl1k(β, t)∣Θl10, ξl1 = 0}
El{Yl1k(t)∣Θl10} ∣Θl10, ξl1 = 0]+ Pr(Θl01)1 − γl2
γl2
Var[Ql1k(β) − ∫ τ
0
Yl1k(t)E{dQl1k(β, t)∣Θl01, ξl1 = 0}
El{Yl1k(t)∣Θl01} ∣Θl01, ξl1 = 0]+ 1
4
Pr(Θl11)1 − γl1
γl1
Varl[Ql1k(β) − ∫ τ
0
Yl1k(t)El{dQl1k(β, t)∣Θl11, ξl1 = 0}
El{Yl1k(t)∣Θl11} ∣Θl11, ξl1 = 0]+ 1
4
Pr(Θl11)1 − γl2
γl2
Varl[Ql1k(β) − ∫ τ
0
Yl1k(t)El{dQl1k(β, t)∣Θl11, ξl1 = 0}
El{Yl1k(t)∣Θl11} ∣Θl11, ξl1 = 0].
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Hence, ŨG(β0) converges to zero in probability and, consequently, (IV) is satisfied. There-
fore, (I), (II), (III), and (IV) are satisfied, which implies that β˜G converges to β0 in probabi-
ilty by the extension of Fourtz [1977]. By consistency of β˜G and Talor expansion of ŨG(β0),
β˜G − β0 is asymptotically normally distributed with mean zero and with variance matrix
A−1ΣG(β0)A−1 where A = ∑2k=1Ak.
Proof of Theorem 4 Note that
Λ̃II0k(β˜G, t) = ∫ t
0
∑nli=1 pilik(u)dNlik(u)
nS˜
(0)
k (β˜G, u) = ∫
t
0
∑nli=1 pilik(u)dMlik(u)
nS˜
(0)
k (β˜G, u) + ∫
t
0
S˜
(0)
k (β0, u)dΛ0k(u)
S˜
(0)
k (β˜G, u)
n1/2{Λ̃II0k(β˜G, t) −Λ0k(t)} can be decomposed into five parts:
n1/2{Λ̃II0k(β˜G, t) −Λ0k(t)}
= n1/2∫ t
0
⎛⎝ 1nS˜(0)k (β˜G, u) − 1nS˜(0)k (β0, u)
⎞⎠d L∑l=1
nl∑
i=1Mlik(u)
+ n1/2∫ t
0
⎛⎝ 1nS˜(0)k (β˜G, u) − 1nS˜(0)k (β0, u)
⎞⎠d L∑l=1
nl∑
i=1{pilik(u) − 1}Mlik(u)
+ n1/2∫ t
0
⎛⎝ 1S˜(0)k (β˜G, u) − 1S˜(0)k (β0, u)
⎞⎠ S˜(0)k (β0, u)dΛ0k(u)
+ ∫ t
0
1
S˜
(0)
k (β0, u)d{n−1/2
L∑
l=1
nl∑
i=1Mlik(u)}
+ ∫ t
0
1
S˜
(0)
k (β0, u){n−1/2
L∑
l=1
nl∑
i=1{pilik(u) − 1}dMlik(u)} (4.22)
By Taylor expansion, it can be written as
1
S˜
(0)
k (β˜G, u) − 1S˜(0)k (β0, u) = −
S˜
(1)
k (β∗, u)T
S˜
(0)
k (β∗, u)2 (β˜G − β0)
where β∗ is on the line segment between β˜G and β0. Plugging into the first term in (4.22),
we have
∫ t
0
⎛⎝− S˜
(1)
k (β∗, u)T
S˜
(0)
k (β∗, u)2
⎞⎠(β˜G − β0){n−1/2d L∑l=1
nl∑
i=1Mlik(u)} , (4.23)
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where β∗ is on the line segment between β˜G and β0. Due to consistency of β˜G, β∗ also
converges to β0 in probability uniformly. Since S˜
(0)
k (β∗, u) and S˜(1)k (β∗, u) are of bounded
variations and S˜
(0)
k (β∗, u) is bounded away from 0, S˜(1)k (β∗,u)TS˜(0)
k
(β∗,u)2 is of bounded variation
and can be written as sum of two monotone functions in t. In addition, we have shown
consistency of β˜G, weak convergence of n−1/2d∑Ll=1∑nli=1Mlik(u) to zero-mean Gaussian
process with continuous sample paths, and the uniform convergence of S˜
(0)
k (β∗, u) and
S˜
(1)
k (β∗, u). Therefore, by lemma 1, (4.23) converges to zero in probability uniformly in t.
By similar arguments for the first term, the second term in (4.22) can be shown to
converges to zero in probability uniformly in t.
It follows from Taylor expansion that the third term in (4.22) can be written as
n1/2∫ t
0
⎛⎝− S˜
(1)
k (β∗, u)T
S˜
(0)
k (β∗, u)2
⎞⎠(β˜G − β0)S˜(0)k (β0, u)dΛ0k(u) (4.24)
Note that β˜G and β∗ converge to β0 in probability uniformly, S˜(0)k (β∗, u) and S˜(0)k (β0, u)
converge to s
(0)
k (β0, u) in probability uniformly where s(0)k (β0, u) is bounded away from
zero, S˜
(1)
k (β∗, u) converges to s(1)k (β0, t) in probability uniformly, and dΛ0k(u) is bounded.
It follows from the above results, (4.24) is asymptotically equivalent to
n1/2lk(β0, t)T (β˜G − β0),
where lk(β0, t)T = ∫ t0 −ek(β,u)dΛ0k(u) and ek(β0, u) = s(1)k (β0, u)/s(0)k (β0, u).
Since S˜
(0)
k (β0, u) converges to s(0)k (β0, u) in probability uniformly and s(0)k (β0, u) is
bounded away from 0, we have S˜
(0)
k (β0, u)−1 pÐ→ s(0)k (β0, u)−1. In addition, n−1/2d∑Ll=1∑nli=1
Mlik(u) converges to a zero-mean Gaussian process with continuous sample paths. Hence,
the fourth term in (4.22) is asymptotically equivalent to
∫ t
0
1
s
(0)
k (β0, u) {n−1/2d
L∑
l=1
nl∑
i=1Mlik(u)} .
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The last term in (4.22) can be written as
∫ t
0
1
S˜
(0)
k (β0, u){n−1/2
L∑
l=1
nl∑
i=1{pilik(u) − 1}dMlik(u)}
= ∫ t
0
1
S˜
(0)
k (β0, u){n−1/2
L∑
l=1
nl∑
i=1{(ξliα˜l − 1)
2∏
j=1(1 −∆lij)}dMlik(u)}
+ ∫ t
0
1
S˜
(0)
k (β0, u){n−1/2
L∑
l=1
nl∑
i=1{(α˜lk(u)−1 − α˜−1l )ξli
2∏
j=1(1 −∆lij)}dMlik(u)}
+ ∫ t
0
1
S˜
(0)
k (β0, u){n−1/2
L∑
l=1
nl∑
i=1{(ηli1γ˜l1 − 1)(1 − ξli)∆li1(1 −∆li2)}dMlik(u)}
+ ∫ t
0
1
S˜
(0)
k (β0, u){n−1/2
L∑
l=1
nl∑
i=1{(γ˜l1k(u)−1 − γ˜−1l1 )ηli1(1 − ξli)∆li1(1 −∆li2)}dMlik(u)}
+ ∫ t
0
1
S˜
(0)
k (β0, u){n−1/2
L∑
l=1
nl∑
i=1{(ηli2γ˜l2 − 1)(1 − ξli)(1 −∆li1)∆li2}dMlik(u)}
+ ∫ t
0
1
S˜
(0)
k (β0, u){n−1/2
L∑
l=1
nl∑
i=1{(γ˜l2k(u)−1 − γ˜−1l2 )ηli2(1 − ξli)(1 −∆li1)∆li2}dMlik(u)}
+ ∫ t
0
1
S˜
(0)
k (β0, u){n−1/2
L∑
l=1
nl∑
i=1{12(ηli1γ˜l3 − 1)(1 − ξli)∆li1∆li2}dMlik(u)}
+ ∫ t
0
1
S˜
(0)
k (β0, u){n−1/2
L∑
l=1
nl∑
i=1{12(γ˜l3k(u)−1 − γ˜−1l3 )ηli1(1 − ξli)∆li1∆li2}dMlik(u)}
+ ∫ t
0
1
S˜
(0)
k (β0, u){n−1/2
L∑
l=1
nl∑
i=1{12(ηli2γ˜l4 − 1)(1 − ξli)∆li1∆li2}dMlik(u)}
+ ∫ t
0
1
S˜
(0)
k (β0, u){n−1/2
L∑
l=1
nl∑
i=1{12(γ˜l4k(u)−1 − γ˜−1l4 )ηli2(1 − ξli)∆li1∆li2}dMlik(u)}(4.25)
Due to uniform convergence of S˜
(0)
k (β0, u)−1 to s(0)k (β0, u)−1 where s(0)k (β0, u) is bounded
away from zero, the asymptotic properties of (4.6), the first and second terms are asymp-
totically equivalent to
n−1/2 L∑
l=1
nl∑
i=1(1 − ξliα˜l )
2∏
j=1(1 −∆lij)∫ t0 Ylik(u){eβTZlik(u)
− E[∏2j=1(1 −∆1j)eβTZlik(u)Yl1k(u)]
E[∏2j=1(1 −∆1j)Yl1k(u)] } ⋅ dΛ0k(u)s(0)k (β0, u) .
By using uniform convergence of S˜
(0)
k (β0, u)−1 to s(0)k (β0, u)−1 where s(0)k (β0, u) is bounded
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away from zero and the asymptotic properties of (4.8), the third and fouth terms are
asymptotically equivalent to
n−1/2 L∑
l=1
nl∑
i=1 ∆li1(1 −∆li2)(1 − ξli)(ηli1γ˜1 − 1)× ∫ t
0
1
s
(0)
k (β0, u)[dMlik(u) − Ylik(u)El[dMlik(u)∣θl10, ξ1 = 0]El[Yl1k(u)∣θl10] ].
By similar arguments, the last term in (4.22) is asymptotically equivalent to
n−1/2 L∑
l=1
nl∑
i=1(1 − ξliα˜l )
2∏
j=1(1 −∆lij)
× ∫ t
0
Ylik(u){eβTZlik(u) − El[∏2j=1(1 −∆1j)eβTZlik(u)Yl1k(u)]
El[∏2j=1(1 −∆1j)Yl1k(u)] } ⋅ dΛ0k(u)s(0)k (β0, u)+ n−1/2 L∑
l=1
nl∑
i=1 ∆li1(1 −∆li2)(1 − ξli)(ηli1γ˜l1 − 1)× ∫ t
0
1
s
(0)
k (β0, u)[dMlik(u) − Ylik(u)El[dMlik(u)∣θl10, ξl1 = 0]El[Yl1k(u)∣θl10] ]+ n−1/2 L∑
l=1
nl∑
i=1(1 −∆li1)∆li2(1 − ξli)(ηli2γ˜l2 − 1)× ∫ t
0
1
s
(0)
k (β0, u)[dMlik(u) − Ylik(u)El[dMlik(u)∣θl01, ξl1 = 0]El[Yl1k(u)∣θl01] ]+ n−1/2 L∑
l=1
nl∑
i=1
1
2
∆li1∆li2(1 − ξli)(ηli1
γ˜l3
− 1)
× ∫ t
0
1
s
(0)
k (β0, u)[dMlik(u) − Ylik(u)El[dMlik(u)∣θl11, ξl1 = 0]El[Yl1k(u)∣θl11] ]+ n−1/2 L∑
l=1
nl∑
i=1
1
2
∆li1∆li2(1 − ξli)(ηli2
γ˜l4
− 1)
× ∫ t
0
1
s
(0)
k (β0, u)[dMlik(u) − Ylik(u)El[dMlik(u)∣θl11, ξl1 = 0]El[Yl1k(u)∣θl11] ]
Combining all the results, we have
n1/2{Λ̃II0k(β˜G, t) −Λ0k(t)}
= n1/2lk(β0, t)T (β˜G − β0) + ∫ t
0
1
s
(0)
k (β0, u) {n−1/2d
L∑
l=1
nl∑
i=1Mlik(u)}
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+ n−1/2 L∑
l=1
nl∑
i=1[(1 − ξliα˜l )
2∏
j=1(1 −∆lij)
× ∫ t
0
Ylik(u){eβTZlik(u) − El[∏2j=1(1 −∆1j)eβTZlik(u)Yl1k(u)]
El[∏2j=1(1 −∆1j)Yl1k(u)] } ⋅ dΛ0k(u)s(0)k (β0, u)+ ∆li1(1 −∆li2)(1 − ξli)(ηli1
γ˜1
− 1)
× ∫ t
0
1
s
(0)
k (β0, u)[dMlik(u) − Ylik(u)El[dMlik(u)∣θl10, ξl1 = 0]El[Yl1k(u)∣θl10] ]+ (1 −∆li1)∆li2(1 − ξli)(ηli2
γ˜2
− 1)
× ∫ t
0
1
s
(0)
k (β0, u)[dMlik(u) − Ylik(u)El[dMlik(u)∣θl01, ξl1 = 0]El[Yl1k(u)∣θl01] ]+ 1
2
∆li1∆li2(1 − ξli)(ηli1
γ˜1
− 1)∫ t
0
1
s
(0)
k (β0, u)[dMlik(u) − Ylik(u)El[dMlik(u)∣θl11, ξl1 = 0]El[Yl1k(u)∣θl11] ]+ 1
2
∆li1∆li2(1 − ξli)(ηli2
γ˜2
− 1)∫ t
0
1
s
(0)
k (β0, u)[dMlik(u) − Ylik(u)El[dMlik(u)∣θl11, ξl1 = 0]El[Yl1k(u)∣θl11] ]]+ op(1)
Note that
n1/2(β˜G − β0) = A(β0)−1[n−1/2 L∑
l=1
nl∑
i=1
2∑
k=1Qlik(β0)
+ n−1/2 L∑
l=1
nl∑
i=1
2∑
k=1(ξliα˜l − 1)
× ∫ τ
0
2∏
j=1(1 −∆lij){Z¯lik(t) − Ylik(t)El[∏
2
j=1(1 −∆1j)Z¯1k(t)]
E[∏2j=1(1 −∆1j)Yl1k(t)] }dMlik(t)
+ n−1/2 L∑
l=1
nl∑
i=1
2∑
k=1(1 − ξli){∆li1(1 −∆li2)(ηli1γ˜l1 − 1)× [Qlik(β) − ∫ τ
0
Ylik(t)E[dQl1k(β, t)∣Θl10, ξl1 = 0]
E[Yl1k(t)∣Θl10] ]+ (1 −∆li1)∆li2(ηli2
γ˜l2
− 1)[Qlik(β) − ∫ τ
0
Ylik(t)E[dQl1k(β, t)∣Θl01, ξl1 = 0]
E[Yl1k(t)∣Θl01] ]+ 1
2
∆li1∆li2(ηli1
γ˜l3
− 1)[Qlik(β) − ∫ τ
0
Ylik(t)E[dQl1k(β)∣Θl11, ξl1 = 0]
E[Yl1k(t)∣Θl11] ]+ 1
2
∆li1∆li2(ηli2
γ˜l4
− 1)[Qlik(β) − ∫ τ
0
Ylik(t)E[dQl1k(β)∣Θl11, ξl1 = 0]
E[Yl1k(t)∣Θl11] ]}] + op(1)
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Using the above equation, we have
n1/2{Λ̃M0k(β˜G, t) −Λ0k(t)}
= n−1/2 L∑
l=1
nl∑
i=1
⎧⎪⎪⎨⎪⎪⎩lk(β0, t)TA(β0)−1
K∑
m=1Qlim(β0) + ∫ t0 1s(0)k (β0, u)dMlik(u)
⎫⎪⎪⎬⎪⎪⎭
+ n−1/2 L∑
l=1
nl∑
i=1(1 − ξliα˜l ){lk(β0, t)TA(β0)−1
K∑
m=1∫ τ0 [Rlim(u)
− Ylim(u)El[∏2j=1(1 −∆l1j)Rl1m(u)]
El[∏2j=1(1 −∆l1j)Yl1m(u)] ]dΛ0m(u)
+ 2∏
j=1(1 −∆lij)∫ t0 Ylik(u)
⎧⎪⎪⎨⎪⎪⎩eβTZlik(u) −
El(∏2j=1(1 −∆l1j)eβTZl1k(u)Yl1k(u))
El(∏2j=1(1 −∆l1j)Yl1k(u))
⎫⎪⎪⎬⎪⎪⎭ dΛ0k(u)s(0)k (β0, u)}+ n−1/2 L∑
l=1
nl∑
i=1[lk(β0, t)TA(β0)−1n−1/2
2∑
m=1(1 − ξli)× {∆li1(1 −∆li2)(ηli1
γ˜l1
− 1)[Qlim(β) − ∫ τ
0
Ylim(u)El[dQl1m(β0, u)∣Θl10, ξl1 = 0]
El[Yl1m(u)∣Θl10] ]+ (1 −∆li1)∆li2(ηli2
γ˜l2
− 1)[Qlim(β) − ∫ τ
0
Ylim(u)El[dQl1m(β0, t)∣Θl01, ξl1 = 0]
El[Yl1m(t)∣Θl01] ]+ 1
2
∆li1∆li2(ηli1
γ˜l3
− 1)[Qlim(β) − ∫ τ
0
Ylim(u)El[dQl1m(β0)∣Θl11, ξl1 = 0]
El[Yl1m(u)∣Θl11] ]+ 1
2
∆li1∆li2(ηli2
γ˜l4
− 1)[Qlim(β0) − ∫ τ
0
Ylim(u)El[dQl1m(β0)∣Θl11, ξl1 = 0]
El[Yl1m(u)∣Θl11] ]}]
+ n−1/2 L∑
l=1
nl∑
i=1[∆li1(1 −∆li2)(1 − ξli)(ηli1γ˜l1 − 1)∫ t0 1s(0)k (β0, u)× [dMlik(u) − Ylik(u)El[dMlik(u)∣θl10, ξl1 = 0]
El[Yl1k(u)∣θl10] ]+ (1 −∆li1)∆li2(1 − ξli)(ηli2
γ˜l2
− 1)∫ t
0
1
s
(0)
k (β0, u)× [dMlik(u) − Ylik(u)El[dMlik(u)∣θl01, ξl1 = 0]
El[Yl1k(u)∣θl01] ]+ 1
2
∆li1∆li2(1 − ξli)(ηli1
γ˜l3
− 1)∫ t
0
1
s
(0)
k (β0, u)[dMlik(u) − Ylik(u)El[dMlik(u)∣θl11, ξl1 = 0]El[Yl1k(u)∣θl11] ]+ 1
2
∆li1∆li2(1 − ξli)(ηli2
γ˜l3
− 1)∫ t
0
1
s
(0)
k (β0, u)[dMlik(u) − Ylik(u)El[dMlik(u)∣θl11, ξl1 = 0]El[Yl1k(u)∣θl11] ]]+ op(1)
= n−1/2 L∑
l=1
nl∑
i=1νlik(β0, t) + n−1/2
L∑
l=1
nl∑
i=1(1 − ξliα˜l )ζlik(β0, t) + n−1/2
L∑
l=1
nl∑
i=1ϕlik(β0, t) + op(1)
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where
νlik(β, t) = lk(β, t)TA(β)−1 K∑
m=1Qlim(β) + ∫ t0 1s(0)k (β,u)dMlik(u),
ζlik(β, t) = lk(β, t)TA(β)−1
× 2∑
m=1∫ τ0 [Rlim(u) − Ylim(u)El[∏
2
j=1(1 −∆l1j)Rl1m(u)]
El[∏2j=1(1 −∆l1j)Yl1m(u)] ]dΛ0m(u)
+ 2∏
j=1(1 −∆lij)∫ t0 Ylik(u)
⎧⎪⎪⎨⎪⎪⎩eβTZlik(u) −
El(∏2j=1(1 −∆1j)eβTZ1k(u)Yl1k(u))
El(∏2j=1(1 −∆1j)Yl1k(u))
⎫⎪⎪⎬⎪⎪⎭ dΛ0k(u)s(0)k (β0, u) ,
ϕlik(β, t) = lk(β, t)TA(β)−1 2∑
m=1(1 − ξli)[∆li1(1 −∆li2)(ηli1γ˜l1 − 1)B(1)lim(β, t∣Θl10)+ (1 −∆li1)∆li2(ηli2
γ˜l2
− 1)B(1)lim(β, t∣Θl01)
+ 1
2
∆li1∆li2{(ηli1
γ˜l3
− 1)B(1)lim(β, t∣Θl11) + (ηli2γ˜l4 − 1)B(1)lim(β, t∣Θl11)}]+ (1 − ξli)[∆li1(1 −∆li2)(ηli1
γ˜l1
− 1)B(2)lik (β, t∣Θl10) + (1 −∆li1)∆li2(ηli2γ˜l2 − 1)B(2)lik (β, t∣Θl01)+ 1
2
∆li1∆li2{(ηli1
γ˜l3
− 1)B(2)lik (β, t∣Θl11) + (ηli2γ˜l4 − 1)B(2)lik (β, t∣Θl11)}]
B
(1)
lik (β, t∣Θljm) = ∫ t
0
1
s
(0)
k (β0, u) [dMlik(u) − Ylik(u)El{dMl1k(u)∣Θl10, ξli = 0}El{Yl1k(u)∣Θljm} ]
B
(2)
lik (β, t∣Θljm) = Qlik(β) − ∫ t
0
Ylik(u)El{dQl1k(β,u)∣Θljm, ξli = 0}
El{Yl1k(β,u)∣Θljm} ,
lk(β, t)T = −∫ t
0
ek(β,u)dΛ0k(u)
Let P (t) = (P (1)(t) + P (2)(t) + P (3)(t)) where P (1)(t) = (P (1)1 (t), P (1)2 (t))T , P (2)(t) =(P (2)1 (t), P (2)2 (t))T , P (3)(t) = (P (3)1 (t), P (3)2 (t))T , P (1)k (t)T = n−1/2∑Ll=1∑nli=1 νlik(β0, t),
P
(2)
k (t)T = n−1/2∑Ll=1∑nli=1 ζlik(β0, t), and P (3)k (t)T = n−1/2∑Ll=1∑nli=1ϕlik(β0, t). Then, by
theorem 4 of Spiekerman and Lin [1998], P (1)(t) = (P (1)1 (t), P (1)2 (t))T converges weakly
to a zero-mean Gaussian process P(1)(t) = (P(1)1 (t),P(1)2 (t))T and covariance functions
between P(1)j (t) and P(1)k (s) is ∑Ll=1 qlEl{νl1j(β0, t), νl1k(β0, s)} for t, s ∈ [0, τ] in D[0, τ]K .
We will show weak convergence of P (2)(t) to a zero-mean Gaussian process P(2)(t).
Note that s
(0)
k (β, t) and El(∏2j=1(1 −∆l1j)Yl1k(t)) are bounded away from zero, lk(β0, t)T ,
eβ
TZlik(t)Ylik(t), El(∏2j=1(1−∆l1j)eβTZl1k(t)Yl1k(t)), and dΛ0k(t) are of bounded variations
based on conditions (b), (c), (d), and (g); A(β0) is positive definite based on (e). Hence,
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it follows from Cramer-Wold device and lemma 2 that the finite dimensional distribution
of P (2)(t) is asymptotically same as that of P(2)(t) for any finite number of time point(t1, . . . , tL). The next thing that we will show is that P (2)(t) has tightness. It suffices
to show the marginal tightness of P
(2)
k (t) for each k since space D[0, τ]K is equipped
with the uniform metric. By applying lemma 2, the marginal tightness follows to P
(2)
k (t).
Combining all the results, P (2)(t) = (P (2)1 (t), P (2)2 (t))T converges weakly to a zero-mean
Gaussian process P(2)(t) = (P(2)1 (t),P(2)2 (t))T and covariance functions between P(2)j (t)
and P(2)k (s) is ∑Ll=1 ql 1−αlαl El{ζl1j(β0, t), ζl1k(β0, s)} for t, s ∈ [0, τ] in D[0, τ]K .
Similarly, P (3)(t) can be shown to converge weakly to a zero-mean Gaussian process
where covariance function P(3)j (t) and P(3)k (s) is ∑Ll=1 qlEl{ϕl1j(β0, t), ϕl1k(β0, s)} where
El{ϕl1j(β0, t), ϕl1k(β0, s)}
= I(j = k)pr(Θl10)(1 − γl1
γl1
)Covl[B(2)lik (β, t∣Θl10)B(2)lik (β, s∣Θl10)∣Θl10, ξl1 = 0]
+ I(j = k)pr(Θl01)(1 − γl2
γl2
)Covl[B(2)lik (β, t∣Θl01)B(2)lik (β, s∣Θl01)∣Θl01, ξl1 = 0]
+ I(j = k)pr(Θl11)
4
(1 − γl1
γl1
)Covl[B(2)lik (β, t∣Θl11)B(2)lik (β, s∣Θl11)∣Θl11, ξl1 = 0]
+ I(j = k)pr(Θl11)
4
(1 − γl2
γl2
)Covl[B(2)lik (β, t∣Θl11)B(2)lik (β, s∣Θl11)∣Θl11, ξl1 = 0]
+ pr(Θl10)(1 − γl1
γl1
)Covl[B(2)lij (β0, t∣Θl10), lk(β0, s)TA(β0)−1B(1)lij (β, s∣Θl10)∣Θl10, ξl1 = 0]
+ pr(Θl01)(1 − γl2
γl2
)Covl[B(2)lij (β0, t∣Θl10), lk(β0, s)TA(β0)−1B(1)lij (β, s∣Θl10)∣Θl10, ξl1 = 0]
+ pr(Θl11)
4
(1 − γl1
γl1
)Covl[B(2)lij (β0, t∣Θl11), lk(β0, s)TA(β0)−1B(1)lij (β, s∣Θl11)∣Θl11, ξl1 = 0]
+ pr(Θl11)
4
(1 − γl2
γl2
)Covl[B(2)lij (β0, t∣Θl11), lk(β0, s)TA(β0)−1B(1)lij (β, s∣Θl11)∣Θl11, ξl1 = 0]
+ pr(Θl10)(1 − γl1
γl1
)Covl[B(2)lik (β0, s∣Θl10), lj(β0, t)TA(β0)−1B(1)lik (β, t∣Θl10)∣Θl10, ξl1 = 0]
+ pr(Θl01)(1 − γl2
γl2
)Covl[B(2)lik (β0, s∣Θl10), lj(β0, t)TA(β0)−1B(1)lik (β, t∣Θl10)∣Θl10, ξl1 = 0]
+ pr(Θl11)
4
(1 − γl1
γl1
)Covl[B(2)lik (β0, s∣Θl11), lj(β0, t)TA(β0)−1B(1)lik (β, t∣Θl11)∣Θl11, ξl1 = 0]
+ pr(Θl11)
4
(1 − γl2
γl2
)Covl[B(2)lik (β0, s∣Θl11), lj(β0, t)TA(β0)−1B(1)lik (β, t∣Θl11)∣Θl11, ξl1 = 0]
+ 2∑
m=1[pr(Θl10)(1 − γl1γl1 )lk(β0, t)TA(β0)−1
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× Covl[B(1)lim(β, t∣Θl10),B(1)lim(β, s∣Θl10)]A(β0)−1lj(β0, s)T+ pr(Θl01)(1 − γl2
γl2
)lk(β0, t)TA(β0)−1
× Covl[B(1)lim(β, t∣Θl01),B(1)lim(β, s∣Θl01)]A(β0)−1lj(β0, s)T+ pr(Θl11)
4
(1 − γl1
γl1
)lk(β0, t)TA(β0)−1
× Covl[B(1)lim(β, t∣Θl11),B(1)lim(β, s∣Θl11)]A(β0)−1lj(β0, s)T+ pr(Θl11)
4
(1 − γl2
γl2
)lk(β0, t)TA(β0)−1
× Covl[B(1)lim(β, t∣Θl11),B(1)lim(β, s∣Θl11)]A(β0)−1lj(β0, s)T ].
By the conditional expectation arguments, all terms are mutually independent. There-
fore, P (t) = P (1)(t) + P (2)(t) + P (3)(t) converges to a zero-mean Gaussian process G(t) =P(1)(t) +P(2)(t) +P(3)(t).
Proof of Theorem 5
We will compare the asymptotic variance for the proposed method and the existing
method. Consider the unstratified generalized case-cohort study (i.e. L = 1). From Theorem
3, the covariance matrix for β˜G involves the first derivative of the weighted estimating
functions, A(β0) and the asymptotic variance of the the weighted estimating functions,
ΣG(β0). The first derivative of the proposed weighted estimating functions, A(β0) is the
same as that of (4.2). Therefore, we only need to compare the asymptotic variance of
the proposed weighted estimating functions ŨG(β) with that of Kang & Cai’s weighted
estimating functions ÛKC(β). Note that n−1/2ŨG(β) can be decomposed into four parts:
= n−1/2 n1∑
i=1
2∑
k=1∫ τ0
⎧⎪⎪⎨⎪⎪⎩Z1ik(t) − s
(1)
k (β0, t)
s
(0)
k (β0, t)
⎫⎪⎪⎬⎪⎪⎭dM1ik(t)
+ n−1/2 n1∑
i=1
2∑
k=1∫ τ0
⎧⎪⎪⎨⎪⎪⎩s
(1)
k (β0, t)
s
(0)
k (β0, t) −
S̃
(1)
k (β0, t)
S̃
(0)
k (β0, t)
⎫⎪⎪⎬⎪⎪⎭dM1ik(t)
+ n−1/2 n1∑
i=1
2∑
k=1∫ τ0 (pi1ik(t) − 1)
⎧⎪⎪⎨⎪⎪⎩Z1ik(t) − s
(1)
k (β0, t)
s
(0)
k (β0, t)
⎫⎪⎪⎬⎪⎪⎭dM1ik(t)
+ n−1/2 n1∑
i=1
2∑
k=1∫ τ0 (pi1ik(t) − 1)
⎧⎪⎪⎨⎪⎪⎩s
(1)
k (β0, t)
s
(0)
k (β0, t) −
S̃
(1)
k (β0, t)
S̃
(0)
k (β0, t)
⎫⎪⎪⎬⎪⎪⎭dM1ik(t) (4.26)
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Since the second and the fourth terms in (4.26) converge to zero in probability uniformly in
t, resepctively and the first term in (4.26) converges to the same limit as that for ÛKC(β),
we only need to compare asymptotic properties of the third term with the proposed weight
in (4.26) with that with the existing weight. Therefore, we will compare asymptotic variance
of the third term with the proposed weight with that with existing weight:
V ar [n1∑
i=1
2∑
k=1∫ τ0 (w1ik(t) − 1) {Z1ik(t) − ek(t)}dM1ik(t)]
−V ar [n1∑
i=1
2∑
k=1∫ τ0 (pi1ik(t) − 1) {Z1ik(t) − ek(t)}dM1ik(t)]
It is sufficient to show the difference between the second moments since the first mo-
ment of E[∑nli=1∑2k=1 ∫ τ0 (wlik(t)− 1){Zlik(t)− ek(t)}dMlik(t)] and E[∑ni=1∑2k=1 ∫ τ0 (pilik(t)−
1){Zlik(t) − ek(t)}dMlik(t)] are zero. Hence, we get
E [n1∑
i=1
2∑
k=1∫ τ0 (w1ik(t) − 1) {Z1ik(t) − ek(t)}dM1ik(t)]
2
−E [n1∑
i=1
2∑
k=1∫ τ0 (pi1ik(t) − 1) {Z1ik(t) − ek(t)}dM1ik(t)]
2
(4.27)
Note that the weight functions w1ik(t) and pi1ik(t) converge to time-invariant weights, w1ik
and pi1i, respectively, where w1ik = (1 − ∆1ik)ξ1iα−11 + ∆1ikξ1i + ∆1ik(1 − ξ1i)η1ikγ−11k and
pi1ik = Π2j=1(1 − ∆1ij)ξ1iα−1 + {1 − Π2j=1(1 − ∆1ij)}ξ1i + ∆1i1(1 − ∆1i2)(1 − ξ1i)η1i1γ−111 + (1 −
∆1i1)∆1i2(1 − ξ1i)η1i2γ−112 + 12∆1i1∆1i2(1 − ξ1i)η1i1γ−111 + 12∆1i1∆1i2(1 − ξ1i)η1i2γ−112 .
Hence, (4.27) is asymptotically equivalent to
E [ 2∑
k=1(w11k − 1)Q11k(t)]
2 −E [ 2∑
k=1(pi11 − 1)Q11k(t)]
2
= E[w2111 − pi211]E[Q2111(t)] +E[w2112 − pi211]E[Q2112(t)]
+ 2{E[w111w112 − pi211]}E[Q111(t)Q112(t)]
≥ 2√E[w2111 − pi211]E[w2112 − pi211]E[Q2111(t)]E[Q2112(t)]+ 2{E[w111w112 − pi211]}E[Q111(t)Q112(t)],
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≥ 2√E[w2111 − pi211]E[w2112 − pi211]√E[Q2111(t)]E[Q2112(t)]+ 2ρ{E[w111w112 − pi211]}√E[Q2111(t)]E[Q2112(t)]= 2[√E[w2111 − pi211]E[w2112 − pi211] + ρ{E[w111w112 − pi211]}]√E[Q2111(t)]E[Q2112(t)].
Since
√
E[Q2111(t)]E[Q2112(t)] is always positive, our prposed weight is more efficient
than the existing weight if
[√E[w2111 − pi211]E[w2112 − pi211] + ρ{E[w111w112 − pi211]}] > 0= √E[w2111 − pi211]E[w2112 − pi211] > −ρ{E[w111w112 − pi211]}= E[w2111 − pi211]E[w2112 − pi211] > [ρ{E[w111w112 − pi211]}]2.
To get the simple form of E[w2111 − pi211], E[w2112 − pi211], and [ρ{E[w111w112 − pi211]}], we
denote
ρ = Corr(Q111(t),Q112(t)), α1 = lim
n→∞pr(ξ1i = 1),
p1 = lim
n→∞pr(∆1i1 = 1), p2 = limn→∞pr(∆1i2 = 1),
γ11 = lim
n→∞pr(η1i1 = 1∣∆1i1(1 − ξ1i) = 1), γ12 = limn→∞pr(η1i2 = 1∣∆1i2(1 − ξ1i) = 1).
Then we get
E[w2111 − pi211]
= 1 − p1
α1
+ αp1 + (1 − α1)p1
γ11
− [(1 − p1)(1 − p2)
α1
+ α1{1 − (1 − p1)(1 − p2)}
+ (1 − α1)p1(1 − p2)
γ11
+ (1 − α1)p1p2
4γ11
+ (1 − α1)p2(1 − p1)
γ12
+ (1 − α1)p1p2
4γ12
]
= p2 − p1p2
α1
− α(p2 − p1p2) + (1 − α1)p1p2
γ11
− (1 − α1)p1p2
4γ11− (1 − α1)(1 − p1)p2
γ12
− (1 − α1)p1p2
4γ12= ( 1
α1
− α1)p2(1 − p1) + (1 − α1) [3p1p2
4γ11
− p2
γ12
+ 3p1p2
4γ12
]
= 1
α1
{(1 − α1)(1 + α1)p2(1 − p1)} + 3(1 − α1)p1p2
4
{ 1
γ11
+ 1
γ12
} − (1 − α1)p2
γ12
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= (1 − α1)p2 [1 + α1
α1
(1 − p1) + 3p1
4
{ 1
γ11
+ 1
γ12
} − 1
γ12
] .
Similarly, E[w2112 − pi211] can be written as
E[w2112 − pi211] = (1 − α1)p1 [1 + α1α1 (1 − p2) + 3p24 { 1γ11 + 1γ12 } − 1γ11 ] .
Also, E[w111w112 − pi211] can be written as
E[w111w112 − pi211]
= (1 − p1)(1 − p2)
α1
+ (1 − p1)p2 + p1(1 − p2) + α1p1p2 + (1 − α1)p1p2 − [(1 − p1)(1 − p2)
α1+ α1{1 − (1 − p1)(1 − p2)} + (1 − α1)p1(1 − p2)
γ11
+ (1 − α1)p1p2
4γ11+ (1 − α1)(1 − p1)p2
γ12
+ (1 − α1)p1p2
4γ12
]
= p1 + p2 − p1p2 − α1(p1 + p2 − p1p2) − (1 − α1) [ p1
γ11
− 3p1p2
4γ11
+ p2
γ12
− 3p1p2
4γ12
]
= (1 − α1) [p1 + p2 − p1p2 + 3p1p2
4
{ 1
γ11
+ 1
γ12
} − p1
γ11
− p2
γ12
]
= (1 − α1) [p1{1 − 1
γ11
} + p2{1 − 1
γ12
} + p1p2{3
4
( 1
γ11
+ 1
γ12
) − 1}]
Thus, we have
E[w2111 − pi211]E[w2112 − pi211] > [ρ{E[w111w112 − pi211]}]2
= p1p2 [1 + α1
α1
(1 − p1) + 3p1
4
{ 1
γ11
+ 1
γ12
} − 1
γ12
] [1 + α1
α1
(1 − p2) + 3p2
4
{ 1
γ11
+ 1
γ12
} − 1
γ11
]
> ρ2 [p1{1 − 1
γ11
} + p2{1 − 1
γ12
} + p1p2{3
4
( 1
γ11
+ 1
γ12
) − 1}]2 .
Therefore, if the condition E[w2111−pi211]E[w2112−pi211] > (ρE[w111w112−pi211])2 is satisfied,
then the asymptotic variance for our proposed method is smaller than that for Kang and Cai
[2010]’s method. Specifically, smaller α1 induces larger (1+α1)/α1, which dominates other
contributions in E[w2111 − pi211]E[w2112 − pi211]. The quantity (ρE[w111w112 − pi211])2 depends
on the selection probability of a subset of cases γ11 and γ12 for fixed the disease rates p1
and p2. This indicates that selecting small size of the subcohort and larger portion of cases
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improves the efficiency for Kang & Cai’s method.
4.4 Simulations
We conducted simulation studies to investigate the finite sample properties of the pro-
posed methods, compare it with Kang and Cai [2010]’s method, and compare the perfor-
mance of stratified sampling with unstratified sampling. Consider the situation that stratum
variables are available and two generalized case-cohort studies have been conducted for non-
rare disease 1 and nonrare disease 2, respectively. In this situation, covariate information are
collected for the subcohort and a portion of the subjects outside the subcohort with disease
1 and disease 2. We generated multivariate failure time data from Clayton-Cuzick model
(Clayton and Cuzick [1985]). The bivariate survival function for the bivariate survival time(T1, T2) given (Zl1, Zl2) has the following form:
F (t1, t2∣Zl1, Zl2) = {S1(t1;Zl1)−1/θ + S2(t2;Zl2)−1/θ − 1}−θ,
where λ0k(t) and βk k = 1,2 are the baseline hazard function and the effect of covariate
for disease k, respectively, θ is the association parameter between the failure times of the
two diseases, and Sk(t;Zl) = Pr(Tk > t∣Zlk) = e− ∫ tk0 λ0k(t)eβkZlkdt. Exponential distribution
with failure rate λ0ke
βkZlk is considered for the marginal distribution of Tk k = 1,2. Two
failure times, T1 and T2 are independent as θ → ∞. The relationship between Kendall’s
tau, τθ, and θ is τθ = 12θ+1 . Smaller Kendall’s tau represents less correlation between T1
and T2. Values of 0.1, 0.67 and 4 are used for θ and the corresponding Kendall’s tau
is 0.83, 0.43 and 0.11, respectively. We set the baseline hazard function λ01 = 2 for the
first failure event type k = 1 and λ02 = 6 for the second failure event type k = 2. For
covariates, we consider the situation Zl1 = Zl2 = Z where Z is generated from Bernouilli
distribution with pr(Z = 1) = 0.5. To consider stratified subcohort sampling from two
strata defined by Vi, we define two parameters: η =Pr(V = 1∣Z = 1) and ν =Pr(V = 0∣Z = 0)
where η is sensitivity and ν is the specificity for Z. Unstratified sampling with same
probability, i.e., η = 0.5 and ν = 0.5 is a special case. Larger values η and ν values than 0.5
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indicate that V is highly correlated with Z. For stratified case-cohort studies, we set the
values [η, ν] = [0.7,0.7] and [η, ν] = [0.9,0.9] . Thus, a stratum variable is simulated with
Pr(V = 1) = (1 − ν)Pr(Z = 0) + ηPr(Z = 1) = 0.5. Censoring time is simulated from uniform
distribution [0, u] where u depends on the specified level of the censoring probability. We
set the event proportions of approximately 8% and 15% for k = 1 and 22% and 36% for k = 2.
The corresponding u values are 0.08 and 0.16, for β = 0.1; 0.06 and 0.11, for β = log(2).
The sample size of the full cohort is set to be n = 1000. We select the subcohort and
a subset of cases by unstratified sampling as well as stratified sampling and consider the
subcohort size of 200. We select the subcohort n˜l = n˜ × ql from each stratum. By using
simple random sampling, we select non-subcohort cases size of m˜lk = (nlk − n˜lk) × γk for
k = 1,2 and l = 0,1. We consider the same sample size for two sets of event proportions.
For event proportion [8%,22%], γk is set to be [1,0.57]; for event proportion [15%,36%],
γk is set to be [0.53,0.44]. For each configuration, 2000 simulations were conducted.
In the first set of simulation, we consider the simulations of two stratified generalized
case-cohort studies with non-rare diseases. Our main interest is to estimate the effect of Z
on disease 1. We will examine the performance of our proposed estimator based on (4.4)
with K = 1 which uses the additional information collected on the sampled subjects with
disease 2 and compare the stratified sampling with the unstratified sampling. We will also
compare our results with those using Kang and Cai [2010]’s method for disease 1 which are
based on (4.2) with K = 1.
Table 4.1 summarizes the results. For different combinations of event proportion, the
subcohort sample size, correlation, and sampling methods, Table 4.1 shows the average of
the estimates for β2, the average of the proposed estimated standard error (SE), empirical
standard deviation (SD), and sample relative efficiency (SRE). The subscripts for SE, SD
refer to the proposed method (P) and Kang and Cai [2010]’s method (K). To compare the
stratified sampling with unstratified sampling, the sample relative efficiency in the proposed
method (SREp) is defined as SD
2
p for unstratified sampling over SD
2
p for stratified sampling.
The sample relative efficiency (SREk) in Kang and Cai [2010]’s method is defined as SD
2
k
for unstratified sampling over SD2k for stratified sampling. STR1 and STR2 represent
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Table 4.1: Simulation result with a single disease outcome (K = 1): β1 = log(2) = 0.693
Model The Proposed method Kang and Cai’s method
P2 γ˜2 τθ β˜
G
2 SEp SDp CRp SREp βˆ2 SEk SDk CRk SREk SRE
UNS 22% 0.57 0.83 0.704 0.221 0.225 95 1.00 0.704 0.227 0.229 95 1.00 1.03
0.43 0.704 0.221 0.229 94 1.00 0.705 0.226 0.233 94 1.00 1.04
0.11 0.702 0.221 0.215 96 1.00 0.704 0.227 0.220 96 1.00 1.04
36% 0.44 0.83 0.706 0.193 0.194 95 1.00 0.701 0.199 0.197 95 1.00 1.03
0.43 0.697 0.193 0.195 94 1.00 0.698 0.199 0.200 94 1.00 1.04
0.11 0.696 0.192 0.194 96 1.00 0.699 0.199 0.199 96 1.00 1.05
STR1 22% 0.57 0.83 0.695 0.215 0.223 95 1.02 0.693 0.223 0.228 95 1.00 1.05[η, ν] 0.43 0.707 0.216 0.214 95 1.14 0.709 0.223 0.217 96 1.15 1.03= [0.7,0.7] 0.11 0.704 0.217 0.215 95 1.00 0.704 0.223 0.218 95 1.01 1.03
36% 0.44 0.83 0.702 0.189 0.192 95 1.02 0.696 0.197 0.195 95 1.02 1.04
0.43 0.697 0.190 0.186 95 1.11 0.697 0.197 0.192 95 1.08 1.07
0.11 0.700 0.189 0.185 95 1.09 0.702 0.197 0.194 96 1.05 1.09
STR2 22% 0.57 0.83 0.701 0.196 0.198 95 1.29 0.698 0.209 0.204 95 1.26 1.06[η, ν] 0.43 0.703 0.200 0.193 96 1.40 0.703 0.209 0.196 97 1.41 1.03= [0.9,0.9] 0.11 0.700 0.202 0.194 96 1.23 0.700 0.209 0.198 96 1.23 1.04
36% 0.44 0.83 0.706 0.174 0.165 97 1.38 0.703 0.191 0.171 97 1.33 1.08
0.43 0.694 0.179 0.167 97 1.36 0.694 0.192 0.172 97 1.35 1.06
0.11 0.700 0.182 0.167 97 1.35 0.699 0.192 0.173 97 1.32 1.08
SE, the average of the estimates of standard error; SD, sample standard deviation; CR, the cov-
erage rate of the nominal 95% confidence intervals; SRE = SD2k/SD2p, sample relative efficiency;
SREp = SD2p for unstratified sampling/SD2p for stratified sampling, sample relative efficiency in
the proposed method; SREk = SD2k for unstratified sampling/SD2k for stratified sampling, sample
relative efficiency in Kang & Cai’s method; UNS, unstratified sampling; STR1, stratified sampling
with [η, ν] = [0.7,0.7]; STR2, stratified sampling with [η, ν] = [0.9,0.9].
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stratified sampling with sensitivity and specificity with [η, ν] = [0.7,0.7] [η, ν] = [0.9,0.9],
respectively.
From the results, we see that both methods are approximately unbiased. The average of
the proposed estimated standard error is close to the empirical standard deviation and the
range of the 95% confidence interval coverage rate is on 94%-97%. In general, the estimates
for stratified sampling of the subcohort and cases have smaller variance than those for
unstratified sampling. To compare the stratified sampling with unstratified sampling, all
the sample relative efficiency (SREp and SREk) for models with stratified sampling (STR1
and STR2) are more than 1, which indicates that stratified sampling is more efficient than
unstratified sampling. This shows that stratum variable available on all the subjects helps
to gain efficiency. When correlation between stratum variables and covariates is larger,
more efficiency gain is obtained. Also, estimated standard errors for the proposed method
are smaller than those for Kang and Cai [2010]’s method. From sample relative efficiency
(SRE), all SREs are larger than 1. Hence, our proposed method gains the efficiency. The
results for β1 are not shown, but they are similar with β2.
In the second set of simulations, we are interested in the joint modeling of the two
diseases (i.e. K = 2). These correspond to (4.2) for Kang and Cai [2010]’s method and
(4.4)) for the proposed method. We examine the performance of our proposed estimator and
compare it to those from Kang and Cai [2010]. Our main interests are to estimate the effect
of Z on disease 1 (β1) and disease 2 (β2) and compare them. Table 4.2 provides summary
statistics for the estimate of β1 for different combinations of event proportion, subcohort
sample size, correlation, and sampling methods. The simulation results suggest that the
estimates for both methods are approximately unbiased and their estimated standard errors
are close to the empirical standard deviations. The range of the coverage rate of the nominal
95% confidence interval is 94%-97%. All sample relative efficiency (SREp and SREk) for
models with stratified sampling (STR1 and STR2) are more than 1 which implies that
stratified sampling is more efficient than that of unstratified sampling and higher efficiency
gain is related with higher sensitivity and specificity. The variance for the propose method
are smaller than those for Kang and Cai [2010]’s method, which indicates that our proposed
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Table 4.2: Simulation result with multiple disease outcomes (K = 2): β = [0.1, 0.7]
Model P1 The Proposed method Kang and Cai’s method[γ˜1, γ˜2] τθ β˜G2 SEp SDp CRpSREp βˆ2 SEk SDk CRk SREk SRE
UNS [8%,22%] 0.83 0.710 0.201 0.205 95 1.00 0.706 0.206 0.208 95 1.00 1.03
[1,0.57] 0.43 0.705 0.202 0.201 96 1.00 0.703 0.206 0.204 95 1.00 1.03
0.11 0.706 0.201 0.206 94 1.00 0.707 0.206 0.209 95 1.00 1.03
[15%,36%] 0.83 0.712 0.178 0.185 94 1.00 0.704 0.182 0.188 94 1.00 1.04
[0.53, 0.44] 0.43 0.710 0.178 0.181 95 1.00 0.709 0.182 0.186 95 1.00 1.05
0.11 0.712 0.176 0.180 95 1.00 0.713 0.182 0.187 94 1.00 1.08
STR1 [8%,22%] 0.83 0.704 0.196 0.196 95 1.10 0.701 0.201 0.199 96 1.09 1.04[η, ν] [1,0.57] 0.43 0.707 0.197 0.192 96 1.09 0.706 0.202 0.196 96 1.08 1.04= [0.7,0.7] 0.11 0.700 0.196 0.198 94 1.09 0.700 0.201 0.203 95 1.07 1.05
[15%,36%] 0.83 0.716 0.175 0.174 95 1.13 0.709 0.181 0.177 95 1.13 1.04
[0.53, 0.44] 0.43 0.705 0.176 0.175 95 1.07 0.703 0.182 0.178 95 1.08 1.04
0.11 0.709 0.174 0.173 95 1.08 0.709 0.181 0.179 95 1.09 1.07
STR2 [8%,22%] 0.83 0.711 0.179 0.172 96 1.42 0.709 0.189 0.177 96 1.38 1.07[η, ν] [1,0.57] 0.43 0.701 0.182 0.171 96 1.38 0.700 0.189 0.174 97 1.38 1.03= [0.9,0.9] 0.11 0.698 0.183 0.174 96 1.40 0.697 0.189 0.177 96 1.39 1.04
[15%,36%] 0.83 0.705 0.164 0.155 97 1.42 0.701 0.179 0.161 97 1.37 1.08
[0.53, 0.44] 0.43 0.700 0.168 0.151 97 1.44 0.699 0.179 0.157 97 1.40 1.07
0.11 0.706 0.169 0.153 97 1.37 0.706 0.179 0.156 97 1.43 1.04
SE, the average of the estimates of standard error; SD, sample standard deviation; CR, the cov-
erage rate of the nominal 95% confidence intervals; SRE = SD2k/SD2p, sample relative efficiency;
SREp = SD2p for unstratified sampling/SD2p for stratified sampling, sample relative efficiency in
the proposed method; SREk = SD2k for unstratified sampling/SD2k for stratified sampling, sample
relative efficiency in Kang & Cai’s method; UNS, unstratified sampling; STR1, stratified sampling
with [η, ν] = [0.7,0.7]; STR2, stratified sampling with [η, ν] = [0.9,0.9].
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Table 4.3: Type I error and power (%) in separate and joint analyses: [η, ν] = [0.7,0.7]
Event Type I error (β1 = β2 = log 2) Power (β1 = 0.1, β2 = 0.7)
S J S J
proportion γ˜ τθ PR KC PR KC PR KC PR KC[8%,22%] [1,0.57] 0.83 1.0 0.9 4.0 5.0 40 44 63 67
0.43 1.7 2.5 4.3 5.2 39 43 54 56
0.11 3.1 2.9 4.5 5.8 41 43 51 54[15%,36%] [0.53, 0.44] 0.83 0.5 1.6 4.2 5.5 52 49 73 69
0.43 1.5 1.7 4.6 4.6 50 49 67 63
0.11 2.7 2.7 5.1 5.1 52 49 62 58
S, Separate analysis; J, Joint analysis; KC, Kang and Cai [2010]’s method; PR, proposed
method.
method are more efficient than those for Kang and Cai [2010]’s method.
We also conducted simulation studies to examine the Type I error rates and powers in
comparing the effect of the risk factor on the two diseases. We conducted the test based on
the joint analysis with stratified sampling with [η, ν] = [0.7,0.7] for the two diseases. We
also conducted tests using the coefficient estimate from separate analysis for each of the
two diseases assuming independence of the sample. Estimating equations (4.2) and (4.4)
with K = 1 are used for the separate analysis and estimating equations (4.2) and (4.4) with
K = 2 are used for the joint analysis. Table 4.3 summarizes the results for Type I error
rates and powers. Type I error rates are obtained by testing H0 ∶ β1 = β2 under setting
β1 = β2 = log(2) at the significant level .05. The settings for the simulation for the power
are the same as before except that β1 = 0.1 and β2 = 0.7. The tests under separate analysis
treat the two estimates, βˆ1 and βˆ2, as from two independent samples. The results indicate
that tests based on our proposed weight function are more powerful than those based on
Kang and Cai [2010]’s weight function and the powers of joint analysis are larger than those
based on the separate analysis. Note that Type I error rates of separate analysis are much
less than .05 while the joint analysis methods have Type I error rates close to .05.
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4.5 Data analysis
We applied the proposed method to a data set from the ARIC study which is a population-
based cohort study [Duncan et al., 2003; Ballantyne et al., 2004]. This study consists of
15,792 men and women 45 - 64 years of age from four U.S. communities recruited during
1987 to 1989. All subjects were followed for incident diabetes. The incident diabetes are
defined as a reported physician diagnosis, use of antidiabetes medications, a fasting (≥ 8
hours) glucose ≥ 7.0 mmol/l, or a nonfasting glucose of ≥ 11.1 mmol/l. Subjects are regarded
as censored if they are alive and event-free at the end of 1998 or lost to follow-up.
Our main interest is to investigate the association between high-sensitivity C-reactive
protein (hs-CRP), which is a biomarker of inflammation, and incident diabetes events. In
order to measure hs-CRP, a case-cohort study was conducted to reduce the cost and save
blood specimen. Hs-CRP is also available on subjects for incident coronary heart disease
(CHD) from another case-cohort study in the ARIC study [Ballantyne et al., 2004]. Using
available hs-CRP from another case-cohort, we excluded subjects with prevalent CHD and
prevalent diabetes at baseline, transient ischemic attach or stroke, had missing follow-up
visits; were minority race group; had no valid diabetes determination at follow-ups, missing
CHD information, and baseline measurements. The full cohort consist of 10,279 subjects.
To preserve frozen biologic specimens and reduce costs, generalized case-cohort design
is used by selecting a subset of incident diabetes events since the rate of diabetes during
follow-up is 11.2%. The subcohort and cases of incident diabetes are randomly selected via
stratified sampling where the strata variables are age at baseline (≤ 55 and > 55), sex, and
race (black and white). Age, gender, race, parental history of diabetes, hypertension, and
center are confounding factors and are adjusted in the model. The risk factor, hs-CRP, is
used as a categorical variables with 4 levels based on quartiles. In table 4.4, hs-CRP (C2),
hs-CRP (C3), and hs-CRP (C4) are indicator variables for hs-CRP values in the second,
third, fourth quartiles, respectively. The hs-CRP values in the first quartile is used as the
reference group in our analysis.
By using available hs-CRP information collected from subjects who have CHD, we can
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Table 4.4: Results for the effect of hs-CRP from the ARIC Study
Proposed method The existing method
Variables β˜Gk SE HR 95% CI βˆGk SE HR 95% CI
hs-CRP(C4) 1.00 0.214 2.71 ( 1.78 , 4.12 ) 1.02 0.220 2.78 ( 1.80 , 4.28 )
hs-CRP(C2) 0.21 0.239 1.23 ( 0.77 , 1.97 ) 0.23 0.243 1.26 ( 0.78 , 2.02 )
hs-CRP(C3) 0.73 0.213 2.07 ( 1.36 , 3.14 ) 0.75 0.220 2.12 ( 1.38 , 3.26 )
Age 0.01 0.011 1.00 ( 0.98 , 1.03 ) 0.01 0.012 1.01 ( 0.98 , 1.03 )
African 0.56 0.278 1.74 ( 1.01 , 3.01 ) 0.55 0.287 1.73 ( 0.98 , 3.03 )
Male 0.31 0.120 1.37 ( 1.08 , 1.73 ) 0.33 0.131 1.40 ( 1.08 , 1.81 )
PHD 0.61 0.153 1.84 ( 1.36 , 2.48 ) 0.63 0.160 1.88 ( 1.37 , 2.57 )
HYP 0.56 0.155 1.75 ( 1.29 , 2.37 ) 0.56 0.161 1.75 ( 1.28 , 2.40 )
Center (F) 0.15 0.228 1.16 ( 0.74 , 1.82 ) 0.18 0.237 1.19 ( 0.75 , 1.90 )
Center (J) -0.11 0.325 0.89 ( 0.47 , 1.69 ) -0.09 0.334 0.92 ( 0.48 , 1.76 )
Center (M) -0.04 0.225 0.96 ( 0.62 , 1.49 ) -0.02 0.233 0.98 ( 0.62 , 1.56 )
hs-CRP, high-sensitivity C-reactive protein; PHD, parental history of diabetes; HYP, hy-
pertension; SE, standard error estimate; HR, hazard ratio estimate; CI, confidence
interval
apply our proposed method to this data set. The total sample size is 1,576 subjects including
572 noncases, 581 diabetes cases, 423 CHD cases. The subcohort size is 669 which consists
of 96 diabetes cases and 572 non-cases. To study the effect of hs-CRP for diabetes, we fit
the model using (4.1) and compare the results for the proposed method in (4.4) and Kang
and Cai [2010]’s method in (4.2) when K = 1.
Table 4.4 represents the estimates, standard errors, hazard ratios, 95% confidence in-
tervals for two methods. The hazard ratio comparing the fourth with the first hs-CRP
quartile group is 2.71 and confidence interval indicates that it is of statistical significance.
Moreover, the hazard ratio comparing the third with the first hs-CRP quartile group is also
statistically significant, but the hazard ratio for the second versus the first quartile group
is not statistically significant. The regression coefficient estimates for the proposed method
are similar with those for the existing method, but all the standard errors are smaller than
those of the existing method and consequently the 95% confidence intervals are narrower.
4.6 Concluding Remarks
We proposed more efficient estimators for stratified generalized case-cohort design than
those for [Kang and Cai, 2010] by using available stratum variables and exposure information
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for the other diseases. For a single disease outcome and multiple disease outcomes, weighted
estimating equations with the proposed weight function were proposed. We have shown that
our proposed estimators are consistent and asymptotically normally distributed under some
regularity conditions. The asymptotic relative efficiency of the proposed was derived and
we can calculate the efficiency gain in practice. Based on simulation results, our proposed
methods improve efficiency and stratified sampling of the subcohort and cases produces
more efficiency gain than unstratified sampling.
In this paper, we proposed the new weight function for the generalized case-cohort study
with two types of diseases. We can extend the general weight function with K diseases:
pilik(t) = K∏
j=1(1 −∆lij)ξliα˜−1lk (t) +
⎧⎪⎪⎨⎪⎪⎩1 −
K∏
j=1(1 −∆lij)
⎫⎪⎪⎬⎪⎪⎭ ξli+ (1 − ξli)[ ∑
m∈M(1)
1
N(M){∏j∈M ∆lij ∏j′∈A−M(1 −∆lij′)}ηlimγ˜−1l,jj′,k(t)],
where α˜lk(t) = ∑nli=1∏Kj=1(1−∆lij)ξliYlik(t)/∑nli=1∏Kj=1(1−∆lij)Ylik(t), A is set with {1,2, . . . ,
K}, M are all possible subsets of A except for ∅, N(M) is the number of elements in M ,
M(1) is one of elements in the set M and γ˜l,jj′,k(t) is the selection probability of cases
among non-subcohort members in each part. Therefore, the situation that there are K
diseases can be proved by using similar arguments.
In practice, full cohort size and the disease rates are fixed. Using the formula in Theorem
5, we can calculate the efficiency gain for different combinations of α1, γ11, and γ12. However,
if the conditions are not satisfied, variance for our proposed method could be smaller than
that for Kang and Cai [2010]. Therefore, our proposed method is not always efficient.
We need to derive the most efficient estimator by specifying the joint distribution of the
correlated failure times from the same subject. This would be worthwhile, especially for
data with expensive covariates. This could be interesting future research.
In some data, proportional hazard assumptions are not appropriate and some investi-
gators could be interested in another association between risk factor and disease outcomes.
Hence, alternatives of proportional hazard models are other types of models such as addi-
tive hazards models, proportional odds model, the accelerated failure time model, and the
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semiparametric transformation model. In addition to proportional hazards models, we can
adapt our approaches to the stratified case-cohort study with the above models.
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Chapter 5
Additive hazards model for stratified
case-cohort design
5.1 Introduction
There are two main principal frameworks to investigate the associations between risk
factors and the disease outcome: Cox [1972]’s proportional hazards model and the additive
hazards model. Most of the authors have studied multiplicative hazards models for relative
risk using proportional hazards models in which covariate effects can be expressed as hazard
ratios. However, the proportional hazards assumption might not be appropriate for some
data. In addition, epidemiologists are often interested in the risk difference attributed to
the exposure and the risk difference is useful in public health decision since it can translate
directly into the number of disease cases [Kulich and Lin, 2000b]. Therefore, additive
hazards models have been a useful and important alternative to Cox [1972]’s proportional
hazards model.
There are some work for additive hazards models. Lin and Ying [1994] proposed semi-
parametric estimation for univariate failure time data and studied asymptotic properties
of the estimators. Yin and Cai [2004] extended this approach to the multivariate failure
time data. By using Lin and Ying [1994]’s estimators, Pipper and Martinusse [2004] also
considered marginal additive hazards models for clustered data.
All the aforementioned work deals with all the subjects in the full cohort. In large cohort
studies, obtaining expensive covariate information on all members in the entire cohort could
be costly and it could be infeasible due to limited financial resource. In order to reduce cost,
the case-cohort study is proposed by Prentice [1986]. Under the case-cohort design, covariate
information can be collected only from the subcohort which is a random sample from whole
cohort and all the subjects who have diseases of interest. The important advantage for the
case-cohort study is that the same subcohort can be used when several types of diseases are
of interest [Wacholder et al., 1991].
A few methods for case-cohort studies with additive hazards models have been studied.
For univariate failure time, Kulich and Lin [2000a] applied additive hazards models to the
case-cohort study and derived the large-sample theory of the proposed estimators. Sun
et al. [2004] extended this approach to competing risks analysis in the case-cohort study.
For multiple disease events, Kang et al. [2012] proposed marginal additive hazards model
for case-cohort studies and consider stratified sampling for selection of the subcohort.
Taking advantage of the case-cohort design, several diseases are usually studied using
the same subcohort. In such situation, the information on the expensive exposure measure
are available on the subcohort as well as on any subjects with any of the diseases under the
study. For example, one of the goals in the Atherosclerosis Risk in Communities (ARIC)
study is to investigate the association between the genetic variation in PTGS1 and coronary
heart disease (CHD) as well as stroke and to compare the effects of the genetic variation
on CHD and stroke [Lee et al., 2008]. In this study, the case-cohort design with stratified
sampling for the subcohort are used. To examine the relationship between the genetic
variation and CHD as well as stroke, two case-cohort studies were conducted separately.
We are interested in examining the effect of PTGS1 on the CHD and stroke.
The genetic variation in PTGS1 was collected from the subcohort and all subjects with
CHD and/or stroke. Typically, when analysis for CHD was conducted, the available infor-
mation for stroke were ignored. This is not efficient use of the available information. In
addition, it is often of interest to compare the effects of risk factors on multiple diseases.
Kang et al. [2012] considered the joint modeling with additive hazards models. However,
they also did not fully use all the available information. These motivate us to consider a
more efficient estimator which uses all the available information for the additive hazards
model with stratified case-cohort design.
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In this paper, we propose estimation procedure in the additive hazards model for tra-
ditional and generalized stratified case-cohort design with univariate failure time as well
as multivariate failure time. In Section 5.2, we propose models and estimation procedures
for the proposed methods. Section 5.3 summarizes asymptotic properties for the proposed
estimators and Section 5.4 reports some simulation results. In Section 5.5, we analyze data
from the ARIC study by using the proposed method. Concluding remarks are provided in
Section 5.6.
5.2 Model
Suppose that a cohort study consists of n independent subjects with K diseases of
interest and can be divided into L mutually exclusive strata based on available information
V from all cohort members. Let Tlik denote the potential failure time and Clik the potential
censoring time for disease k of subject i within stratum l. We assume that Tlik is independent
of Clik given covariates. Let Zlik(t) be a p × 1 possibly time-dependent covariates vector
for diseases k of subject i within stratum l at time t. We assume that time-dependent
covariates are external; that is, they are not influenced by the disease processes [Kalbfleisch
and Prentice, 2002]. Let Xlik = min(Tlik,Clik) denote the observed time, ∆lik = I(Tlik ≤
Clik) the indicator for failure, Nlik(t) = I(Xlik ≤ t,∆lik = 1) the counting process, and
Ylik(t) = I(Xlik ≥ t) the at risk indicator for disease k of subject i within stratum l, where
I(.) is the indicator function. Let Vi denote a discrete random variable for subject i as a
stratum variable. The stratum variable is assumed to be independent of Tlik given Zlik(t),
i.e., Vi affects Tlik only through Zlik(t) [Kulich and Lin, 2004]. Let τ denote the end of
study time.
Consider the following additive hazards model for Tlik given Zlik(t)
λlik{t∣Zlik(t)} = λ0k(t) + βT0 Zlik(t), (5.1)
where λ0k(t) is an unspecified baseline hazard function for disease k of subject i and β0 is
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p-dimensional fixed and unknown parameters. Model (5.1) can incorporate disease-type-
specific effect model λik{t∣Z∗lik(t)} = λ0k(t)+βTk Z∗lik(t) as a special case. Specifically, we de-
fine βT0 = (βT1 , . . . , βTk , . . . , βTK) and Zlik(t)T = (0Ti1, . . . ,0Ti(k−1),{Z∗lik(t)}T ,0Tli(k+1), . . . ,0TliK)
where 0T is a 1 × p zero vector. We have βT0 Zlik(t) = βTk Z∗lik(t).
First, we consider the traditional case-cohort design with stratified sampling and refer
to this design as traditional stratified case-cohort design. Suppose that the total size of
cohort n is partitioned into nl intervals for l = 1, . . . , L. Under traditional stratified case-
cohort design, we assume that subjects in the subcohort are selected by stratified random
sampling. Specifically, we select a fixed size n˜l subjects from the nl subjects in stratum l into
the subcohort by using simple random sampling and the total subcohort size is n˜ = ΣLl=1n˜l.
Let ξli be an indicator for subcohort membership for subject i in stratum l. Each
subject in stratum l has the same probability α˜l = Pr(ξli = 1) = n˜l/nl into the subcohort.
Zlik(t)(0 ≤ t ≤ τ) are measured for subjects in the subcohort and those with any disease of
interest.
In many biomedical and clinical studies with common diseases or the large number of
cases, selecting all cases is not feasible due to limited resources. Under this situation, it
is appropriate to consider the stratified case-cohort design which has flexibility to select a
different portion of all cases among the non-subcohort members in a different stratum. We
refer to this design as generalized stratified case-cohort design.
Under the generalized stratified case-cohort design, after selection of subcohort, we
select a fixed number m˜lk of the type k disease cases among non-subcohort members in
stratum l by simple random sampling. Denote by m˜k = ΣLl=1m˜lk the total size of the type
k disease cases. Let ηlik be the indicator for whether subject i in stratum l is sampled for
non-subcohort disease k. Let γ˜lk = Pr (ηlik = 1∣∆lik = 1, ξli = 0) = m˜lk/(nlk − n˜lk) denote the
selection probability of subjects among non-subcohort members in stratum l with disease
k, where nlk and n˜lk denote the number of disease k in the cohort and in the subcohort
within stratum l, respectively. Due to sampling scheme, the elements in (ηl1k, . . . , ηlnlk) are
correlated, however, (ηl1k, . . . , ηlnlk) is independent of (ηl′1k′ , . . . , ηl′nl′k′) for k ≠ k′ or l ≠ l′.
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5.2.1 Estimation for univariate failure time
Consider the situation with only one rare disease of interest, but with covariate infor-
mation available for subjects with other diseases. Under this situation, the observable
information is (Xlik,∆lik, ξli, Zlik(t),0 ≤ t ≤ Xlik, Vi) when ξli = 1 or ∆lik = 1 and is(Xlik,∆lik, ξli, Vi) when ξli = 0 and ∆lik = 0. In the situation that covariate information
are not available for subjects with other diseases, Kulich and Lin [2000a] proposed the ad-
ditive hazards model for traditional case-cohort studies for a single disease using stratified
simple random sampling. For example, if we are interested in disease k and ignore the
covariate information collected on subjects with the other disease, the true regression pa-
rameter β0 in (5.1) can be estimated by solving the estimating equation [Kulich and Lin,
2000a]:
UAk (β) = L∑
l=1
nl∑
i=1ρik ∫ τ0 {Zlik(t) − Z¯k(t)}{dNlik(t) − βTZlik(t)Ylik(t)dt} = 0, (5.2)
where
Z¯k(t) = ∑Ll=1∑nli=1 ρlikZlik(t)Ylik(t)∑Ll=1∑nli=1 ρlikYlik(t)
and ρlik = ∆lik + (1 −∆lik)ξliαˆ−1lk with αˆlk = ∑nli=1 ξli(1 −∆lik)/∑nli=1(1 −∆lik). Here αˆlk, an
estimator for the true selection probability α˜, is the proportion of the sampled subjects
in the subcohort without disease k among all subjects in stratum l without disease k.
This approach for the weight function was first proposed by Kalbfleisch and Lawless [1988]
and Borgan et al. [2000] proposed the time-varying weight version ρlik(t) where ρlik(t) =
∆lik + (1 − ∆lik)ξliαˆ−1lk (t) with αˆlk(t) = ∑nli=1 ξli(1 − ∆lik)Ylik(t)/∑nli=1(1 − ∆lik)Ylik(t). βˆ is
defined as the solution to (5.2) and has the following explicit form:
βˆA = [ L∑
l=1
nl∑
i=1ρlik ∫ τ0 {Zlik(t) − Z¯k(t)}⊗2Ylik(t)dt]
−1 L∑
l=1
nl∑
i=1∫ τ0 {Zlik(t) − Z¯k(t)}dNlik(t),
where a⊗2 = aaT .
To make full use of collected covariate information on subjects with other diseases, we
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consider the following weighted estimating equation:
U Ik (β) = L∑
l=1
nl∑
i=1∫ τ0 ψlik(t){Zlik(t) − Z¯Ik(t)}{dNlik(t) − βTZlik(t)Ylik(t)dt} = 0, (5.3)
where
Z¯Ik(t) = L∑
l=1
nl∑
i=1ψlik(t)Zlik(t)Ylik(t)/
L∑
l=1
nl∑
i=1ψlik(t)Ylik(t)
and ψlik(t) is a possibly time-dependent weight function which has the following form:
ψlik(t) = {1 − K∏
j=1(1 −∆lij)} +
K∏
j=1(1 −∆lij)ξliα̃−1lk (t) (5.4)
where α̃lk(t) = ∑nli=1 ξi{∏Kj=1(1−∆lij)}Ylik(t)/∑nli=1{∏Kj=1(1−∆lij)}Ylik(t). The explicit form
of β˜I which is defined by the solution of the estimating equation (5.3) is following:
β˜I = [ L∑
l=1
nl∑
i=1∫ τ0 ψlik(t){Zlik(t) − Z¯Ik(t)}⊗2Ylik(t)dt]
−1 L∑
l=1
nl∑
i=1∫ τ0 {Zlik(t) − Z¯Ik(t)}dNlik(t).
In the situation that two case-cohort studies were conducted using the same subcohort for
disease 1 and disease 2, respectively, covariate information are available for the subcohort
members as well as subjects with disease 1 and/or disease 2. If we are interested in esti-
mating the covariate effect for disease 1, the time-varying weight function from the existing
method is ρli1(t) = ∆li1+(1−∆li1)ξliαˆ−11l (t) = 1 when ∆li1 = 1 and ρli1 = αˆ−1l1 (t) when ∆li1 = 0
and ξli = 1, regardless of disease 2 information. Therefore, the existing weight function does
not use information collected on subjects with disease 2. On the other hand, our proposed
weight function for disease 1 is ψli1(t) = {1 −∏2j=1(1 − ∆lij)} +∏2j=1(1 − ∆lij)ξliα̃−11l (t) = 1
when ∆li1 = 1 or ∆li2 = 1 and ψli1(t) = α̃−11l (t) when ∆li1 = 0, ∆li2 = 0, and ξli = 1. This
weight function takes disease 2 information into consideration. Note that α̃lk(t), which is an
estimator of the true sampling probability α˜, is the proportion of sampled subjects among
those who do not have any diseases in stratum l and are remaining in the risk set at time t.
When estimating the effect of risk factors on a disease, the proposed weight uses covariate
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information collected on subjects with other failure events.
Let Λ0k(t) = ∫ τ0 λ0k(s)ds. We propose to estimate Λ0k(t) by a Breslow-Aalen type
estimator Λ˜I0k(β˜I , t), where
Λ˜I0k(β, t) = ∫ τ
0
∑Ll=1∑nli=1ψlik(u){dNlik(u) − Ylik(u)βTZlik(u)du}∑Ll=1∑nli=1ψlik(u)Ylik(u) . (5.5)
If the disease of interest is common, then the generalized case-cohort design is more
appropriate than the traditional case-cohort design. We can extend our approach to the
generalized stratified case-cohort design. We consider the following weight function pilik(t)
with two types of diseases (i.e. K = 2):
pilik(t) = Π2j=1(1 −∆lij)ξliα˜−1lk (t) + {1 −Π2j=1(1 −∆lij)} ξli
+ ∆li1(1 −∆li2)(1 − ξli)ηli1γ˜−1l1k(t) + (1 −∆li1)∆li2(1 − ξli)ηli2γ˜−1l2k(t)
+ 1
2
∆li1∆li2(1 − ξli)ηli1γ˜−1l3k(t) + 12∆li1∆li2(1 − ξli)ηli2γ˜−1l4k(t), (5.6)
where
α˜lk(t) = nl∑
i=1 Π2j=1(1 −∆lij)ξliYlik(t)/{
nl∑
i=1 Π2j=1(1 −∆lij)Ylik(t)}
γ˜l1k(t) = nl∑
i=1 ∆li1(1 −∆li2)(1 − ξli)ηli1Ylik(t)/{
nl∑
i=1 ∆li1(1 −∆li2)(1 − ξli)Ylik(t)}
γ˜l2k(t) = nl∑
i=1(1 −∆li1)∆li2(1 − ξli)ηli2Ylik(t)/{
nl∑
i=1(1 −∆li1)∆li2(1 − ξli)Ylik(t)}
γ˜l3k(t) = nl∑
i=1 ∆li1∆li2(1 − ξli)ηli1Ylik(t)/{
nl∑
i=1 ∆li1∆li2(1 − ξli)Ylik(t)}
γ˜l4k(t) = nl∑
i=1 ∆li1∆li2(1 − ξli)ηli2Ylik(t)/{
nl∑
i=1 ∆li1∆li2(1 − ξli)Ylik(t)}.
For the generalized case-cohort data, we can construct the weighted estimating functions and
the estimator for the baseline cumulative hazard function by replacing the weight function
ψlik(t) with pilik(t) in (5.3). The explicit form of β˜IG which is defined by the solution of the
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estimating equation with a weight function pilik(t) is following:
β˜IG = [ L∑
l=1
nl∑
i=1∫ τ0 pilik(t){Zlik(t) − Z¯Ik(t)}⊗2Ylik(t)dt]
−1
× L∑
l=1
nl∑
i=1∫ τ0 pilik(t){Zlik(t) − Z¯Ik(t)}dNlik(t).
5.2.2 Estimation for multivariate failure time
Suppose that there are n = ΣLl=1nl independent subjects with K diseases of interest.
Let independent failure time vector be Tli = (Tli1, . . . , Tlik) and the observed time vector
be Xli = (Xli1, . . . ,Xlik, ) i = 1, . . . , n. Thus, for subject i in stratum l complete observa-
tions are (Xlik,∆lik, ξli, Zlik(t),0 ≤ t ≤ τ, k = 1, . . . ,K,Vi) when ξli = 1 or ∆lik = 1 and(Xlik,∆lik, ξi, k = 1, . . . ,K,Vi) when ξli = 0 and ∆lik = 0.
For traditional stratified case-cohort data with K rare diseases, we consider the esti-
mating equation
U II(β) = L∑
l=1
nl∑
i=1
K∑
k=1∫ τ0 ψlik(t){Zlik(t) − Z¯Ik(t)}{dNlik(t) − βTZlik(t)Ylik(t)dt} = 0, (5.7)
with ψlik(t) defined as in (5.4).
The estimator of the hazards regression parameter β0, β˜
II , is defined as the solution to
(5.7) which has the following explicit form:
β˜II = [ L∑
l=1
nl∑
i=1
K∑
k=1∫ τ0 ψlik(t){Zlik(t) − Z¯Ik(t)}⊗2Ylik(t)dt]
−1 L∑
l=1
nl∑
i=1
K∑
k=1∫ τ0 {Zlik(t) − Z¯Ik(t)}dNlik(t).
Let Λ0k(t) = ∫ τ0 λ0k(s)ds. A Breslow-Aalen type estimator of the baseline cumulative
hazard function is given by Λ˜II0k(β˜II , t), where
Λ˜II0k(β, t) = ∫ τ
0
∑Ll=1∑nli=1ψlik(u){dNlik(u) − Yik(u)βTZlik(u)du}∑Ll=1∑nli=1ψlik(u)Ylik(u) . (5.8)
Under the generalized case-cohort design, the estimating equation and estimator of the
baseline cumulative hazard function are the same as those in (5.7) and (5.8) replacing ψlik(t)
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by pilik(t) defined as in (5.6). The estimator β˜IIG has the explicit form:
β˜IIG = [ L∑
l=1
nl∑
i=1
K∑
k=1∫ τ0 piik(t){Zlik(t) − Z¯Ik(t)}⊗2Ylik(t)dt]
−1
× L∑
l=1
nl∑
i=1
K∑
k=1∫ τ0 pilik(t){Zlik(t) − Z¯Ik(t)}dNlik(t).
5.3 Asymptotic properties
5.3.1 Asymptotic properties of β˜IIG and Λ˜
II
0k(β˜IIG , t)
In this section, we will study the asymptotic properties of the proposed methods. Since
the estimators for the univariate failure time are a special case of those for the multivariate
failure time and the traditional case-cohort study is a special case of the generalized case-
cohort study, we will only present the results for the multivariate case for the generalized
case-cohort study. We make the following assumptions:
(a) {Tli,Cli, Zli}, i = 1, . . . , n and l = 1, . . . , L are independent and identically distributed
where Tli = (Tli1, . . . , TliK)T , Cli = (Cli1, . . . ,CliK)T , and Zli = (Zli1, . . . , ZliK)T ;
(b) P{Ylik(t) = 1} > 0 for t ∈ [0, τ] , i = 1, . . . , nl, k = 1,2, and L = 1, . . . , L;
(c) ∣Zlik(0)∣ + ∫ τ0 ∣dZlik(t)∣ < Dz <∞, i = 1, . . . , nl, k = 1,2, and L = 1, . . . , L almost surely
and Dz is a constant;
(d) The matrixAk is positive definite for k = 1,2 whereAk = ΣLl=1qlEl(∫ τ0 Yl1k(t){Zl1k(t)⊗2−[E{Yl1k(t)Zl1k(t)}/E{Yl1k(t)}]⊗2}dt) where ql = limn→∞ nl/n;
(e) For all k = 1,2, ∫ τ0 λ0k(t)dt <∞;
To show the desired asymptotic properties for generalized case-cohort samples, the following
conditions are also needed:
(f) For all l = 1, . . . , L, limn→∞ α˜l = αl, where α˜l = n˜l/nl and αl is a positive constant.
(g) limn→∞ γ˜l1k = limn→∞ γ˜l3k = γl1, limn→∞ γ˜l2k = limn→∞ γ˜l4k = γl2 where γ˜l1k = Pr[ηli1 =
1∣∆li1 = 1,∆li2 = 0, ξli = 0] = m˜l10/(n1l0 − n˜l10), m˜ljk denotes the number of sampled
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diseased subjects in non-subcohort with (∆l1 = j and ∆l2 = k), nljk and n˜ljk denote
the number of subjects with diseases (∆l1 = j and ∆l2 = k) in the cohort and the
subcohort in stratum l, respectively, γ˜l2k = m˜l01/(nl01 − n˜l01), γ˜l3k = m˜l111/(nl11 − n˜l11),
γ˜l4k = m˜2l11/(nl11 − n˜l11), and γlk is a positive constant on (0,1] for all k = 1,2 and
l = 1, . . . , L.
(h) limn→∞ nlk/nl = plk, where plk is a positive constant on [0,1] for all k = 1,2 and
l = 1, . . . , L.
(i) limn→∞ nl/n = ql, where ql is a positive constant on [0,1] for all l = 1, . . . , L.
The following theorems summarize the main results. Here is the asymptotic properties
for β˜IIG .
Theorem 6. Under the regularity conditions (a)-(i), β˜IIG converges in probability to β0 and
n1/2(β˜IIG −β0) converges in distribution to a mean zero normal distribution with covariance
matrix A(β0)−1∑Ll=1 ΣGII(β0)A(β0)−1, where
A(β) = K∑
k=1Ak(β), ΣGII(β) =
L∑
l=1 ql[V aI,l(β) + 1 − αlαl V aII,l(β) + (1 − αl)
2∑
k=1V aIII,lk(β)],
V aI,l(β) = El[ 2∑
k=1Ql1k(β)]⊗2,
V aII,l(β) = V arl ⎡⎢⎢⎢⎢⎣
2∏
j=1(1 −∆lij)
2∑
k=1∫ τ0 [Bl1k(β, t) − Ylik(t)E[∏
2
j=1(1 −∆lij)Bl1k(β0, t)]
El[∏2j=1(1 −∆lij)Yl1k(t)] dt]
⎤⎥⎥⎥⎥⎦ ,
V aIII,lk(β) = Pr[θl10]1 − γl1γl1 V arl [Ql1k(β) − ∫ τ0 Yl1k(t)El[dQl1k(β, t)∣θl10, ξl1 = 0]El[Yl1k(t)∣θl10] ∣θl10, ξl1 = 0]
+Pr[θl01]1 − γl2
γl2
V arl [Ql1k(β) − ∫ τ
0
Yl1k(t)El[dQl1k(β, t)∣θl01, ξl1 = 0]
El[Yl1k(t)∣θl01] ∣θl01, ξl1 = 0]
+Pr[θl11]
4
[1 − γl1
γl1
+ 1 − γl2
γl2
]V arl [Ql1k(β) − ∫ τ
0
Yl1k(t)E[dQl1k(β, t)∣θl11, ξl1 = 0]
El[Yl1k(t)∣θl11] ∣θl11, ξl1 = 0] ,
Qlik(t, β) = ∫ t
0
{Zlik(t) − ek(t)}dMlik(t),
Blik(t, β) = {Zl1k(t) − ek(t)}Yl1k(t)(λ0k(t) + βTZlik(t)),
ek(t) = ∑Ll=1 qlEl[Yl1k(t)Zl1k(t)]∑Ll=1 qlEl[Yl1k(t)] , θljk = {∆li1 = j and ∆li2 = k}.
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Note that ΣGIIl (β0) consists of three parts. The first part V aI,l(β0) is a contribution to
the variance from the full cohort, the second part V aII,l(β0) is due to sampling subcohort
from the full cohort, and the last one V aIII,l(β0) is due to sampling a fraction of all cases.
If we select all cases, which is the traditional stratified case-cohort study, the last variance
goes to zero.
We summarize the asymptotic properties of the proposed baseline cumulative hazard
estimator Λ˜II0k(β˜IIG , t) in the next theorem.
Theorem 7. Under the regularity conditions (a)-(i), Λ˜II0k(β˜IIG , t) is a consistent estima-
tor of Λ0k(t) in t ∈ [0, τ] and G(t) = {G1(t), . . . ,GK(t)}T = [n1/2{Λ˜II01(β˜IIG , t) − Λ01(t)},
n1/2{Λ˜II02(β˜IIG (t)−Λ02(t))}]T converges weakly to the Gaussian process G(t) = {G1(t),G2(t)}T
in D[0, τ]K with mean zero and the following covariance function Gjk(t, s) between Gj(t)
and Gk(s) for j ≠ k.
Gjk(t, s)(β0) = L∑
l=1 ql[El{µl1j(β0, t)µl1k(β0, s)} + 1 − αlαl El{wl1j(β0, t)wl1k(β0, s)}+ El{νl1j(β0, t)νl1k(β0, s)}],
where the explicit forms of µlik,wlik, and νlik(β, t) are given in Appendix.
The proof of Λ˜G0k(β˜IIG , t) is provided in Appendix. The proof uses Taylor expansion,
Kolmogorov-Centsov theorem, weak convergence of the baseline cumulative hazard esti-
mator from full cohort studies with multivariate failure time, Ha´jek [1960]’s central limit
theorem for finite population sampling, and Cramer-Wold device.
5.3.2 Proofs of Theorems
Proof of Theorem 6
We first show the consistency of β˜IIG . Denote Ũ
G
n = n−1l ŨG. By Taylor expansion series,
β˜IIG can be written as
β˜IIG = β0 + [−∂ŨGn (β0)∂β0 ]
−1
ŨGn (β0) + op(1) (5.9)
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Based on the extension of Fourtz [1977], if the following conditions are satisfied
(I)
∂ŨGn (β)
∂βT
exists and is continuous in an open neighborhood B of β0,
(II)
∂ŨGn (β)
∂βT
is negative definite with probability going to one as n →∞,
(III) -
∂ŨGn (β)
∂βT
converges to A(β0) in probability uniformly for β in an open neighborhood
about β0,
(IV) ŨGn (β) converges to 0 in probability,
then, we can show that β˜IIG converges to β0 in probability. One can write
−∂ŨGn (β)
∂βT
= 1
n
L∑
l=1
nl∑
i=1
2∑
k=1∫ τ0 pilik(t){Zlik(t) − Z¯IIk (t)}Zlik(t)Ylik(t)dt
= 1
n
L∑
l=1
nl∑
i=1
2∑
k=1∫ τ0 pilik(t)Ylik(t){Zlik(t)⊗2 − Z¯IIk (t)Zlik(t)}dt
= 1
n
L∑
l=1
nl∑
i=1
2∑
k=1∫ τ0 pilik(t)Ylik(t){Zlik(t)⊗2 − Z¯IIk (t)⊗2}dt (5.10)
Since (5.10) is constant with respect to β , (I) is satisfied. In order to show that (II)
and (III) are satisfied, we need to show uniform convergence of Z¯IIk (t) to ek(t) such that
supt∈[0,τ] ∥ Z¯IIk (t) − ek(t) ∥ pÐ→ 0 as n→∞ for k = 1,2. It is sufficient to show that
sup
t∈[0,τ] ∥ n−1 L∑l=1
nl∑
i=1pilik(t)Ylik(t)Zlik(t)⊗d − n−1
L∑
l=1
nl∑
i=1Ylik(t)Zlik(t)⊗d ∥ pÐ→ 0as n→∞ for d = 0,1.
It can be written as
n−1 L∑
l=1
nl∑
i=1pilik(t)Ylik(t)Zlik(t)⊗d − n−1
L∑
l=1
nl∑
i=1Ylik(t)Zlik(t)⊗d
= n−1 L∑
l=1
nl∑
i=1[ξliα˜l − 1]
2∏
j=1(1 −∆lij)Ylik(t)Zlik(t)⊗d
− n−1 L∑
l=1
nl∑
i=1[α˜−1l − α˜lk(t)−1]ξli
2∏
j=1(1 −∆lij)Ylik(t)Zlik(t)⊗d
+ n−1 L∑
l=1
nl∑
i=1[ ηli1γ˜l1k − 1]∆li1(1 −∆li2)(1 − ξli)Ylik(t)Zlik(t)⊗d
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− n−1 L∑
l=1
nl∑
i=1[γ˜−1l1 − γ˜l1k(t)−1]ηli1∆li1(1 −∆li2)(1 − ξli)Ylik(t)Zlik(t)⊗d
+ n−1 L∑
l=1
nl∑
i=1[ηli2γ˜l2 − 1](1 −∆li1)∆li2(1 − ξli)Ylik(t)Zlik(t)⊗d
− n−1 L∑
l=1
nl∑
i=1[γ˜−1l2 − γ˜l2k(t)−1]ηli2(1 −∆li1)∆li2(1 − ξli)Ylik(t)Zlik(t)⊗d
+ n−1 L∑
l=1
nl∑
i=1
1
2
[ ηli1
γ˜l3k
− 1]∆li1∆li2(1 − ξli)Ylik(t)Zlik(t)⊗d
− n−1 L∑
l=1
nl∑
i=1
1
2
[γ˜−1l3 − γ˜l3k(t)−1]ηli1∆li1∆li2(1 − ξli)Ylik(t)Zlik(t)⊗d
+ n−1 L∑
l=1
nl∑
i=1
1
2
[ηli2
γ˜l4
− 1]∆li1∆li2(1 − ξli)Ylik(t)Zlik(t)⊗d
− n−1 L∑
l=1
nl∑
i=1
1
2
[γ˜−1l4 − γ˜l4k(t)−1]ηli2∆li1∆li2(1 − ξli)Ylik(t)Zlik(t)⊗d
Then, one can write
∥ n−1 L∑
l=1
nl∑
i=1pilik(t)Ylik(t)Zlik(t)⊗d − n−1
L∑
l=1
nl∑
i=1Ylik(t)Zlik(t)⊗d ∥
≤ ∥ n−1 L∑
l=1
nl∑
i=1[ξliα˜l − 1]
2∏
j=1(1 −∆lij)Ylik(t)Zlik(t)⊗d ∥
+ ∥ n−1 L∑
l=1
nl∑
i=1[α˜−1l − α˜lk(t)−1]ξli
2∏
j=1(1 −∆lij)Ylik(t)Zlik(t)⊗d ∥
+ ∥ n−1 L∑
l=1
nl∑
i=1[ ηli1γ˜l1k − 1]∆li1(1 −∆li2)(1 − ξli)Ylik(t)Zlik(t)⊗d ∥
+ ∥ n−1 L∑
l=1
nl∑
i=1[γ˜−1l1 − γ˜l1k(t)−1]ηli1∆li1(1 −∆li2)(1 − ξli)Ylik(t)Zlik(t)⊗d ∥
+ ∥ n−1 L∑
l=1
nl∑
i=1[ηli2γ˜l2 − 1](1 −∆li1)∆li2(1 − ξli)Ylik(t)Zlik(t)⊗d ∥
+ ∥ n−1 L∑
l=1
nl∑
i=1[γ˜−1l2 − γ˜l2k(t)−1]ηli2(1 −∆li1)∆li2(1 − ξli)Ylik(t)Zlik(t)⊗d ∥
+ ∥ n−1 L∑
l=1
nl∑
i=1
1
2
[ ηli1
γ˜l3k
− 1]∆li1∆li2(1 − ξli)Ylik(t)Zlik(t)⊗d ∥
+ ∥ n−1 L∑
l=1
nl∑
i=1
1
2
[γ˜−1l3 − γ˜l3k(t)−1]ηli1∆li1∆li2(1 − ξli)Ylik(t)Zlik(t)⊗d ∥
+ ∥ n−1 L∑
l=1
nl∑
i=1
1
2
[ηli2
γ˜l4
− 1]∆li1∆li2(1 − ξli)Ylik(t)Zlik(t)⊗d ∥
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+ ∥ n−1 L∑
l=1
nl∑
i=1
1
2
[γ˜−1l4 − γ˜l4k(t)−1]ηli2∆li1∆li2(1 − ξli)Ylik(t)Zlik(t)⊗d ∥ (5.11)
Based on condition (c), the total variation of∏2j=1(1−∆lij)Ylik(t)Zlik(t)⊗d, ∆li1(1−∆li2)(1−
ξli)Ylik(t)Zlik(t)⊗d, (1−∆li1)∆li2(1−ξli)Ylik(t)Zlik(t)⊗d, and ∆li1∆li2(1−ξli)Ylik(t)Zlik(t)⊗d
are finite on [0, τ]. By applying lemma 2, the first, third, fifth, seventh, and ninth terms in
(5.11) converge to zero in probability uniformly in t.
Note that α˜−1l − α˜lk(t)−1 converges to zero in probability uniformly in t by lemma 2
since ∏2j=1(1 − ∆lij)Ylik(t) is bounded variation and El[∏2j=1(1 − ∆l1j)Yl1k(t)] is bounded
away from zero. Similarly, γ˜−1l1 − γ˜l1k(t)−1, γ˜−1l2 − γ˜l2k(t)−1, γ˜−1l3 − γ˜l3k(t)−1, and γ˜−1l4 − γ˜l4k(t)−1
can be shown to converge to zero in probability uniformly in t, respectively. By lemma
2, 1nl ∑nli=1 ξli∏2j=1(1 − ∆lij)Ylik(t) ∥ Zlik(t)⊗d ∥ converges to αEl[∏2j=1(1 − ∆l1j)Yl1k(t) ∥
Zl1k(t)⊗d ∥] in probability uniformly in t. Thus, the second, fourth, sixth, eighth, and tenth
terms in (5.11) converge to zero in probability uniformly in t, respectively. Combining all the
above results, n−1(∑Ll=1∑nli=1 pilik(t)Ylik(t)Zlik(t)⊗d−n−1∑Ll=1∑nli=1 Ylik(t)Zlik(t)⊗d) converges
to zero in probability uniformly in t as n→∞ for d = 0,1.
Since Ylik(t)Zlik(t)⊗d is bounded variation based on condition (c), n−1∑Ll=1∑nli=1 Ylik(t)
Zlik(t)⊗d converges to ∑Ll=1 qlEl[Yl1k(t)Zlik(t)⊗d]. Therefore, it can be shown that
sup
t∈[0,τ] ∥ n−1 L∑l=1
nl∑
i=1pilik(t)Ylik(t)Zlik(t)⊗d −
L∑
l=1 qlEl[Yl1k(t)Zlik(t)⊗d] ∥ pÐ→ 0 as n→∞ for d = 0,1.
Since ∑Ll=1 qlEl[Yl1k(t)] is bounded away from zero based on condition (b), Z¯IIk (t) can be
shown to converge to ek(t) in probability uniformly in t as n → ∞ for k = 1,2. One can
write
−∂ŨGn (β)
∂βT
= 1
n
L∑
l=1
nl∑
i=1
2∑
k=1∫ τ0 pilik(t)Ylik(t){Zlik(t)⊗2 − Z¯IIk (t)⊗2}dt
= 1
n
L∑
l=1
nl∑
i=1
2∑
k=1∫ τ0 Ylik(t){Zlik(t)⊗2 − Z¯IIk (t)⊗2}dt
+ 1
n
L∑
l=1
nl∑
i=1
2∑
k=1∫ τ0 (pilik(t) − 1)Ylik(t){Zlik(t)⊗2 − Z¯IIk (t)⊗2}dt. (5.12)
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Note that the first term in (5.12) converges toA = ∑Ll=1 qlEl[∑2k=1 ∫ τ0 pil1k(t)Yl1k(t){Zl1k(t)⊗2−
ek(t)⊗2}dt] where ql = limn→∞ nl/n in probability as n →∞ by the uniform convergence of
Z¯IIk (t) to ek(t).
Now we will show that the second term converges to zero in probability uniformly in t.
The second term in (5.12) can be written as
1
n
L∑
l=1
nl∑
i=1
2∑
k=1∫ τ0 (ξliα˜l − 1)
2∏
j=1(1 −∆lij)Ylik(t){Zlik(t)⊗2 − Z¯IIk (t)⊗2}dt
+ 1
n
L∑
l=1
nl∑
i=1
2∑
k=1∫ τ0 [α˜lk(t)−1 − α˜−1l ]ξli
2∏
j=1(1 −∆lij)Ylik(t){Zlik(t)⊗2 − Z¯IIk (t)⊗2}dt
+ 1
n
L∑
l=1
nl∑
i=1
2∑
k=1∫ τ0 (ηli1γ˜l1 − 1)∆li1(1 −∆li2)(1 − ξli)Ylik(t){Zlik(t)⊗2 − Z¯k(t)⊗2}dt
+ 1
n
L∑
l=1
nl∑
i=1
2∑
k=1∫ τ0 [γ˜l1k(t)−1 − γ˜−1l1 ]ηli1(1 − ξli)∆li1(1 −∆li2)Ylik(t){Zlik(t)⊗2 − Z¯IIk (t)⊗2}dt
+ 1
n
L∑
l=1
nl∑
i=1
2∑
k=1∫ τ0 (ηli2γ˜l2 − 1)(1 −∆li1)∆li2(1 − ξli)Ylik(t){Zlik(t)⊗2 − Z¯IIk (t)⊗2}dt
+ 1
n
L∑
l=1
nl∑
i=1
2∑
k=1∫ τ0 [γ˜l2k(t)−1 − γ˜−1l2 ]ηli2(1 − ξli)(1 −∆li1)∆li2Ylik(t){Zlik(t)⊗2 − Z¯IIk (t)⊗2}dt
+ 1
2n
L∑
l=1
nl∑
i=1
2∑
k=1∫ τ0 ( ηli1γ˜l3k − 1)∆li1∆li2(1 − ξli)Ylik(t){Zlik(t)⊗2 − Z¯IIk (t)⊗2}dt
+ 1
2n
L∑
l=1
nl∑
i=1
2∑
k=1∫ τ0 [γ˜l3k(t)−1 − γ˜−1l3 ]ηli1(1 − ξli)∆li1∆li2Ylik(t){Zlik(t)⊗2 − Z¯IIk (t)⊗2}dt
+ 1
2n
L∑
l=1
nl∑
i=1
2∑
k=1∫ τ0 (ηli2γ˜l4 − 1)∆li1∆li2(1 − ξli)Ylik(t){Zlik(t)⊗2 − Z¯IIk (t)⊗2}dt
+ 1
2n
L∑
l=1
nl∑
i=1
2∑
k=1∫ τ0 [γ˜l4k(t)−1 − γ˜−1l4 ]ηli2(1 − ξli)∆li1∆li2Ylik(t){Zlik(t)⊗2 − Z¯IIk (t)⊗2}dt
(5.13)
By the uniform convergence of Z¯IIk (t) to ek(t), the first term in (5.13) is asymptotically
equivalent to n−1∑Ll=1∑nli=1∑2k=1 ∫ τ0 ( ξliα˜l −1)∏2j=1(1−∆lij)Ylik(t){Zlik(t)⊗2−ek(t)⊗2}dt. Sim-
ilarly, the third term, the fifth term, seventh term, and ninth term in (5.13) are asymp-
totically equivalent to n−1∑Ll=1∑nli=1∑2k=1 ∫ τ0 (ηli1γ˜l1 −1)∆li1(1−∆li2)(1−ξli)Ylik(t){Zlik(t)⊗2−
ek(t)⊗2}dt, n−1∑Ll=1∑nli=1∑2k=1 ∫ τ0 (ηli2γ˜l2 −1)(1−∆li1)∆li2(1−ξli)Ylik(t){Zlik(t)⊗2−ek(t)⊗2}dt,(2n)−1∑Ll=1∑nli=1∑2k=1 ∫ τ0 ( ηli1γ˜l3k−1)∆li1∆li2(1−ξli)Ylik(t){Zlik(t)⊗2−ek(t)⊗2}dt, and (2n)−1∑Ll=1
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∑nli=1∑2k=1 ∫ τ0 (ηli2γ˜l4 − 1)(1 − ξli)∆li1∆li2Ylik(t){Zlik(t)⊗2 − ek(t)⊗2}dt, respectively.
Based on condition (c), ∏2j=1(1 − ∆lij)Ylik(t){Zlik(t)⊗2 − ek(t)⊗2}, ∆li1(1 − ∆li2)(1 −
ξli)Ylik(t){Zlik(t)⊗2−ek(t)⊗2}, (1−∆li1)∆li2(1−ξli)Ylik(t){Zlik(t)⊗2−ek(t)⊗2}, ∆li1∆li2(1−
ξli)Ylik(t){Zlik(t)⊗2 − ek(t)⊗2} are of bounded variations and they are independent and
identically distributed. It follows from lemma 2 that the first term, the third term, the
fifth term, seventh term, and ninth term can be shown to converge to zero in probability
uniformly in t, respectively.
Since α˜lk(t)−1 − α˜−1l , γ˜l1k(t)−1 − γ˜−1l1 , γ˜l2k(t)−1 − γ˜−1l2 , γ˜l3k(t)−1 − γ˜−1l3 , and γ˜l4k(t)−1 − γ˜−1l4
converge to zero in probability uniformly respectively and Z¯IIk (t) converges to ek(t) in
probability uniformly in t, we can show that the second, fourth, sixth, eighth, and tenth
terms converge to zero in probability uniformly in t respectively.
Combining all the results, we have
−∂ŨGn (β)
∂βT
pÐ→ A as n→∞
, and, thus, (II) and (III) are satisfied.
Now, n1/2ŨGn (β) can be decomposed into four parts:
n1/2ŨGn (β) = n−1/2 L∑
l=1
nl∑
i=1
2∑
k=1∫ τ0 pilik(t){Zlik(t) − Z¯IIk (t)}dMlik(t)
= n−1/2 L∑
l=1
nl∑
i=1
2∑
k=1∫ τ0 pilik(t){Zlik(t) − ek(t) + ek(t) − Z¯IIk (t)}dMlik(t)
= n−1/2 L∑
l=1
nl∑
i=1
2∑
k=1∫ τ0 {Zlik(t) − ek(t)}dMlik(t)
+ n−1/2 L∑
l=1
nl∑
i=1
2∑
k=1∫ τ0 {pilik(t) − 1}{Zlik(t) − ek(t)}dMlik(t)
+ n−1/2 L∑
l=1
nl∑
i=1
2∑
k=1∫ τ0 {ek(t) − Z¯IIk (t)}dMlik(t)
+ n−1/2 L∑
l=1
nl∑
i=1
2∑
k=1∫ τ0 {pilik(t) − 1}{ek(t) − Z¯IIk (t)}dMlik(t) (5.14)
Since the first term in (5.14) is the pseudo partial likelihood score function for the full likeli-
hood, it is asymptotically zero-mean normal with covariance VI,l(β0) = ∑Ll=1 qlEl[∑2k=1Ql1k(β0)]⊗2
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where Qlik(t, β) = ∫ t0 {Zlik(t) − ek(t)}dMlik(t) [Yin and Cai, 2004].
The third term can be shown to converge to zero. Note that for fixed t, Ml1k(t), . . . ,Mlnk(t)
are identically and independent distributed zero-mean random variables and ∑nli=1Mlik(t)
is sum of identically and independently distributed zero-mean random variables.
Since M2lik(0) <∞ and M2lik(τ) <∞ are satisfied based on condition (c) and (e), Mlik(t)
is of bounded variation and therefore it can be written as a difference of two monotone
functions in t. From the example of 2.11.16 of van der Vaart and Wellner [1996](p215),
n
−1/2
l ∑nli=1Mlik(t) converges weakly to a zero-mean Gaussian process, say PM,lk(t).
To establish the existence of stochastic processes with continuous sample paths, we will
use Kolmogorov-Centsov theorem. If conditions of Kolmogorov-Centsov theorem E{PM,lk(t)−PM,lk(s)}4 ≤ C∗z ∣t − s∣2 and E{PM,lk(t) − PM,lk(s)}2 ≤ C ∣t − s∣ for all t ≥ s are satisfied,
then we can show that PM,lk(t) has continuous sample paths. Note that EPM,lk(t)2 =
E[n−1l ∑nli=1Mlik(t)2] = EMlik(t)2 = E[∫ t0 Ylik(u)(λ0k(u)du+βT0 Zlik(u))du], and E{PM,lk(t)−PM,lk(s)}2 = EPM,lk(t)2 - EPM,lk(s)2= E[∫ ts Ylik(u)(λ0k(u)du + βT0 Zlik(u))du]. Based on
condition (c), (e), λ0k(.) and βT0 Zlik(.) are of bounded variations on [0, τ]. Thus, it follows
from mean value theorem that there exists a constant C such that E[∫ ts Ylik(u)(λ0k(u)du+
βT0 Zlik(u))du] ≤ C(t − s) for s ≤ t. Hence, E[{PM,lk(t) − PM,lk(s)}2] ≤ C(t − s) and
E[PM,lk(t) − PM,lk(s)}4] = Var(PM,lk(t) − PM,lk(s))2 + E{(PM,lk(t) − PM,lk(s))2}2 = 3{E(PM,lk(t)−PM,lk(s))2}2 ≤ C∗∣t−s∣2 for some constant C∗. Since two conditions are satis-
fied, it follows that PM,lk(t) has continuous sample path from Kolmogorov-Centsov theorem.
Based on conditions (b) and (c), it can be shown that n−1∑Ll=1∑nli=1 pilik(t)Ylik(t)Zlik(t) and
n−1∑Ll=1∑nli=1 pilik(t)Ylik(t) are of bounded variations and specially n−1∑Ll=1∑nli=1 pilik(t)Ylik(t)
is bounded away from zero. Thus Z¯IIk (t) is of bounded variation and can be written as
Z¯IIk (t) = Gk1 −Gk1 where both Gk1 and Gk2 are nonnegative, monotone functions in t, and
bounded. Therefore, Z¯IIk (t) is the sum of two monotone functions. By Lemma 1, the third
term in (5.14) converges to zero in probability uniformly in t as n→∞.
By similar arguments, the fourth term in (5.14) converges to zero in probability uni-
formly since pilik(t) − 1 is of bounded variation.
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Now, the second term in (5.14) can be written as
n−1/2 L∑
l=1
nl∑
i=1
2∑
k=1∫ τ0 {pilik(t) − 1}{Zlik(t) − ek(t)}dMlik(t)
= n−1/2 L∑
l=1
nl∑
i=1
2∑
k=1∫ τ0 (ξliα˜l − 1)
2∏
j=1(1 −∆lij){Zlik(t) − ek(t)}dMlik(t)
+ n−1/2 L∑
l=1
nl∑
i=1
2∑
k=1∫ τ0 (α˜lk(t)−1 − α˜−1l )ξli
2∏
j=1(1 −∆lij){Zlik(t) − ek(t)}dMlik(t)
+ n−1/2 L∑
l=1
nl∑
i=1
2∑
k=1∫ τ0 (ηli1γ˜l1 − 1)∆li1(1 −∆li2)(1 − ξli){Zlik(t) − ek(t)}dMlik(t)
+ n−1/2 L∑
l=1
nl∑
i=1
2∑
k=1∫ τ0 (γ˜l1k(t)−1 − γ˜−1l1k)ηli1∆li1(1 −∆li2)(1 − ξli){Zlik(t) − ek(t)}dMlik(t)
+ n−1/2 L∑
l=1
nl∑
i=1
2∑
k=1∫ τ0 (ηli2γ˜l2 − 1)(1 −∆li1)∆li2(1 − ξli){Zlik(t) − ek(t)}dMlik(t)
+ n−1/2 L∑
l=1
nl∑
i=1
2∑
k=1∫ τ0 (γ˜l2k(t)−1 − γ˜−1l2k)ηli2(1 −∆li1)∆li2(1 − ξli){Zlik(t) − ek(t)}dMlik(t)
+ n−1/2 L∑
l=1
nl∑
i=1
2∑
k=1
1
2
∫ τ
0
( ηli1
γ˜l3k
− 1)∆li1∆li2(1 − ξli){Zlik(t) − ek(t)}dMlik(t)
+ n−1/2 L∑
l=1
nl∑
i=1
2∑
k=1
1
2
∫ τ
0
(γ˜l3k(t)−1 − γ˜−1l3k)ηli1∆li1∆li2(1 − ξli){Zlik(t) − ek(t)}dMlik(t)
+ n−1/2 L∑
l=1
nl∑
i=1
2∑
k=1
1
2
∫ τ
0
(ηli2
γ˜l4
− 1)∆li1∆li2(1 − ξli){Zlik(t) − ek(t)}dMlik(t)
+ n−1/2 L∑
l=1
nl∑
i=1
2∑
k=1
1
2
∫ τ
0
(γ˜l4k(t)−1 − γ˜−1l4k)ηli2∆li1∆li2(1 − ξli){Zlik(t) − ek(t)}dMlik(t)
(5.15)
Using the result of (4.6), the second term in (5.15) can be written as
n−1/2 L∑
l=1
nl∑
i=1
2∑
k=1∫ τ0 1α˜lEl(∏2j=1(1 −∆l1j)Yl1k(t)) 1nl
⎧⎪⎪⎨⎪⎪⎩
nl∑
m=1(1 − ξlmα˜l )
2∏
j=1(1 −∆lmj)Ylmk(t)
⎫⎪⎪⎬⎪⎪⎭× ξli 2∏
j=1(1 −∆lij){Zlik(t) − ek(t)}dMlik(t) + op(1)
= n−1/2 L∑
l=1
nl∑
i=1
2∏
j=1(1 −∆lij)(1 − ξliα˜l )
× 2∑
k=1∫ τ0 Ylik(t)n
−1
l ∑nlm=1 ξlmα˜l ∏2j=1(1 −∆lmj){Zlmk(t) − ek(t)}dMlmk(t)
El[∏2j=1(1 −∆l1j)Yl1k(t))] + op(1)
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It follows from Glivenko-Cantelli lemma and Lemma 2 that n−1l ∑nlm=1 ξlmα˜l ∏2j=1(1−∆lmj){Zlmk(t)−
ek(t)}dMlmk(t) can be written as
n−1l nl∑
m=1
ξlm
α˜l
2∏
j=1(1 −∆lmj){Zlmk(t) − ek(t)}dMlmk(t)
= n−1l nl∑
m=1
ξlm
α˜l
2∏
j=1(1 −∆lmj){Zlmk(t) − ek(t)}{dNlmk(t) − Ylmk(t)(λ0k(t) + βT0 Zlmk(t))dt}
= −n−1l nl∑
m=1
ξlm
α˜l
2∏
j=1(1 −∆lmj){Zlmk(t) − ek(t)}Ylmk(t)(λ0k(t) + βT0 Zlmk(t))dt
→ −El[ 2∏
j=1(1 −∆l1j){Zl1k(t) − ek(t)}Yl1k(t)(λ0k(t) + βTZl1k(t))]dt
Since only censored observations contribute to this term, the last equality holds.
Therefore, the second term on the right-side of (5.15) is asymptotically equivalent to
n−1/2 L∑
l=1
nl∑
i=1
2∏
j=1(1 −∆lij)(ξliα˜l − 1)
2∑
k=1∫ τ0 Ylik(t)El[∏
2
j=1(1 −∆l1j)Blik(t, β)]
El[∏2j=1(1 −∆l1jYl1k(t))] dt
whereBlik(t, β) = {Zlik(t)−ek(t)}Ylik(t)[λ0k(t)+βTZlik(t)] and ek(t) = ∑Ll=1 qlEl[Yl1k(t)Zl1k(t)]∑Ll=1 qlEl[Yl1k(t)] .
The first term on the right-side of (5.15) is asymptotically equivalent to
−n−1/2 L∑
l=1
nl∑
i=1
2∑
k=1∫ τ0 (ξliα˜l − 1)
2∏
j=1(1 −∆lij){Zlik(t) − ek(t)}Ylmk(t)(λ0k(t) + βT0 Zlmk(t))dt
= −n−1/2 L∑
l=1
nl∑
i=1
2∑
k=1∫ τ0 (ξliα˜l − 1)
2∏
j=1(1 −∆lij)Blik(t, β)dt
Combining these results, it can be shown that the first and second terms in (5.15) are
asymptotically equivalent to
n−1/2 L∑
l=1
nl∑
i=1
2∑
k=1
2∏
j=1(1 −∆lij)(1 − ξliα˜l )∫ τ0
⎡⎢⎢⎢⎣Blik(t, β) − Ylik(t)El[∏
2
j=1(1 −∆l1j)Bl1k(t, β)]
El[∏2j=1(1 −∆l1j)Yl1k(t)]
⎤⎥⎥⎥⎦dt
Using the result of (4.8), Glivenko-Cantelli lemma and Lemma 2, it can be shown that the
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fourth, the sixth, the eighth, and tenth terms in (5.15) are asymptotically equivalent to
n−1/2 L∑
l=1
nl∑
i=1
2∑
k=1 ∆li1(1 −∆li2)(1 − ξli)(ηli1γ˜l1 − 1)× ∫ τ
0
Ylik(t)El[{Zl1k(t) − ek(t)}dMl1k(t)∣θl10, ξl1 = 0]
El[Yl1k(t)∣θl10]
+ n−1/2 L∑
l=1
nl∑
i=1
2∑
k=1(1 −∆li1)∆li2(1 − ξli)(ηli2γ˜l2 − 1)× ∫ τ
0
Ylik(t)El[{Zl1k(t) − ek(t)}dMl1k(t)∣θl01, ξl1 = 0]
El[Yl1k(t)∣θl01]
+ n−1/2 L∑
l=1
nl∑
i=1
2∑
k=1 ∆li1∆li2(1 − ξli)(ηli1γ˜l3 − 1)∫ τ0 Ylik(t)El[{Zl1k(t) − ek(t)}dMl1k(t)∣θl11, ξl1 = 0]El[Yl1k(t)∣θl11]
+ n−1/2 L∑
l=1
nl∑
i=1
2∑
k=1 ∆li1∆li2(1 − ξli)(ηli2γ˜l4 − 1)∫ τ0 Ylik(t)El[{Zl1k(t) − ek(t)}dMl1k(t)∣θl11, ξl1 = 0]El[Yl1k(t)∣θl11] .
Combining all results, the term in (5.14) is asymptotically equivalent to
n−1/2 L∑
l=1
nl∑
i=1
2∑
k=1Qlik(t, β)
+ n−1/2 L∑
l=1
nl∑
i=1
2∑
k=1
2∏
j=1(1 −∆lij)(1 − ξliα˜l )∫ τ0
⎡⎢⎢⎢⎣Blik(β0, t) − Ylik(t)El[∏
2
j=1(1 −∆l1j)Bl1k(t, β)]
El[∏2j=1(1 −∆l1j)Yl1k(t)]
⎤⎥⎥⎥⎦dt
+ n−1/2 L∑
l=1
nl∑
i=1
2∑
k=1 ∆li1(1 −∆li2)(1 − ηli1γ˜l1 ) [Qlik(β) − ∫ τ0 Ylik(t)El[dQl1k(t, β)∣θl10, ξl1 = 0]El[Yl1k(t)∣θl10] ]
+ n−1/2 L∑
l=1
nl∑
i=1
2∑
k=1(1 −∆li1)∆li2(1 − ηli2γ˜l2 ) [Qlik(β) − ∫ τ0 Ylik(t)El[dQl1k(t, β)∣θl01, ξl1 = 0]El[Yl1k(t)∣θl01] ]
+ n−1/2 L∑
l=1
nl∑
i=1
2∑
k=1
1
2
∆li1∆li2(1 − ηli1
γ˜l3k
) [Qlik(β) − ∫ τ
0
Ylik(t)El[dQl1k(t, β)∣θl11, ξl1 = 0]
El[Yl1k(t)∣θl11] ]
+ n−1/2 L∑
l=1
nl∑
i=1
2∑
k=1
1
2
∆li1∆li2(1 − ηli2
γ˜l4
) [Qlik(β) − ∫ τ
0
Ylik(t)El[dQl1k(t, β)∣θl11, ξl1 = 0]
El[Yl1k(t)∣θl11] ] (5.16)
By Ha´jek [1960]’s central limit theorem and conditions (c) and (f), the second term in (5.16)
is asymptotically zero-mean normal random variable with covariance matrix∑Ll=1 ql 1−αlαl VII,l(β0)
where
VII,l(β0) = V arl ⎡⎢⎢⎢⎢⎣
2∏
j=1(1 −∆l1j)
2∑
k=1∫ τ0 [Bl1k(β0, t) − Yl1k(t)El[∏
2
j=1(1 −∆l1j)Bl1k(t, β0)]
El[∏2j=1(1 −∆l1j)Yl1k(t)] ]dt
⎤⎥⎥⎥⎥⎦ .
It follows from Lemma 2 and Ha´jek [1960]’s central limit theorem that the third, fourth,
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and fifth terms are asymptotically zero-mean normal with covariance matrix ∑Ll=1 ql(1 −
αl)∑2k=1 VIII,lk(β0) where
VIII,lk(β0)
= Pr[θl10]1 − γl1
γl1
V arl [Ql1k(β0) − ∫ τ
0
Yl1k(t)El[dQl1k(t, β0)∣θl10, ξl1 = 0]
El[Yl1k(t)∣θl10] ∣θl10, ξl1 = 0]
+Pr[θl01]1 − γl2
γl2
V arl [Ql1k(β0) − ∫ τ
0
Yl1k(t)El[dQl1k(t, β0)∣θl01, ξl1 = 0]
El[Yl1k(t)∣θl01] ∣θl01, ξl1 = 0]+Pr[θl11]
4
[1 − γl1
γl1
+ 1 − γl2
γl2
]
× V arl [Ql1k(β0) − ∫ τ
0
Yl1k(t)El[dQl1k(t, β0)∣θl11, ξl1 = 0]
El[Yl1k(t)∣θl11] ∣θl11, ξl1 = 0] .
In addition, n−1/2∑Ll=1∑nli=1∑2k=1Qlik(β0) and n−1/2∑Ll=1∑nli=1∑2k=1(1 − ξliα˜l ) ∫ τ0 ∏2j=1(1 −
∆lij)Llik(t, β)dt where Llik(t) = Blik(t, β)−Ylik(t)El[∏2j=1(1−∆l1j)Bl1k(t,β)]El[∏2j=1(1−∆l1j)Yl1k(t)] dt are independent
since
Covl
⎛⎝n−1/2l nl∑i=1
2∑
k=1Qlik(β0), n−1/2l
nl∑
i=1
2∑
k=1( ξli1 − α˜l )∫ τ0
2∏
j=1(1 −∆lij)Llik(t)dMlik(t)⎞⎠
= El ⎧⎪⎪⎨⎪⎪⎩n−1/2l
nl∑
i=1
2∑
k=1Qlik(β0)
nl∑
i=1
2∑
k=1( ξli1 − α˜l )∫ τ0
2∏
j=1(1 −∆lij)Llik(t)dMlik(t)⎞⎠
= El ⎧⎪⎪⎨⎪⎪⎩E ⎛⎝n−1l
nl∑
i=1
2∑
k=1Qlik(β0)
nl∑
i=1
2∑
k=1( ξli1 − α˜l )∫ τ0
2∏
j=1(1 −∆lij)Llik(t)dMlik(t)∣F(τ)⎞⎠
⎫⎪⎪⎬⎪⎪⎭
= El ⎧⎪⎪⎨⎪⎪⎩n−1l
nl∑
i=1
2∑
k=1Qlik(β0)
nl∑
i=1
2∑
k=1E (( ξli1 − α˜l )∣F(τ))∫ τ0
2∏
j=1(1 −∆lij)Llik(t)dMlik(t)
⎫⎪⎪⎬⎪⎪⎭ = 0
By using same arguments, n−1/2∑Ll=1∑nli=1∑2k=1Qlik(β0) and the third to the last term in
(5.16) are independent. Since ξli and ηlik (k = 1,2) are independent, n−1/2∑Ll=1∑nli=1∑2k=1(1−
ξli
α˜l
) ∫ τ0 ∏2j=1(1−∆lij)Llik(t)dMlik(t) and the third to the last term in (5.16) are independent.
Therefore, n−1/2U˜G(β0) converges weakly to zero-mean normal vector with covariance
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matrix ΣGII(β0) where
ΣGII(β) = L∑
l=1 ql [VI,l(β) + 1 − αlαl VII,l(β) + (1 − αl)
2∑
k=1VIII,lk(β)] ,
VI,l(β) = El[ 2∑
k=1Ql1k(β)]⊗2,
VII,l(β) = V arl ⎡⎢⎢⎢⎢⎣
2∏
j=1(1 −∆lij)
2∑
k=1∫ τ0 [Bl1k(t, β) − Yl1k(t)El[∏
2
j=1(1 −∆l1j)Bl1k(t, β)]
El[∏2j=1(1 −∆l1j)Yl1k(t)] ]dt
⎤⎥⎥⎥⎥⎦ ,
VIII,lk(β)
= Pr[θl10]1 − γl1
γl1
V arl [Ql1k(β) − ∫ τ
0
Yl1k(t)El[dQl1k(t, β)∣θl10, ξl1 = 0]
El[Yl1k(t)∣θl10] ∣θl10, ξl1 = 0]
+ Pr[θl01]1 − γl2
γl2
V arl [Ql1k(β) − ∫ τ
0
Yl1k(t)El[dQl1k(t, β)∣θl01, ξl1 = 0]
El[Yl1k(t)∣θl01] ∣θl01, ξl1 = 0]+ Pr[θl11]
4
[1 − γl1
γl1
+ 1 − γl2
γl2
]
× V ar [Ql1k(β) − ∫ τ
0
Yl1k(t)El[dQl1k(t, β)∣θl11, ξl1 = 0]
El[Yl1k(t)∣θl11] ∣θl11, ξl1 = 0] .
Therefore, ŨGn (β) converges to zero in probability and (iv) is satisfied.
Since all conditions (i), (ii), (iii) and (iv) are satisfied, β˜IIG is a consistent estimator of
β0 by an extension of Fourtz [1977]. By consistency of β˜
II
G and Taylor expansion of Ũ
G
II(β)
such as
ŨGn (β) = ŨGn (β0) + ∂ŨGn (β)∂β [β˜IIG − β0] + op(1),
n1/2(β˜IIG − β0) is asymptotically normally distributed with mean zero and with variance
matrix A−1ΣGII(β0)A−1 where A = ∑2k=1Ak.
Now, here is an outline for the proof of Theorem 7.
Proof of Theorem 7
Λ̃II0k(β˜II , t) = ∫ t
0
∑Ll=1∑nli=1 pilik(u){dNlik(u) − Ylik(u)βTZlik(u)du}∑Ll=1∑nli=1 pilik(u)Ylik(u)
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We can decompose n1/2{Λ̃II0k(β˜II , t) −Λ0k(t)} into three parts:
n1/2{Λ̃II0k(β˜II , t) −Λ0k(t)}
= n1/2{Λ̃II0k(β˜II , t) − Λ̃II0k(β0, t) + Λ̃II0k(β0, t) −Λ0k(t)}
= n1/2∫ t
0
∑Ll=1∑nli=1 pilik(u)Ylik(u){β0 − β˜II}TZlik(u)du∑Ll=1∑nli=1 pilik(u)Ylik(u)+ n1/2∫ t
0
∑Ll=1∑nli=1 pilik(u){dNlik(u) − Ylik(u)β0Zlik(u)du}∑Ll=1∑nli=1 pilik(u)Ylik(u)− n1/2∫ t
0
∑Ll=1∑nli=1 pilik(u)Ylik(u)λ0k(u)∑Ll=1∑nli=1 pilik(u)Ylik(u)
= n1/2∫ t
0
∑Ll=1∑nli=1 pilik(u)Ylik(u){β0 − β˜II}TZlik(u)du∑nli=1 pilik(u)Ylik(u) + ∫ t0 ∑
L
l=1∑nli=1 pilik(u)dMlik(u)∑Ll=1∑nli=1 pilik(u)Ylik(u) ]
= n1/2∫ t
0
∑Ll=1∑nli=1 pilik(u)Ylik(u){β0 − β˜II}TZlik(u)du∑Ll=1∑nli=1 pilik(u)Ylik(u) + n1/2∫
t
0
∑Ll=1∑nli=1 dMlik(u)∑Ll=1∑nli=1 pilik(u)Ylik(u)+ n1/2∫ t
0
∑Ll=1∑nli=1{pilik(u) − 1}dMlik(u)∑Ll=1∑nli=1 pilik(u)Ylik(u) . (5.17)
Due to the uniform convergence of Z¯IIk (t) to ek(t), the first term in (5.17) is asymptot-
ically equivalent to n
1/2
l (β˜II − β0)lk(t), where lk(t) = ∫ τ0 −ek(u)du.
Note that [n−1∑Ll=1∑nli=1 pilik(t)Ylik(t)]−1 can be written as a sum of two monotone func-
tion in t, converges to [∑Ll=1 qlEl[Yl1k(t)]]−1 where ∑Ll=1 qlEl[Yl1k(u)] is bounded away from
zero, and n−1/2∑Ll=1∑nli=1Mlik(t) converges to a zero-mean Gaussian process with continuous
sample path. By Lemma 1, the second term in (5.17) is asymptotically equivalent to
∫ t
0
1∑Ll=1 qlEl[Yl1k(t)]d{n1/2
L∑
l=1
nl∑
i=1Mlik(u)}.
The third term in(5.17) can be written as
∫ t
0
∑Ll=1∑nli=1{pilik(u) − 1}dMlik(u)∑Ll=1∑nli=1 pilik(u)Ylik(u)= n−1/2∫ t
0
1∑Ll=1∑nli=1 pilik(u)Ylik(u){
L∑
l=1
nl∑
i=1(1 − ξliα˜l )
2∏
j=1(1 −∆lij)dMlik(u)
+ L∑
l=1
nl∑
i=1(α˜lk(t)−1 − α˜−1l )ξli
2∏
j=1(1 −∆lij)dMlik(u)
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+ L∑
l=1
nl∑
i=1[( ηli1γ˜l1k − 1)∆li1(1 −∆li2)(1 − ξli) + {γ˜l1k(t)−1 − γ˜−1l1 }ηli1∆li1(1 −∆li2)(1 − ξli)]dMlik(u)
+ L∑
l=1
nl∑
i=1[( ηli2γ˜l2k − 1)(1 −∆li1)∆li2(1 − ξli) + {γ˜l2k(t)−1 − γ˜−1l2 }ηli2(1 −∆li1)∆li2(1 − ξli)]dMlik(u)
+ L∑
l=1
nl∑
i=1[12( ηli1γ˜l3k − 1)∆li1∆li2(1 − ξli) + {γ˜l3k(t)−1 − γ˜−1l3 }ηli1∆li1∆li2(1 − ξli)]dMlik(u)
+ L∑
l=1
nl∑
i=1[12( ηli2γ˜l4k − 1)∆li1∆li2(1 − ξli) + {γ˜l4k(t)−1 − γ˜−1l4 }ηli1∆li1∆li2(1 − ξli)]dMlik(u)}. (5.18)
Since {n−1∑Ll=1∑nli=1 pilik(t)Ylik(t)}−1 converges to∑Ll=1 qlEl[Yl1k(u)]−1, where∑Ll=1 qlEl[Yl1k(u)]
is bounded away from zero in probability uniformly, the first term in (5.18) is asymptotically
equivalent to n−1/2∑Ll=1∑nli=1(1 − ξliα˜l )∏2j=1(1 −∆lij) ∫ t0 Ylik(t){λ0k(u)+βT0 Zlik(u)}du∑Ll=1 qlEl[Yl1k(u)] .
By the result of (4.6), the second term in (5.18) can be written as
n−1/2∫ t
0
1∑Ll=1∑nli=1 pilik(u)Ylik(u)
L∑
l=1
nl∑
i=1(α˜lk(t)−1 − α˜−1l )ξli
2∏
j=1(1 −∆lij)dMlik(u)
= n−1/2∫ t
0
1∑Ll=1∑nli=1 pilik(u)Ylik(u)
L∑
l=1
nl∑
i=1( 1α˜lEl[∏2j=1(1 −∆l1j)Yl1k(t)]
× n−1l ⎧⎪⎪⎨⎪⎪⎩
nl∑
m=1(1 − ξlmα˜l )
2∏
j=1(1 −∆lmj)Ylmk(t)
⎫⎪⎪⎬⎪⎪⎭)ξli
2∏
j=1(1 −∆lij)dMlik(u)
= n−1/2∫ t
0
1∑Ll=1∑nli=1 pilik(u)Ylik(u)
L∑
l=1
nl∑
i=1(ξliα˜l − 1)
2∏
j=1(1 −∆lij)∫ t0 1El[∏2j=1(1 −∆l1j)Yl1k(u)]
× Ylik(u)n−1l nl∑
i=1
ξli
α˜l
2∏
j=1(1 −∆lij)(Ylik(t){λ0k(u) + βT0 Zl1k(u)}).
If follows from the uniform convergence of {n−1∑Ll=1∑nli=1 pilik(u)Ylik(u)}−1 to {∑Ll=1 qlEl[Yl1k(u)]},
n−1l ∑nli=1 ξliα˜l ∏2j=1(1−∆lij)Ylik(u) to El[∏2j=1(1−∆l1j)Yl1k(u)], n−1l ∑nli=1 ξliα˜l ∏2j=1(1−∆lij)Ylik(u)
βT0 Zl1k(u) to El[∏2j=1(1 − ∆l1j)Yl1k(u)βT0 Zl1k(u)] and Lemma 2 that the second term in
(5.18) is asymptotically equivalent to
n−1/2 L∑
l=1
nl∑
i=1(ξliα˜l − 1)
2∏
j=1(1 −∆lij)
× ∫ t
0
Ylik(u)El[∏2j=1(1 −∆l1j)Yl1k(u){λ0k(u) + βT0 Zl1k(u)}]
El[∏2j=1(1 −∆l1j)Yl1k(u)] ⋅ du∑Ll=1 qlEl[Yl1k(u)] .
Combining the above results, the first and second term on the right-hand side of (5.18)
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are asymptotically equivalent to
n−1/2 L∑
l=1
nl∑
i=1(1 − ξliα˜l )
2∏
j=1(1 −∆lij)
× ∫ t
0
Ylik(u) ⎡⎢⎢⎢⎣βT0 Zlik(u) − El[∏
2
j=1(1 −∆l1j)Yl1k(u)βT0 Zlik(u)]
El[∏2j=1(1 −∆l1j)Yl1k(u)]
⎤⎥⎥⎥⎦ ⋅ du∑Ll=1 qlEl[Yl1k(u)] .
Similarly, the third to the last term on the right-hand side of (5.18) are asymptotically
equivalent to
n−1/2 L∑
l=1
nl∑
i=1(ηli1γ˜l1 − 1)∆li1(1 −∆li2)(1 − ξli)
× ∫ t
0
1∑Ll=1 qlEl[Y11k(u)] [dMlik(u) − Ylik(u)El[dMl1k(u)∣θl10, ξli = 0]El[Yl1k(u)∣θl10] ]+ n−1/2 L∑
l=1
nl∑
i=1(ηli2γ˜l2 − 1)(1 −∆li1)∆li2(1 − ξli)
× ∫ t
0
1∑Ll=1 qlEl[Y11k(u)] [dMlik(u) − Ylik(u)El[dMl1k(u)∣θl01, ξli = 0]El[Yl1k(u)∣θl01] ]+ n−1/2 L∑
l=1
nl∑
i=1
1
2
(ηli1
γ˜l3
− 1)∆li1∆li2(1 − ξli)
× ∫ t
0
1∑Ll=1 qlEl[Yl1k(u)] [dMlik(u) − Ylik(u)El[dMl1k(u)∣θl11, ξli = 0]El[Yl1k(u)∣θl11] ]+ n−1/2 L∑
l=1
nl∑
i=1
1
2
(ηli2
γ˜l4
− 1)∆li1∆li2(1 − ξli)
× ∫ t
0
1∑Ll=1 qlEl[Yl1k(u)] [dMlik(u) − Ylik(u)El[dMl1k(u)∣θl11, ξli = 0]El[Yl1k(u)∣θl11] ] .
Note that n
1/2
l (β˜II − β0) is asymptotically equivalent to
A−1{n−1/2 L∑
l=1
nl∑
i=1
2∑
k=1Qlik(t, β0)
+ n−1/2 L∑
l=1
nl∑
i=1
2∑
k=1
2∏
j=1(1 −∆lij)(ξliα˜l − 1)∫ τ0 [Blik(t, β0) − Ylik(t)El[∏
2
j=1(1 −∆lij)Bl1k(t, β0)]
El[∏2j=1(1 −∆l1j)Yl1k(t)] ]dt)
+ n−1/2 L∑
l=1
nl∑
i=1
2∑
k=1 ∆li1(1 −∆li2)(1 − ξli)(ηli1γ˜l1 − 1)× [Qlik(t, β0) − ∫ τ
0
Ylik(t)El[dQl1k(t, β0)∣θl10, ξl1 = 1]
El[Yl1k(t)∣θl10] ]
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+ n−1/2 L∑
l=1
nl∑
i=1
2∑
k=1(1 −∆li1)∆li2(1 − ξli)(ηli2γ˜l2 − 1)× [Qlik(t, β0) − ∫ τ
0
Ylik(t)El[dQl1k(t, β0)∣θl01, ξ1 = 1]
El[Yl1k(t)∣θl01] ]
+ n−1/2 L∑
l=1
nl∑
i=1
2∑
k=1
1
2
∆li1∆li2(1 − ξli)( ηli1
γ˜l3k
− 1)
× [Qlik(t, β0) − ∫ τ
0
Ylik(t)El[dQl1k(t, β0)∣θl11, ξl1 = 1]
El[Yl1k(t)∣θl11] ]
+ n−1/2 L∑
l=1
nl∑
i=1
2∑
k=1
1
2
∆li1∆li2(1 − ξli)(ηli2
γ˜l4
− 1)
× [Qlik(t, β0) − ∫ τ
0
Ylik(t)El[dQl1k(t, β0)∣θl11, ξl1 = 1]
El[Yl1k(t)∣θl11] ]}
Combining all the results, we have
n1/2{Λ˜II0k(β˜II , t) −Λ0k(t)}
= lk(t)TA−1{n−1/2 L∑
l=1
nl∑
i=1
2∑
k=1Qlik(t, β0)
+ n−1/2 L∑
l=1
nl∑
i=1
2∑
k=1
2∏
j=1(1 −∆lij)(ξliα˜l − 1)∫ τ0 [Blik(t, β0) − Ylik(t)El[∏
2
j=1(1 −∆lij)Bl1k(t, β0)]
El[∏2j=1(1 −∆lij)Yl1k(t)] ]dt
+ n−1/2 L∑
l=1
nl∑
i=1
2∑
k=1 ∆li1(1 −∆li2)(1 − ξli)(ηli1γ˜l1 − 1)× [Qlik(t, β0) − ∫ τ
0
Ylik(t)El[dQl1k(t, β0)∣θl10, ξl1 = 1]
El[Yl1k(t)∣θl10] ]
+ n−1/2 L∑
l=1
nl∑
i=1
2∑
k=1(1 −∆li1)∆li2(1 − ξli)(ηli2γ˜l2 − 1)× [Qlik(t, β0) − ∫ τ
0
Ylik(t)El[dQl1k(t, β0)∣θl01, ξl1 = 1]
El[Yl1k(t)∣θl01] ]
+ n−1/2 L∑
l=1
nl∑
i=1
2∑
k=1
1
2
∆li1∆li2(1 − ξli)( ηli1
γ˜l3k
− 1)
× [Qlik(t, β0) − ∫ τ
0
Ylik(t)El[dQl1k(t, β0)∣θl11, ξl1 = 1]
El[Yl1k(t)∣θl11] ]
+ n−1/2 L∑
l=1
nl∑
i=1
2∑
k=1
1
2
∆li1∆li2(1 − ξli)(ηli2
γ˜l4
− 1)
× [Qlik(t, β0) − ∫ τ
0
Ylik(t)El[dQl1k(t, β0)∣θl11, ξl1 = 1]
El[Yl1k(t)∣θl11] ]}
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+ ∫ t
0
1∑Ll=1 qlEl[Yl1k(u)]d{n1/2
L∑
l=1
nl∑
i=1Mlik(u)} + n−1/2
L∑
l=1
nl∑
i=1(1 − ξliα˜l )
2∏
j=1(1 −∆lij)
× ∫ t
0
Ylik(u) ⎡⎢⎢⎢⎣βT0 Zlik(u) − El[∏
2
j=1(1 −∆l1j)Yl1k(u)βT0 Zlik(u)]
El[∏2j=1(1 −∆l1j)Yl1k(u)]
⎤⎥⎥⎥⎦ ⋅ du∑Ll=1 qlEl[Ylik(u)]
+ n−1/2 L∑
l=1
nl∑
i=1(ηli1γ˜l1 − 1)∆li1(1 −∆li2)(1 − ξli)
× ∫ t
0
1∑Ll=1 qlEl[Yl1k(u)] [dMlik(u) − Ylik(u)El[dMlik(t, β0)∣θl10, ξli = 0]El[Yl1k(u)∣θl10] ]+ n−1/2 L∑
l=1
nl∑
i=1(ηli2γ˜l2 − 1)(1 −∆li1)∆li2(1 − ξli)
× ∫ t
0
1∑Ll=1 qlEl[Yl1k(u)] [dMlik(u) − Ylik(u)El[dMlik(β0, u)∣θl01, ξli = 0]El[Yl1k(u)∣θl01] ]+ n−1/2 L∑
l=1
nl∑
i=1
1
2
( ηli1
γ˜l3k
− 1)∆li1∆li2(1 − ξli)
× ∫ t
0
1∑Ll=1 qlE[Yl1k(u)] [dMlik(u) − Ylik(u)El[dMlik(β0, u)∣θl11, ξli = 0]El[Yl1k(u)∣θ11] ]+ n−1/2 L∑
l=1
nl∑
i=1
1
2
(ηli2
γ˜l4
− 1)∆li1∆li2(1 − ξli)
× ∫ t
0
1∑Ll=1 qlEl[Yl1k(u)] [dMlik(u) − Ylik(u)El[dMlik(β0, u)∣θl11, ξli = 0]El[Yl1k(u)∣θl11] ]+ op(1)
Therefore,
n1/2{Λ˜II0k(β˜II , t) −Λ0k(t)}
= n−1/2 L∑
l=1
nl∑
i=1µlik(β0, t) + n−1/2
L∑
l=1
nl∑
i=1(1 − ξliα˜l )wlik(β0, t) + n−1/2
L∑
l=1
nl∑
i=1νlik(β0, t) + op(1),
where
µlik(β, t) = lk(t)TA−1 2∑
m=1Qlim(β) + ∫ t0 1∑Ll=1 qlEl[Yl1k(u)]dMlik(u),
wlik(β, t) = lk(t)TA−1 2∑
m=1
2∏
j=1(1 −∆lij)
× ∫ τ
0
[Blim(u,β) − Ylim(u)El[∏2j=1(1 −∆l1j)Bl1m(u,β)]
El[∏2j=1(1 −∆l1j)Yl1m(u)] ]du
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+ 2∏
j=1(1 −∆lij)∫ t0 Ylik(u){βT0 Zlik(u)
− El[∏2j=1(1 −∆l1j)Yl1k(u)βT0 Zl1k(u)]
El[∏2j=1(1 −∆l1j)Yl1k(u)] ⋅ du∑Ll=1 qlEl[Yl1k(u)]},
νlik(β, t) = lk(t)TA−1 2∑
m=1ν
(1)
lim(β, t) + ν(2)lim(β, t),
ν
(1)
lik (β, t) = ∆li1(1 −∆li2)(1 − ξli)(ηli1γ˜l1 − 1)ν(1)lik,1(β, t)+(1 −∆li1)∆li2(1 − ξli)(ηli2
γ˜l2
− 1)ν(1)lik,2(β, t),
+1
2
∆li1∆li2(1 − ξli)[(ηli1
γ˜l3
− 1) + (ηli2
γ˜l4
− 1)]ν(1)lim,3(β, t),
ν
(1)
lik,1(β, t) = Qlik(β, t) − ∫ τ
0
Ylik(t)El[dQl1k(β, t)∣θl10, ξl1 = 1]
El[Yl1k(t)∣θl10] ,
ν
(1)
lik,2(β, t) = Qik(β, t) − ∫ τ
0
Yik(t)El[dQl1k(β, t)∣θl01, ξl1 = 1]
El[Yl1k(t)∣θl01] ,
ν
(1)
lik,3(β, t) = Qlik(β, t) − ∫ τ
0
Ylik(t)El[dQl1k(β, t)∣θl11, ξl1 = 1]
El[Yl1k(t)∣θl11] ,
ν
(2)
lik (β, t) = (1 − ξli){∆li1(1 −∆li2)(ηli1γ˜1k − 1)ν(2)lik,1(β, t) + (1 −∆li1)∆li2(ηli2γ˜2k − 1)ν(2)lik,2(β, t),+1
2
∆li1∆li2{(ηli1
γ˜3k
− 1) + (ηli2
γ˜4k
− 1)}ν(2)lik,3(β, t)},
ν
(2)
lik,1(β, t) = ∫ t
0
1∑Ll=1 qlEl[Yl1k(u)][dMlik(β,u) − Ylik(u)El[dMl1k(β,u)∣θl10, ξl1 = 0]El[Yl1k(u)∣θl10] ],
ν
(2)
lik,2(β, t) = ∫ t
0
1∑Ll=1 qlEl[Yl1k(u)][dMlik(β,u) − Ylik(u)El[dMl1k(β,u)∣θl01, ξl1 = 0]El[Yl1k(u)∣θl01] ],
ν
(2)
lik,3(β, t) = ∫ t
0
1∑Ll=1 qlEl[Yl1k(u)][dMlik(β,u) − Ylik(u)El[dMl1k(β,u)∣θl11, ξl1 = 0]El[Yl1k(u)∣θl11] ]
LetG(1)(t) = {G(1)1 (t),G(1)2 (t)}T whereG(1)k (t) = n−1/2∑Ll=1∑nli=1 µlik(β, t), G(2)(t) = {G(2)1 (t),
G
(2)
2 (t)}T whereG(2)k (t) = n−1/2∑Ll=1∑nli=1(1− ξliα˜l )wlik(β, t), andG(3)(t) = {G(3)1 (t),G(3)2 (t)}T
where G
(3)
k (t) = n−1/2∑Ll=1∑nli=1 νlik(β, t) for k = 1,2.
Then, G(1)(t) converges weakly to a zero-mean Gaussian process, G(1)(t) = {G(1)1 (t),G(1)2 (t)}T
inD[0, τ]k where the covariance function between G(1)j (t) and G(1)k (s) is El[µl1j(t, β0), µl1k(s, β0)]
by theorem 2 of Yin and Cai [2004].
It can be shown that G(2)(t) converges weakly to a zero-mean Gaussian process G(2)(t) ={G(2)1 (t),G(2)2 (t)} where covariance function G(2)j (t) and G(2)k (s) is 1−αlαl El[wl1j(β0, t),wl1k(β0, s)]
by Lemma 2, Cramer-Wold device and the marginal tightness of G
(2)
k (t) for each k.
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Similarly, G(3)(t) converges weakly to a zero-mean Gaussian process where covariance
function G(3)j (t) and G(3)k (s) is
(1 − αl)[(I(j = k)[Pr[θl10](1 − γl1
γl1
)Covl[ν(2)l1k,1(β0, t), ν(2)l1k,1(β0, s)∣θl10, ξl1 = 0]
+ Pr[θl01](1 − γl2
γl2
)Covl[ν(2)l1k,2(β0, t), ν(2)l1k,2(β0, s)∣θl01, ξl1 = 0]
+ 1
4
Pr[θl11](1 − γl1
γl1
+ 1 − γl2
γl2
)Covl[ν(2)l1k,3(β0, t), ν(2)l1k,3(β0, s)∣θl11, ξl1 = 0]])
+ Pr[θl10](1 − γl1
γl1
)Covl[ν(2)l1j,1(β0, t), lk(s)TA−1ν(1)l1j,1(β0, t)∣θl10, ξl1 = 0]
+ Pr[θl01](1 − γl2
γl2
)Covl[ν(2)l1j,2(β0, t), lk(s)TA−1ν(1)l1j,2(β0, t)∣θl01, ξl1 = 0]
+ 1
4
Pr[θl11](1 − γl1
γl1
+ 1 − γl2
γl2
)Covl[ν(2)l1j,3(β0, t), lk(s)TA−1ν(1)l1j,3(β0, t)∣θl11, ξl1 = 0]
+ Pr[θl10](1 − γl1
γl1
)Covl[ν(2)l1k,1(β0, s), lj(t)TA−1ν(1)l1k,1(β0, s)∣θl10, ξl1 = 0]
+ Pr[θl01](1 − γl2
γl2
)Covl[ν(2)l1k,2(β0, s), lj(t)TA−1ν(1)l1k,2(β0, s)∣θl01, ξl1 = 0]
+ 1
4
Pr[θl11](1 − γl1
γl1
+ 1 − γl2
γl2
)Covl[ν(2)l1k,3(β0, s), lj(t)TA−1ν(1)l1k,3(β0, s)∣θl11, ξl1 = 0]
+ 2∑
m=1(Pr[θl10](1 − γl1γl1 )lj(t)TA−1Covl[ν(1)l1m,1(β0, t), ν(1)l1m,1(β0, s)∣θl10, ξl1 = 0]A−1lk(s)+ Pr[θl01](1 − γl2
γl2
)lj(t)TA−1Covl[ν(1)l1m,2(β0, t), ν(1)l1m,2(β0, s)∣θl01, ξl1 = 0]A−1lk(s)
+ Pr[θl11](1 − γl1
γl1
+ 1 − γl2
γl2
)lj(t)TA−1Covl[ν(1)l1m,3(β0, t), ν(1)l1m,3(β0, s)∣θl11, ξl1 = 0]A−1lk(s))]
By the conditional expectation arguments, all terms are mutually independent. Therefore,
G(t) = G(1)(t)+G(2)(t)+G(3)(t) converges to a zero-mean Gaussian process G(t) = G(1)(t)+G(2)(t) + G(3)(t).
5.4 Simulations
We conducted simulation studies to examine the performance of the proposed methods
and compare the existing methods with the proposed methods. Correlated bivariate failure
time data were generated from Clayton-Cuzick model [Clayton and Cuzick, 1985]. The
bivariate survival function for the bivariate survival time (T1, T2) given (Zl1, Zl2) has the
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following form:
F (t1, t2 ∣ Zl1, Zl2) = {e ∫ t10 (λ01(t)+β0Zl1)dtθ + e ∫ t20 (λ02(t)+β0Zl2)dtθ − 1}−θ,
where λ0k(t) and βk, k = 1,2 are the baseline hazard function and the effect of covariate for
disease k, respectively, l is a dichotomous stratum variable, and θ is the parameter related
with correlation between the failure times of the two diseases. Smaller θ indicates higher
correlation between the two failure times T1 and T2. The relationship between Kendall’s
tau, τθ, and θ is τθ = 12θ+1 . For θ, we used values of 0.10, 0.67, and 4 and the corresponding
Kendall’s tau values are 0.83, 0.43, and 0.11, respectively. We set the baseline hazard
function λ01 = 2 for the first failure event type k = 1 and λ02 = 4 for the second failure event
type k = 2. The regression parameters are examined at β0 = 0 and 0.3.
We generate Z from Bernouilli distribution with pr(Z = 1) = 0.5 under the situation
Zl1 = Zl2 = Z. To consider stratified subcohort sampling from two strata defined by Vi, we
define two parameters: η =Pr(V = 1∣Z = 1) and ν =Pr(V = 0∣Z = 0) where η is sensitivity
and ν is the specificity for Z. Unstratified sampling with same probability, i.e., η = 0.5 and
ν = 0.5 is a special case. Larger values η and ν values than 0.5 indicate that V is highly
correlated with Z. For stratified case-cohort studies, we set the values [η, ν] = [0.7,0.7].
Thus, a stratum variable is simulated with Pr(V = 1) = (1− ν)Pr(Z = 0)+ ηPr(Z = 1) = 0.5.
Censoring times are generated from uniform distribution [0, u] where u depends on the
specified level of the censoring probability.
For simulations of the traditional case-cohort study, we set the event proportions of
approximately 8% and 20% for k = 1 and 14% and 35% for k = 2. For the simulations of
the generalized case-cohort study, the event proportions are considered as 15% and 25% for
k = 1 and 26% and 42% for k = 2 and we sample half of the cases outsides the subcohort,[γ1, γ2] = [0.5,0.5]. The sample size of the full cohort is set to be n = 1000. For stratified
sampling, we consider the total subcohort size of 100 and 200 and select the subcohort
n˜l = n˜ × ql from each stratum. For each configuration, we conducted 2000 simulations.
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Table 5.1: Simulation result for the traditional case-cohort study: K = 1, β1 = 0
Event The Proposed weight Kulich and Lin’s method
S PR n˜ τθ β˜
I
1 SEp SDp CRp βˆ
A
1 SEk SDk CRk SRE SREp SREk
UN 8% 100 0⋅10 0⋅001 0⋅622 0⋅621 0⋅96 0⋅000 0⋅643 0⋅633 0⋅96 1⋅05 1⋅00 1⋅00
0⋅67 -0⋅005 0⋅610 0⋅623 0⋅95 -0⋅002 0⋅639 0⋅652 0⋅95 1⋅10 1⋅00 1⋅00
4 0⋅012 0⋅613 0⋅649 0⋅95 0⋅014 0⋅644 0⋅677 0⋅95 1⋅09 1⋅00 1⋅00
200 0⋅10 -0⋅005 0⋅527 0⋅536 0⋅95 -0⋅006 0⋅537 0⋅543 0⋅95 1⋅02 1⋅00 1⋅00
0⋅67 0⋅007 0⋅525 0⋅532 0⋅94 0⋅013 0⋅539 0⋅546 0⋅94 1⋅05 1⋅00 1⋅00
4 -0⋅002 0⋅523 0⋅523 0⋅95 0⋅004 0⋅538 0⋅542 0⋅95 1⋅07 1⋅00 1⋅00
20% 100 0⋅10 -0⋅001 0⋅485 0⋅505 0⋅95 -0⋅005 0⋅525 0⋅548 0⋅95 1⋅18 1⋅00 1⋅00
0⋅67 0⋅022 0⋅466 0⋅488 0⋅94 0⋅032 0⋅525 0⋅539 0⋅96 1⋅22 1⋅00 1⋅00
4 0⋅002 0⋅453 0⋅477 0⋅94 0⋅010 0⋅525 0⋅551 0⋅95 1⋅33 1⋅00 1⋅00
200 0⋅10 0⋅008 0⋅385 0⋅395 0⋅95 0⋅007 0⋅406 0⋅412 0⋅95 1⋅09 1⋅00 1⋅00
0⋅67 0⋅001 0⋅374 0⋅375 0⋅95 0⋅000 0⋅406 0⋅402 0⋅96 1⋅15 1⋅00 1⋅00
4 -0⋅007 0⋅367 0⋅375 0⋅95 -0⋅012 0⋅405 0⋅412 0⋅95 1⋅20 1⋅00 1⋅00
STR 8% 100 0⋅10 0⋅006 0⋅601 0⋅621 0⋅95 0⋅003 0⋅618 0⋅631 0⋅95 1⋅03 1⋅00 1⋅01
0⋅67 0⋅001 0⋅593 0⋅594 0⋅96 -0⋅002 0⋅617 0⋅620 0⋅96 1⋅09 1⋅10 1⋅10
4 -0⋅001 0⋅596 0⋅600 0⋅96 -0⋅003 0⋅621 0⋅626 0⋅96 1⋅09 1⋅17 1⋅17
200 0⋅10 -0⋅005 0⋅520 0⋅522 0⋅95 -0⋅004 0⋅528 0⋅528 0⋅95 1⋅02 1⋅05 1⋅06
0⋅67 0⋅021 0⋅515 0⋅521 0⋅95 0⋅021 0⋅526 0⋅534 0⋅95 1⋅05 1⋅04 1⋅05
4 -0⋅008 0⋅514 0⋅517 0⋅95 -0⋅006 0⋅526 0⋅529 0⋅95 1⋅05 1⋅02 1⋅05
20% 100 0⋅10 -0⋅007 0⋅470 0⋅480 0⋅95 -0⋅007 0⋅502 0⋅512 0⋅96 1⋅14 1⋅11 1⋅15
0⋅67 0⋅004 0⋅454 0⋅460 0⋅95 -0⋅004 0⋅503 0⋅507 0⋅96 1⋅21 1⋅12 1⋅13
4 -0⋅015 0⋅442 0⋅456 0⋅94 -0⋅009 0⋅503 0⋅509 0⋅96 1⋅25 1⋅09 1⋅17
200 0⋅10 -0⋅005 0⋅377 0⋅383 0⋅95 -0⋅004 0⋅394 0⋅405 0⋅94 1⋅12 1⋅06 1⋅03
0⋅67 -0⋅005 0⋅367 0⋅357 0⋅96 -0⋅005 0⋅393 0⋅377 0⋅97 1⋅12 1⋅10 1⋅14
4 -0⋅006 0⋅361 0⋅370 0⋅95 -0⋅005 0⋅392 0⋅403 0⋅95 1⋅19 1⋅03 1⋅04
S, sampling; PR, proportion; UN, unstratified sampling; STR, stratified sampling; SE, the average
of the estimates of standard error; SD, sample standard deviation; CR, the coverage rate of the
nominal 95% confidence intervals; SRE = SD2k/SD2p, sample relative efficiency; SREp, sample
relative efficiency of proposed estimators with unstratified sampling relative to stratified sampling;
SREk, sample relative efficiency of Kulich and Lin’s estimators with unstratified sampling relative
to stratified sampling.
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Table 5.2: Simulation result for the generalized case-cohort study: K = 1, β1 = 0
Event The Proposed weight The existing method
S PR n˜ τθ β˜
I
G1 SEp SDp CRp βˆ
G
1 SEk SDk CRk SRE SREp SREk
UN 15% 100 0⋅10 -0⋅051 1⋅065 1⋅075 0⋅96 -0⋅047 1⋅085 1⋅104 0⋅95 1⋅06 1⋅00 1⋅00
0⋅67 0⋅000 1⋅040 1⋅047 0⋅95 -0⋅003 1⋅083 1⋅101 0⋅95 1⋅10 1⋅00 1⋅00
4 -0⋅004 1⋅030 1⋅052 0⋅95 -0⋅012 1⋅089 1⋅109 0⋅96 1⋅11 1⋅00 1⋅00
200 0⋅10 0⋅003 0⋅822 0⋅804 0⋅96 0⋅016 0⋅842 0⋅839 0⋅96 1⋅09 1⋅00 1⋅00
0⋅67 -0⋅021 0⋅815 0⋅823 0⋅95 -0⋅019 0⋅841 0⋅850 0⋅96 1⋅07 1⋅00 1⋅00
4 -0⋅003 0⋅810 0⋅803 0⋅96 0⋅002 0⋅842 0⋅840 0⋅95 1⋅09 1⋅00 1⋅00
25% 100 0⋅10 -0⋅004 0⋅953 0⋅990 0⋅94 0⋅003 0⋅969 1⋅008 0⋅94 1⋅04 1⋅00 1⋅00
0⋅67 -0⋅020 0⋅926 0⋅964 0⋅95 -0⋅010 0⋅971 1⋅014 0⋅95 1⋅11 1⋅00 1⋅00
4 0⋅005 0⋅888 0⋅919 0⋅95 0⋅002 0⋅973 0⋅998 0⋅95 1⋅18 1⋅00 1⋅00
200 0⋅10 0⋅001 0⋅714 0⋅707 0⋅96 -0⋅005 0⋅729 0⋅725 0⋅96 1⋅05 1⋅00 1⋅00
0⋅67 -0⋅008 0⋅703 0⋅729 0⋅95 -0⋅009 0⋅730 0⋅763 0⋅95 1⋅10 1⋅00 1⋅00
4 0⋅003 0⋅684 0⋅704 0⋅95 0⋅004 0⋅728 0⋅736 0⋅95 1⋅09 1⋅00 1⋅00
STR 15% 100 0⋅10 0⋅007 1⋅040 1⋅029 0⋅96 0⋅008 1⋅057 1⋅050 0⋅96 1⋅04 1⋅09 1⋅11
0⋅67 0⋅025 1⋅019 1⋅008 0⋅96 0⋅011 1⋅056 1⋅042 0⋅96 1⋅07 1⋅08 1⋅11
4 -0⋅022 1⋅006 0⋅992 0⋅96 -0⋅022 1⋅056 1⋅045 0⋅96 1⋅11 1⋅12 1⋅13
200 0⋅10 -0⋅014 0⋅808 0⋅803 0⋅96 -0⋅015 0⋅825 0⋅822 0⋅95 1⋅05 1⋅00 1⋅04
0⋅67 0⋅005 0⋅806 0⋅798 0⋅96 0⋅005 0⋅828 0⋅831 0⋅95 1⋅09 1⋅06 1⋅05
4 -0⋅002 0⋅800 0⋅795 0⋅95 0⋅004 0⋅827 0⋅830 0⋅95 1⋅09 1⋅02 1⋅02
25% 100 0⋅10 0⋅000 0⋅938 0⋅919 0⋅96 -0⋅003 0⋅954 0⋅937 0⋅96 1⋅04 1⋅16 1⋅16
0⋅67 0⋅038 0⋅913 0⋅899 0⋅95 0⋅033 0⋅954 0⋅951 0⋅95 1⋅12 1⋅15 1⋅14
4 0⋅000 0⋅875 0⋅831 0⋅96 0⋅000 0⋅949 0⋅922 0⋅96 1⋅23 1⋅22 1⋅17
200 0⋅10 0⋅017 0⋅705 0⋅678 0⋅96 0⋅019 0⋅720 0⋅695 0⋅96 1⋅05 1⋅09 1⋅09
0⋅67 -0⋅018 0⋅695 0⋅682 0⋅96 -0⋅017 0⋅720 0⋅711 0⋅95 1⋅09 1⋅14 1⋅15
4 0⋅002 0⋅679 0⋅665 0⋅96 0⋅002 0⋅719 0⋅705 0⋅96 1⋅13 1⋅12 1⋅09
S, sampling; PR, proportion; UN, unstratified sampling; STR, stratified sampling; SE, the average
of the estimates of standard error; SD, sample standard deviation; CR, the coverage rate of the
nominal 95% confidence intervals; SRE = SD2k/SD2p, sample relative efficiency; SREp, sample
relative efficiency of proposed estimators with unstratified sampling relative to stratified sampling;
SREk, sample relative efficiency of the existing estimators with unstratified sampling relative to
stratified sampling.
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Table 5.3: Simulation result for the traditional case-cohort study: K = 2, β0 = 0.3
Event The Proposed weight Kang & Cai’s method
S PR n˜ τθ β˜
II SEp SDp CRp βˆ
A SEk SDk CRk SRE SREp SREk
UN [8%,14%] 100 0⋅10 0⋅320 0⋅803 0⋅829 0⋅95 0⋅317 0⋅815 0⋅835 0⋅96 1⋅02 1⋅00 1⋅00
0⋅67 0⋅280 0⋅757 0⋅781 0⋅96 0⋅283 0⋅777 0⋅793 0⋅96 1⋅03 1⋅00 1⋅00
4 0⋅301 0⋅740 0⋅765 0⋅95 0⋅297 0⋅764 0⋅784 0⋅95 1⋅05 1⋅00 1⋅00
200 0⋅10 0⋅311 0⋅647 0⋅653 0⋅95 0⋅311 0⋅654 0⋅655 0⋅95 1⋅01 1⋅00 1⋅00
0⋅67 0⋅323 0⋅599 0⋅603 0⋅95 0⋅322 0⋅610 0⋅610 0⋅95 1⋅02 1⋅00 1⋅00
4 0⋅298 0⋅580 0⋅595 0⋅95 0⋅298 0⋅593 0⋅603 0⋅95 1⋅03 1⋅00 1⋅00[20%,35%] 100 0⋅10 0⋅292 0⋅680 0⋅700 0⋅95 0⋅295 0⋅694 0⋅714 0⋅95 1⋅04 1⋅00 1⋅00
0⋅67 0⋅300 0⋅632 0⋅645 0⋅95 0⋅297 0⋅663 0⋅665 0⋅95 1⋅06 1⋅00 1⋅00
4 0⋅323 0⋅596 0⋅610 0⋅94 0⋅319 0⋅643 0⋅645 0⋅95 1⋅12 1⋅00 1⋅00
200 0⋅10 0⋅307 0⋅514 0⋅533 0⋅94 0⋅309 0⋅521 0⋅538 0⋅94 1⋅02 1⋅00 1⋅00
0⋅67 0⋅309 0⋅476 0⋅498 0⋅95 0⋅309 0⋅493 0⋅513 0⋅94 1⋅06 1⋅00 1⋅00
4 0⋅311 0⋅445 0⋅462 0⋅94 0⋅316 0⋅472 0⋅488 0⋅94 1⋅12 1⋅00 1⋅00
STR [8%,14%] 100 0⋅10 0⋅286 0⋅772 0⋅797 0⋅95 0⋅285 0⋅781 0⋅802 0⋅95 1⋅02 1⋅08 1⋅08
0⋅67 0⋅325 0⋅724 0⋅749 0⋅95 0⋅327 0⋅738 0⋅759 0⋅95 1⋅03 1⋅09 1⋅09
4 0⋅302 0⋅706 0⋅710 0⋅96 0⋅300 0⋅723 0⋅720 0⋅96 1⋅03 1⋅16 1⋅19
200 0⋅10 0⋅292 0⋅628 0⋅637 0⋅95 0⋅292 0⋅632 0⋅640 0⋅95 1⋅01 1⋅05 1⋅05
0⋅67 0⋅302 0⋅580 0⋅578 0⋅95 0⋅301 0⋅587 0⋅583 0⋅95 1⋅01 1⋅09 1⋅09
4 0⋅282 0⋅562 0⋅569 0⋅95 0⋅281 0⋅570 0⋅580 0⋅95 1⋅04 1⋅09 1⋅08[20%,35%] 100 0⋅10 0⋅324 0⋅655 0⋅650 0⋅96 0⋅325 0⋅664 0⋅663 0⋅96 1⋅04 1⋅16 1⋅16
0⋅67 0⋅302 0⋅610 0⋅601 0⋅95 0⋅304 0⋅632 0⋅629 0⋅95 1⋅10 1⋅15 1⋅12
4 0⋅292 0⋅576 0⋅598 0⋅94 0⋅289 0⋅611 0⋅637 0⋅95 1⋅13 1⋅04 1⋅03
200 0⋅10 0⋅315 0⋅497 0⋅490 0⋅95 0⋅317 0⋅502 0⋅496 0⋅96 1⋅02 1⋅18 1⋅17
0⋅67 0⋅310 0⋅460 0⋅458 0⋅95 0⋅311 0⋅472 0⋅478 0⋅95 1⋅09 1⋅19 1⋅15
4 0⋅301 0⋅431 0⋅445 0⋅95 0⋅300 0⋅450 0⋅469 0⋅94 1⋅11 1⋅08 1⋅09
S, sampling; PR, proportion; UN, unstratified sampling; STR, stratified sampling; SE, the average
of the estimates of standard error; SD, sample standard deviation; CR, the coverage rate of the
nominal 95% confidence intervals; SRE = SD2k/SD2p, sample relative efficiency; SREp, sample
relative efficiency of proposed estimators with unstratified sampling relative to stratified sampling;
SREk, sample relative efficiency of the existing estimators with unstratified sampling relative to
stratified sampling.
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We first considered traditional case-cohort sample with a single disease but with co-
variates available on subjects with other diseases. We examine the the performance of our
proposed estimator and compare our results with those with the time-varying weight [Kulich
and Lin, 2000a]. Moreover, we compare the results of unstratified sampling with stratified
sampling using the proposed and Kulich and Lin [2000a] estimators, respectively. Table
5.1 reports the summary of β˜I1 and βˆ
A
1 . For different combinations of β, event proportion,
subcohort sample size, and correlation, Table 5.1 shows the average of the estimates β˜I1 , the
average of the proposed estimated standard error (SE), empirical standard deviation (SD),
sample relative efficiency of the proposed estimators relative to estimators of Kulich and Lin
[2000a] (SRE), sample relative efficiency of proposed estimators with unstratified sampling
relative to with stratified sampling (SREp), and sample relative efficiency of estimators
of Kulich and Lin [2000a] with unstratified sampling relative to with stratified sampling
(SREk). The subscripts for SE, SD, SRE refer to the proposed method (P) and the existing
traditional case-cohort analysis for additive hazards models, Kulich and Lin [2000a] (K).
The simulation results suggest that both methods are approximately unbiased across the
setup for β = 0.3 with both event proportions (8% and 20%) and correlations (0.10, 0.67,
and 4). The average of the proposed estimated standard error is close to the empirical
standard deviation and it is smaller with lower correlation, larger event proportions or sub-
cohort size, as expected. The 95% confidence interval coverage rate ranges between 94%
and 97%. All the sample relative efficiency (SRE), defined as SD2k/SD2p, are larger than 1
which indicates that the proposed estimates are more efficient than those from Kulich and
Lin [2000a]. This shows that the extra information collected on subjects with the other
disease helps to gain efficiency. In general, the efficiency is larger in situations with larger
event proportion, smaller subcohort size, and smaller correlation. Also, SREp and SREk
for stratified sampling are more than 1 suggesting that stratified sampling is more efficient
than unstratified sampling. However, when the disease rate is low and the subcohort size
is larger, the proposed method does not improve much efficiency.
In the second set of simulation, we are interested in the non-rare event and we sample half
of the cases outside the subcohort. We examine the performance of our proposed estimator
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Table 5.4: Simulation result for the generalized case-cohort study: K = 2, β0 = 0.3
Event The Proposed weight The existing method
S PR n˜ τθ β˜
II
G SEp SDp CRp βˆ
A SEk SDk CRk SRE SREp SREk
UN [15%,26%] 100 0⋅10 0⋅303 0⋅760 0⋅760 0⋅96 0⋅308 0⋅781 0⋅773 0⋅96 1⋅04 1⋅00 1⋅00
0⋅67 0⋅307 0⋅720 0⋅716 0⋅96 0⋅311 0⋅751 0⋅749 0⋅96 1⋅09 1⋅00 1⋅00
4 0⋅314 0⋅697 0⋅711 0⋅95 0⋅325 0⋅736 0⋅764 0⋅95 1⋅16 1⋅00 1⋅00
200 0⋅10 0⋅297 0⋅591 0⋅607 0⋅95 0⋅301 0⋅609 0⋅622 0⋅95 1⋅05 1⋅00 1⋅00
0⋅67 0⋅296 0⋅559 0⋅544 0⋅95 0⋅298 0⋅579 0⋅569 0⋅96 1⋅10 1⋅00 1⋅00
4 0⋅315 0⋅542 0⋅526 0⋅96 0⋅317 0⋅564 0⋅564 0⋅95 1⋅15 1⋅00 1⋅00[25%,42%] 100 0⋅10 0⋅293 0⋅677 0⋅692 0⋅95 0⋅292 0⋅697 0⋅708 0⋅95 1⋅05 1⋅00 1⋅00
0⋅67 0⋅301 0⋅632 0⋅643 0⋅95 0⋅299 0⋅668 0⋅682 0⋅95 1⋅12 1⋅00 1⋅00
4 0⋅302 0⋅592 0⋅587 0⋅95 0⋅313 0⋅646 0⋅654 0⋅95 1⋅24 1⋅00 1⋅00
200 0⋅10 0⋅304 0⋅512 0⋅521 0⋅95 0⋅302 0⋅527 0⋅527 0⋅96 1⋅02 1⋅00 1⋅00
0⋅67 0⋅285 0⋅481 0⋅488 0⋅95 0⋅292 0⋅502 0⋅512 0⋅95 1⋅10 1⋅00 1⋅00
4 0⋅307 0⋅451 0⋅440 0⋅96 0⋅308 0⋅480 0⋅480 0⋅95 1⋅19 1⋅00 1⋅00
STR [15%,26%] 100 0⋅10 0⋅304 0⋅737 0⋅731 0⋅96 0⋅306 0⋅754 0⋅748 0⋅96 1⋅05 1⋅08 1⋅07
0⋅67 0⋅312 0⋅698 0⋅659 0⋅96 0⋅310 0⋅720 0⋅693 0⋅96 1⋅10 1⋅18 1⋅17
4 0⋅315 0⋅678 0⋅662 0⋅97 0⋅319 0⋅706 0⋅708 0⋅96 1⋅14 1⋅15 1⋅17
200 0⋅10 0⋅278 0⋅579 0⋅582 0⋅95 0⋅281 0⋅593 0⋅596 0⋅95 1⋅05 1⋅09 1⋅09
0⋅67 0⋅295 0⋅549 0⋅539 0⋅96 0⋅299 0⋅563 0⋅559 0⋅95 1⋅08 1⋅02 1⋅04
4 0⋅310 0⋅530 0⋅523 0⋅95 0⋅314 0⋅545 0⋅556 0⋅94 1⋅13 1⋅01 1⋅03[25%,42%] 100 0⋅10 0⋅288 0⋅656 0⋅650 0⋅96 0⋅295 0⋅671 0⋅664 0⋅96 1⋅04 1⋅13 1⋅14
0⋅67 0⋅285 0⋅620 0⋅602 0⋅95 0⋅286 0⋅646 0⋅634 0⋅96 1⋅11 1⋅14 1⋅16
4 0⋅295 0⋅583 0⋅569 0⋅95 0⋅299 0⋅623 0⋅617 0⋅96 1⋅18 1⋅06 1⋅13
200 0⋅10 0⋅304 0⋅501 0⋅494 0⋅95 0⋅303 0⋅513 0⋅507 0⋅96 1⋅05 1⋅11 1⋅08
0⋅67 0⋅293 0⋅473 0⋅450 0⋅96 0⋅296 0⋅489 0⋅474 0⋅96 1⋅11 1⋅18 1⋅17
4 0⋅295 0⋅445 0⋅434 0⋅96 0⋅301 0⋅466 0⋅466 0⋅95 1⋅15 1⋅03 1⋅06
S, sampling; PR, proportion; UN, unstratified sampling; STR, stratified sampling; SE, the average
of the estimates of standard error; SD, sample standard deviation; CR, the coverage rate of the
nominal 95% confidence intervals; SRE = SD2k/SD2p, sample relative efficiency; SREp, sample
relative efficiency of proposed estimators with unstratified sampling relative to stratified sampling;
SREk, sample relative efficiency of the existing estimators with unstratified sampling relative to
stratified sampling.
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and compare it to the existing method with a single disease outcome in the generalized
case-cohort study. Table 5.2 summarizes the results. Overall performance are similar to
Table 5.1: the unbiased estimates for β1, estimated standard errors close to the empirical
standard deviations, the 95% confidence interval coverage rate close to the nominal level.
All the sample relative efficiency (SRE) are more than 1 which implies that our proposed
method is more efficient than that of Kang et al. [2012]. Moreover, all the sample relative
efficiency of stratified sampling with unstratified sampling (SREp and SREk) are more than
1 which suggest that stratified sampling is more efficient than unstratified sampling.
In the third set of simulation, we consider the joint modeling of the two diseases for
case-cohort sample with the rare event. We examine the performance of our proposed
estimator and compare it to the existing method with multiple disease outcome. Table 5.3
provides summary statistics for β˜II and βˆA. We found that biases in the coefficient estimates
are small; estimated standard errors close to the empirical standard deviations; the 95%
confidence interval coverage rate ranges in 94% and 96%. All the sample relative efficiency
(SRE) with more than 1 indicates that our proposed method is more efficient than that
of the existing method. For stratified sampling design, all the sample relative efficiency of
both proposed and exiting estimators are more than 1. This shows that stratified sampling
for the subcohort improve the efficiency for the traditional case-cohort study with multiple
outcomes.
Table 5.4 summarizes the simulation results for the joint modeling of two non-rare
diseases. We used the selection probability of cases with 0.5 for each disease. Overall, the
performance is similar to Table 5.3. For the proposed estimator, sample relative efficiency
gain of stratified sampling relative to unstratified sampling ranges in 1% to 18%. For the
existing estimator, it ranges in 3% to 17%. They imply that estimators with stratified
sampling are more efficient than those with unstratified sampling.
5.5 Data Analysis
We applied the proposed method to data from the Atherosclerosis Risk in Communities
(ARIC) study [Lee et al., 2008]. This study is a longitudinal and population-based cohort
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study consisting of 15,792 men and women aged from 45 to 64 years recruited from four
US communities. For this analysis, the follow up for incident coronary heart disease (CHD)
event and incident stroke event is through 1998. Incident CHD event is defined as defi-
nite or probable myocardial infarction, electrocardiographic evidence of silent myocardial
infarction, definite CHD death, or coronary revascularization procedure. Incident stroke
was defined as a definite or probable ischemic stroke. We regarded the subject as censored
if he or she was free of that event type by December 31, 1998 or lost to follow-up during
the study.
The primary aim of this study was to investigate the association between PTGS1 poly-
morphisms and risk of incident CHD and stroke. Cyclooxygenase-derived prostaglandins
can be significant modifiers of risk of cardiovascular diseases event. It has been suggested
that variation in the genes encoding cyclooxygenase-derived prostaglandins (PTGS1) play
an important role of cardiovascular disease risk [Antman et al., 2005; Camitta et al., 2001;
Ulrich et al., 2002].
Using case-cohort design, genomic DNA genotyped for the polymorphisms in PTGS1
were available on all incident CHD, ischemic stroke cases, and the subcohort. The subcohort
was selected by using stratified sampling design with three stratum variables: age (≥ 55 or< 55 years), gender, and race (Caucasian or African American). After excluding subjects
with missing genotype data and covaroates, a full cohort consisted of a total of 13,731
subjects which includes 900 subjects with only CHD, 188 subjects with only stroke, 61
subjects with both CHD and stroke. The subcohort involved 850 disease-free subjects, 72
subjects with only CHD, 15 subject with only stroke, and 7 subjects with both CHD and
stoke. The total size of assayed samples was 1,999. To adjust for confounding and other
risk factors, traditional and clinical covariates related to cardiovascular diseases are used:
age, gender, race, study center, current smoking status, diabetes, and hypertension.
In order to study the effects of genetic variation (PTGS1) on CHD as well as stroke,
we fit the model using (5.1). Since all cases for CHD and stoke are selected and we are
interested in comparing the risk effects on CHD and on stroke, we conduct the joint analysis
for traditional stratified case-cohort design.
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Table 5.5: Analysis results for the effects of PTGS1 G/A+A/A versus G/G (×10−6)
Proposed method Kang & Cai’s method
Variable β˜II SE P-value β˜ SE P-value
CHD PTGS1 2.52 2.94 0.196 2.47 2.94 0.201
African -10.95 6.68 0.051 -10.44 6.80 0.063
Age 0.69 0.18 < 0.001 0.69 0.18 < 0.001
Male 20.03 2.15 < 0.001 19.85 2.16 < 0.001
Center(F) -1.38 3.36 0.341 -1.61 3.37 0.317
Center(J) -1.94 7.29 0.395 -2.64 7.42 0.361
Center(M) -9.05 3.03 < 0.001 -9.00 3.05 < 0.001
Current smoking 12.93 2.61 < 0.001 12.89 2.63 < 0.001
Diabetes 22.67 5.32 < 0.001 23.27 5.46 < 0.001
Hypertension 15.43 2.75 < 0.001 15.55 2.78 < 0.001
Storke PTGS1 2.76 1.46 0.029 2.97 1.52 0.025
African 1.37 3.42 0.344 1.54 3.36 0.324
Age 0.33 0.07 < 0.001 0.34 0.07 < 0.001
Male 2.42 0.79 < 0.001 2.33 0.81 < 0.001
Center(F) -0.42 1.08 0.350 -0.48 1.14 0.337
Center(J) 0.59 3.70 0.437 0.24 3.68 0.474
Center(M) -0.48 0.96 0.310 -0.79 0.98 0.211
Current smoking 3.94 1.05 < 0.001 4.26 1.09 < 0.001
Diabetes 9.32 2.30 < 0.001 8.43 2.24 < 0.001
Hypertension 6.01 1.10 < 0.001 5.90 1.13 < 0.001
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Table 5.5 represents the results of additive hazards regression parameters estimates for
PTGS1 G/A+A/A versus G/G, estimated standard errors (SE), and P-values. We fit the
model allowing for different effects for CHD and stoke. The effects of PTGS1 on both CHD
and stroke are not statistically significant with P-value of 0.196 and 0.201, respectively. We
also fit the same model using Kang et al. [2012]’s method. Except for the standard errors
of African, Center (J) and diabetes on stroke, all the standard errors for the proposed
estimator are slightly smaller than those for the estimator of Kang et al. [2012].
5.6 Concluding remarks
By using the new weight function, we have proposed more efficient estimators for the
additive hazards model in stratified case-cohort design with rare and non-rare diseases. The
new weight functions incorporate the extra information for subjects with other diseases,
which can help to increase efficiency relative to existing methods. Moreover, stratified
sampling for the subcohort also improved the efficiency relative to unstratified sampling.
However, under the situation that the disease rate is low, the proposed method did not
improve much efficiency due to small amount of extra information.
In many biomedical and clinical studies, multiple case-cohort studies have been con-
ducted separately. Under the situation, covariate information collected on subjects with
the other diseases can be obtained and stratum variables are often available on all the co-
hort members. By using available information for subjects with other diseases and stratum
variables, we are able to estimate the risk effects more efficiently in additive hazards model
for case-cohort studies.
It would be worthwhile to consider models with different association between failure time
and risk factors. Therefore, we can adapt our approaches to other types of models such
as proportional odds model, the accelerated failure time model, and the semiparametric
transformation model by using all available information including stratum variables and
covariate information for other diseases. They are expected to improve efficiency.
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Chapter 6
Summary and Future Research
In this dissertation, we have studied more efficient statistical methods for case-cohort
studies with univariate and multivariate failure times. Specially, the following topics are
considered: 1) more efficient estimators for the traditional case-cohort study 2) stratified
case-cohort study with nonrare diseases, and 3) more efficient estimation in additive hazards
models for stratified case-cohort studies.
Case-cohort study design is generally used to reduce cost in large cohort studies. When
several diseases are of interest, several case-cohort studies are usually conducted using the
same subcohort. When these case-cohort data are analyzed, the common practice is to an-
alyze each disease separately ignoring data collected in subjects with the other diseases. In
addition, many baseline covariates are often available for the full cohort. Hence, the main
contribution of this dissertation is to provide statistical methods for case-cohort studies
which use all available information. We proposed new weights for both rare and nonrare
diseases. We developed weighted estimating equations with new weight functions for pa-
rameter estimation and studied the cumulative baseline hazard functions.
In Chapter 2.3.3, we considered case-cohort studies with rare diseases. In Chapter 3.6,
stratified case-cohort studies with nonrare diseases were considered. In Chapter 4.6, we
considered additive hazards models for stratified case-cohort studies.
The asymptotic properties of the proposed estimators were shown to be consistent and
asymptotically normally distributed under some regularity conditions. We investigated the
finite sample properties of the proposed methods and compared those with the existing
methods. The simulation results show that our proposed methods worked properly and
were more efficient than the existing methods. We applied our proposed methods to data
from the Busselton Health Study and the Atherosclerosis Risk in Communities study.
There are many directions that can be pursued in my future research.
First, I would like to extend the current methodology to competing risks. In the compet-
ing risks situation, a subject can only experience at most one event, while in the situation
we considered a subject can still experience the other events after experiencing one event.
Consequently, in the competing risks situation, a subject is at risk for all types of events
simultaneously and will not be at risk for any other events as soon as one event occurs.
I will adapt the approach in my dissertation to competing risks by modifying the at-risk
process and the weight function.
The second topic is to consider the joint modeling of survival time and longitudinal
covariates via shared random effects in case-cohort studies. Our current approaches can
allow the time-dependent covariates only when there are no missing data in covariates.
However, in many follow-up studies, the entire time-dependent covariate history is not
always available. I would like to investigate the joint modeling approach to address the
missing covariate data problem.
Last, I would like to apply our proposed approaches to case-cohort studies with models
including proportional odds model, the accelerated failure time model, and the semiparamet-
ric transformation model. In some data, the proportional or additive hazards assumption
may not always be true. Therefore, it is worthwhile to consider modeling association from
different aspects.
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